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The	course	of	anorexia	nervosa	(AN)	 is	protracted	and	 it	 remains	a	serious	 illness	with	the	highest	




nervosa.	Chapter	2	systematically	 reviews	studies	examining	the	 impact	of	experimentally	 induced	
negative	 and	 positive	 mood	 on	 eating	 behaviour	 across	 eating	 and	 weight	 disorders.	 The	 meta-
analyses	demonstrated	 that	negative	mood	has	an	 impact	on	eating	behaviour	particularly	among	





examine	 its	 effect	 on	 threat-related	 processing	 and	 social-emotional	 difficulties.	 The	 findings	
demonstrated	 that	although	 intranasal	oxytocin	may	modulate	 some	aspects	of	 threat	processing,	
such	as	cortisol	 response	and	attentional	bias	among	people	with	AN,	 it	has	 little	effect	on	social-
emotional	processing.	Taken	together,	the	findings	indicate	that	there	is	currently	little	evidence	to	
support	 the	 use	 of	 intranasal	 oxytocin	 in	 the	 treatment	 of	 AN	 or	 other	 psychiatric	 disorders.	
Interestingly,	 these	 findings	also	suggest	 that	subjective	mood	can	have	a	strong	 impact	on	eating	
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pre-processing	 and	 subject	 level	 analysis	 of	 the	 neuroimaging	 data	 were	 conducted	 by	 Dr	 Owen	
















Wee	 Ng.	 The	 candidate	 conducted	 the	 meta-analyses	 and	 Dr	 John	 Hodsoll	 provided	 statistical	
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C	 Disturbances	 in	 perception	 of	 body	 shape	 and	 weight,	 strong	




















































GRADE	 evidence	 for	 the	 use	 of	 psychological	 and	 psychopharmacological	 interventions	 in	 the	
treatment	of	adults	with	AN.	Furthermore,	there	is	a	substantial	lack	of	well	conducted	randomised	






2017).	 The	 NICE	 guidelines	 recommend	 psychological	 therapies,	 including	 cognitive	 behavioural	
therapy	 (CBT-ED),	 Maudsley	 Anorexia	 Nervosa	 Treatment	 for	 Adults	 (MANTRA),	 and	 specialist	
supportive	 clinical	 management	 (SSCM),	 to	 be	 considered	 in	 the	 treatment	 of	 AN	 (NICE,	 2017).	
However,	the	evidence	base	for	these	interventions	is	still	small.	Although,	recent	small	RCTs	suggest	
that	 CBT-ED	 may	 be	 helpful	 in	 targeting	 key	 eating	 disorder	 cognitions	 and	 increase	 BMI	 in	 AN	
(Fairburn	 et	 al.,	 2013;	 Fairburn	 et	 al.,	 2015),	 replication	 of	 these	 findings	 in	 larger	 trials	 remains	
necessary	before	firm	recommendations	can	be	made.	Only	two	RCTs	investigating	the	effectiveness	
of	MANTRA	 have	 thus	 far	 been	 conducted	 and	 both	 trials	 indicate	 that	 the	 intervention	may	 be	
effective	 in	 increasing	BMI	and	 reducing	 core	eating	disorder	psychopathology,	but	 improvements	
were	not	significantly	greater	than	those	seen	in	patients	in	the	control	condition	(Schmidt	et	al.,	2012;	
Schmidt	et	al.,	2015).	Finally,	there	is	some	emerging	evidence	that	SSCM	may	be	helpful	in	targeting	








first	 line	 treatments	 in	 AN,	 but	 should	 be	 considered	 to	 compliment	 psychological	 therapy	 (NICE,	













There	 are	 currently	 no	 gold	 standard	 treatments	 for	 AN	 (NICE,	 2017).	 The	 importance	 of	 further	
research	into	the	causal	and	maintaining	mechanisms	in	eating	disorders	as	well	as	the	mechanisms	
that	could	support	change	has	been	highlighted	(Jansen,	2001,	2016).	These	findings	could	be	used	to	




























The	negative	 valence	 systems	 are	primarily	
involved	 in	 supporting	 functions	 such	 as	
threat	processing,	aversive	emotional	states,	
and	 anxiety	 and	 stress	 responses.	 These	
systems	 are	 involved	 in	 activation	 of	 the	
body’s	 fight	or	 flight	 systems,	 including	 the	
hypothalamic-pituitary-adrenal	axis,	and	are	
activated	 in	 the	 face	 of	 threat.	 However,	
these	 systems	 may	 also	 become	
hypersensitive	 or	 overactive	 even	when	no	
clear	threat	is	present.	
These	systems	can	be	investigated	
in	 experimental	 research	 by	
examining	 physiological	 startle	







The	 positive	 valence	 systems	 are	 primarily	
involved	 in	 supporting	 reward	 learning,	
reward	 processing,	 and	 motivational	
responses.	 The	 system	 is	 activated	when	 a	
person	 is	 exposed	 to	 learned	 cues	 that	
trigger	 motivated	 approach	 responses	 or	
willingness	to	work	in	order	to	gain	a	reward.	
Under	 some	 certain	 circumstances	 these	
systems	 can	 give	 rise	 to	 maladaptive	
behaviours.		
These	systems	can	be	investigated	




Cognitive	systems	 The	 cognitive	 systems	 are	 involved	 in	
supporting	a	number	of	cognitive	processes,	
including	 attention,	 working	 memory	 and	
language.	Under	 some	circumstances	 these	
processes	can	become	maladaptive,	leading	
to	 cognitive	 rigidity	 and	 anomalies	 in	
memory	bias.	
These	systems	can	be	investigated	
in	 experimental	 research	 by	





The	 systems	 of	 social	 processes	 include	 a	
variety	of	functions	involved	in	interpersonal	
interaction,	 such	 as	 attachment,	 theory	 of	
mind,	 and	 interpretation	 and	expression	of	
facial	affect.	In	some	case	anomalies	in	these	
processes	 may	 rise	 causing	 interpersonal	
difficulties.	
These	systems	can	be	investigated	











functions	 such	 as	 homeostatic	 balance,	
including	 energy	 maintenance	 and	















play	a	 role	 in	 the	development	and	progression	of	core	eating	disorder	behaviours	 (Connan	et	al.,	

























pathoplastic	 changes	 in	 information	processing	 can	develop	 (Williamson	et	 al.,	 1999;	 Schmidt	 and	
Treasure,	2006;	Yackobovitch-Gavan	et	al.,	2009;	Steinglass	et	al.,	2011;	Monteleone	et	al.,	2017).	
Experimental	work	has	shown	that	people	with	AN	show	elevated	negative	facial	reactions	and	report	
increased	 fear	 and	 disgust	 in	 response	 to	 food	 stimuli	 (Léonard	 et	 al.,	 1998;	 Uher	 et	 al.,	 2004;	
Soussignan	et	al.,	2011).	Further	work	has	also	reported	anomalies	in	attentional	biases	towards	food	
and	eating	related	stimuli	in	AN,	suggesting	that	people	with	AN	may	view	these	stimuli	as	threatening	












the	accurate	 interpretation	of	 complex	emotions	and	emotional	 theory	of	mind	 (Oldershaw	et	al.,	








Chapter	3	of	 this	 thesis	 further	explores	the	neural	processes	that	underlie	anomalies	 in	 implicit	
processing	of	facial	affect	in	people	with	AN.	
	



















isolation	or	perceived	 isolation,	 in	 turn,	has	been	 found	to	 impair	mental	and	physical	health,	and	
elevate	 social	 threat	 sensitivity	 (Cornwell	 and	 Waite,	 2009;	 Cacioppo	 et	 al.,	 2010;	 Cacioppo	 and	
Cacioppo,	2014).	Isolation	is	also	believed	to	give	more	space	to	eating	disorder	thoughts,	negatively	
impact	 brain	 functioning,	 and	 perpetuate	 reliance	 on	 core	 eating	 disorder	 behaviours	 as	 coping	
mechanisms	(Fairburn	et	al.,	2003;	Treasure	and	Schmidt,	2013;	Treasure	et	al.,	2015a).	Thus,	taken	










processing,	 and	 social	 functioning,	 and	 has	 been	 suggested	 to	 be	 a	 potential	 new	 target	 for	










hypothalamus,	which	 in	 turn	 begin	 to	 release	 oxytocin	 (Onaka,	 2004;	 Kormos	 and	Gaszner,	 2013;	
Gobrogge	and	Wang,	2015).	Oxytocin	is	thought	to	play	a	role	in	a	negative	feedback	loop,	promoting	
the	activity	and	release	of	an	inhibitory	neurotransmitters,	such	as	GABA,	which	in	turn	suppress	the	
increased	 activation	 in	 the	 HPA	 axis	 and	 the	 amygdala	 (Yoshida	 et	 al.,	 2009;	 Onaka	 et	 al.,	 2012;	
Gobrogge	and	Wang,	2015).	Thus,	oxytocin	is	thought	to	be	a	type	of	anxiolytic,	keeping	other	stress	






oxytocin	 release	during	 stressful	 tasks	 appears	 to	 suppress	HPA	 axis	 hyperactivation	 (Smith	 et	 al.,	




amygdala	 or	 infralimbic	 cortex	 exogenous	 oxytocin	 reduced	 fear	 responses	 to	 learned	 threat,	
facilitating	 fear	 extinction	 (Neumann	 and	 Slattery,	 2016).	 Furthermore,	 exogenous	 oxytocin	

























































the	 systems	 of	 social	 processes	 in	 humans	 (Van	 Ijzendoorn	 and	 Bakermans-Kranenburg,	 2012;	
Shahrestani	 et	 al.,	 2013).	 Previous	meta-analytic	 reviews	 have	 suggested	 that	 intranasal	 oxytocin	
improves	the	recognition	of	basic	emotions,	and	increases	trust	among	healthy	individuals	with	small	
effect	sizes	(Van	Ijzendoorn	and	Bakermans-Kranenburg,	2012;	Shahrestani	et	al.,	2013).	Additionally,	












recent	meta-analytic	 review	 reported	 small,	 but	 generally	positive	effect	of	 intranasal	oxytocin	on	
social-emotional	 functioning	 and	 psychopathology	 among	 people	 with	 ASD,	 anxiety	 disorders,	
depression,	schizophrenia,	and	borderline	personality	disorder	(BPD)	(Bakermans-Kranenburg	and	van	





disorders	have	 found	 that	a	 single	dose	of	 intranasal	oxytocin	attenuates	attentional	bias	 towards	
negative	 facial	 expressions	 in	 AN	 and	 improves	 sensitivity	 to	 recognise	 basic	 emotions	 in	 bulimia	
















The	neurodevelopmental	model	of	AN	 is	presented	 in	Figure	2.	The	model	postulates	 that	genetic	
factors	along	with	attachment	difficulties	and	anomalies	in	the	negative	valence	system,	including	the	
physiological	response	to	interpersonal	stress,	contribute	to	the	development	of	AN	(Connan	et	al.,	
2003).	 Attachment	 and	 other	 early	 life	 difficulties	 are	 believed	 to	 influence	 the	 development	 of	
neurobiological	 systems,	 such	 as	 the	 hypothalamic-pituitary-adrenal	 (HPA)	 axis,	 altering	 the	
development	of	associated	feedback	mechanisms.	Preclinical	studies	have	documented	that	together	
with	 genetic	 vulnerabilities,	 early	 life	 difficulties	 are	 associated	 with	 anomalies	 in	 the	 functional	
architecture	of	the	HPA	axis	leading	to	chronically	elevated	level	of	glucocorticoid	receptors	and	CRF	










































this	 is	believed	to	 lead	to	the	starvation	syndrome,	 ingrained	habits,	and	reduced	neural	plasticity.	
Support	for	this	model	comes	from	functional	magnetic	resonance	imaging	(fMRI)	studies	that	have	








modulate	 fear-	 and	 anxiety-related	 behaviours	 in	 rodents	 (Yoshida	 et	 al.,	 2009;	 Parr	 et	 al.,	 2013;	
Neumann	and	Slattery,	2016).	Emerging	research	among	humans	has	also	suggested	that	intranasal	



















AN.	 She	 proposed	 that	 difficult	 early	 experiences	 feed	 into	 further	 anomalies	 in	 social-emotional	
processing	and	interoception,	and	ultimately	to	disordered	eating,	which	in	turn	perpetuates	these	
anomalies	 (Bruch,	 1982).	 The	 original	 model	 has	 recently	 been	 updated	 to	 include	 findings	 from	
experimental	 work	 conducted	 since	 the	 conception	 of	 the	 model	 and	 is	 presented	 in	 Figure	 6	
(Treasure	and	Cardi,	2017).	The	authors	found	extensive	support	for	the	original	model	and	provided	




anomalies	 in	 emotional	 and	 reward	 processing	 (Teicher	 et	 al.,	 2016).	 Additionally,	 studies	 using	
ecological	momentary	assessments	that	have	documented	that	episodes	of	food	restriction	in	AN	are	
often	preceded	by	 interpersonal	 stress	 (Engel	 et	 al.,	 2013).	 These	 findings	 suggest	 that	 the	eating	
disorder	behaviours	are	used	as	maladaptive	coping	mechanisms	to	deal	with	elevated	anxiety	and	
interpersonal	difficulties.	Thus,	the	model	highlights	that	in	addition	to	weight	restoration,	treatments	








Within	 the	updated	 theoretical	model	of	 the	aetiology	of	AN,	 the	neuropeptide	oxytocin	could	be	
beneficial	 in	 improving	 social-emotional	 functioning	 (Figure	 7).	 Previous	 work	 has	 documented	
improvements	 in	 social	 cognition,	 including	 interpretation	 of	 emotions	 and	 social	 communication,	
following	oxytocin	administration	 in	healthy	 individuals	 as	well	 as	among	clinical	populations	 (Van	
Ijzendoorn	 and	 Bakermans-Kranenburg,	 2012;	 Bakermans-Kranenburg	 and	 van	 Ijzendoorn,	 2013;	
Shahrestani	 et	 al.,	 2013).	 By	 modulating	 social-emotional	 difficulties,	 oxytocin	 may	 be	 beneficial	
influencing	core	eating	disorder	behaviours,	which	are	believed	to	be	used	as	coping	mechanisms	to	
deal	with	these	difficulties.			













The	 overall	 aim	 of	 this	 thesis	 was	 to	 examine	 the	 processes	 that	 influence	 eating	 behaviour	 and	
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a  b  s  t  r  a  c  t
Objective:  The  aim  of this  study  was  to conduct  a  meta-analysis  to  quantify  the effect  of  induced  negative
and  positive  mood  on meal  consumption  in  healthy  participants  and  patients  with  eating  and  weight
disorders.
Method:  The  search  term  “MOOD”  was  combined  with the following  keywords:  “TEST  MEAL”  or  “LAB-
ORATORY  FEEDING”  or  “LABORATORY  MEAL”  or “TASTE  TEST”  or “TASTE  TASK” to  identify  the  relevant
studies.
Results:  Thirty-three  studies  were  selected,  including  2491  participants.  Two  meta-analyses  compared
negative  mood  or  positive  mood  with  neutral  mood.  Induced  negative  mood  was  significantly  associ-
ated with  greater  food  intake,  especially  in restrained  eaters  and  binge  eaters.  Positive  mood  was  also
associated  with  greater  caloric  intake  across  groups.
Conclusion: These  findings  support  the causal  relationship  between  negative  mood  and  greater  food
intake,  especially  in  restrained  eaters  and  binge  eaters.  Preliminary  evidence  indicates  that  strategies
to  improve  positive  mood  might  be  of benefit  for people  with  anorexia  nervosa  and  bulimia  nervosa,
although  the  size  of the  effect  across  a single  meal  is  small.
©  2015  Elsevier  Ltd. All  rights  reserved.
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Food intake is not only regulated by metabolic needs (Elmquist
et al., 2005; Manning and Batterham, 2014), but is also affected by
emotional states, motivations and self-regulatory processes (e.g.
Treasure et al., 2011). Negative affect and increased or decreased
cognitive control can override the basic maintenance of energy bal-
ance (Zheng et al., 2009; Adam and Epel, 2007), with subgroups of
individuals reducing or increasing food intake to cope with stress
and negative emotions (Epel et al., 2004; Macht, 2008; Stone and
Brownell, 1994).
Negative emotions or difficulties with emotional regulation
have been found to be transdiagnostic risk and maintenance factors
for all forms of eating and weight disorders. Negative affect predicts
the future onset of eating disorder symptoms in a large number
of prospective studies (Jacobi et al., 2011; Vannucci et al., 2015;
Michopoulos et al., 2015); also it mediates the relationship between
childhood violence (abuse and bullying) and obesity (Midei and
Matthews, 2011). In contrast, positive affect has been found to pro-
tect against the development of metabolic syndrome (Midei and
Matthews, 2011).
Negative mood as a possible maintaining factor for eating dis-
orders has been examined using daily assessments of negative
emotions and eating disorder symptoms in naturalistic settings
(ecological momentary assessment – EMA). Studies employing
EMA techniques show a consistent association between negative
mood and bulimic symptoms in clinical populations (Haedt-Matt
and Keel, 2011), with the highest rates of bingeing and purging
occurring on days characterised by high negative affect (Crosby
et al., 2009). Similar patterns are observed in anorexia nervosa,
with an association between restriction and daily labile mood
(Engel et al., 2005) and anxiety (Lavender et al., 2013). Studies
in populations with tendencies to overeat (i.e. obese individuals)
and/or restrict their caloric intake (i.e. restrained eaters) show a
less clear association between abnormal eating behaviours and
negative mood and report inconsistent findings (e.g. Goldschmidt
et al., 2013; Haynes et al., 2003; Yeomans and Coughlan,
2009).
A limitation of the EMA  studies is that they can only indi-
cate an association between two variables. In order to test the
hypothesis that mood plays a casual role in the regulation of eat-
ing behaviours is necessary to use an experimental design in which
mood is experimentally shifted and the resultant eating behaviour
is observed. The aim of this systematic review and meta-analysis
is to quantify the impact of induced negative and positive mood
on eating behaviour in laboratory, controlled studies in partici-
pants with a range of eating behaviours (healthy controls: HCs,
restrained eaters: RE, patients with anorexia nervosa: AN, bulimia
nervosa: BN, binge eating disorder: BED, other specified feed-




The electronic databases AGRIS (1991 – present), Embase (1974
– present), HMIC (1979 – present), International Pharmaceutical
Abstracts (1970 – present), Maternity and Infant Care (1971 –
present), MEDLINE (1946 – present) and PsycINFO (1806 – present)
using OVID; Science Citation Index Expanded (1900 – present),
Social Sciences Citation Index (1956 – present) and Arts & Human-
ities Citation Index (1975 – present) using Web  of Knowledge®;
and United States National Library of Medicine using PubMed were
searched to identify relevant research articles written in English
and published in peer reviewed journals during the available years
up to February 2015, following the PRISMA guidelines (Moher,
2009).
1.2. Search terms
The search terms “MOOD” was combined with the following
keywords: “TEST MEAL” or “LABORATORY FEEDING” or “LABORA-
TORY MEAL” or “TASTE TEST” or “TASTE TASK” or “FOOD INTAKE”.
We selected the key word “mood” as it typically describes a perva-
sive and predominant emotional state, compared to “affect” which
describes a more sudden and short lived reaction (Ketai, 1975).
1.3. Eligibility criteria
To be included in the meta-analysis studies were required to:
(1) investigate the impact of experimentally induced mood on eat-
ing behaviour, (2) use procedures to induce a psychological change
in mood rather than physiological stress, (3) have a laboratory test-
meal during which participants are invited to eat as much as they
want to and feel comfortable with, (4) have at least one mood condi-
tion and a neutral condition to allow for comparisons (i.e. negative
vs. neutral; positive vs. neutral), (5) include an adult population
(≥18 years old) of: (a) HCs (i.e. individuals who  never suffered from
mental illnesses), (b) REs (i.e. individuals who  consciously monitor
their food intake to remain slim or promote weight loss), (c) partic-
ipants with a diagnosis of EDs (AN, BN, BED, sub-BED) or (d) obese
participants (i.e. Body Mass Index – BMI  – ≥30), (6) provide sample
size and empirical data (mean, standard deviation – SD)  on mood
ratings before and after mood induction and on the amount of food
consumed during the test-meal in order to calculate effect sizes
(ESs; principal summary measures) and (7) had a minimum of 15
participants per group.
1.4. Study selection
The initial literature search yielded 7777 papers with 2
additional papers found through personal correspondence. After
removing duplicates, 5167 papers were screened based on the
abstract and 5097 papers were excluded for not meeting the inclu-
sion criteria. Further 36 papers were excluded for not reporting
relevant data or for including heterogeneous groups of REs. Addi-
tionally, one paper was excluded for using a supervised test meal.
During the test meal, participants admitted to hospital were asked
to consume their lunch for the day, rather than subjectively choose
the amount and type of foods they wanted to eat after mood induc-
tion. Thirty-three studies were finally included in the meta-analysis
(see Fig. 1 for a summary of the studies selection process).
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Fig. 1. Study selection. Flow chart of study selection.
J.L. and V.C. carried out the literature searches, final screening
and eligibility and criteria compliance assessment. Any cases where
eligibility remained uncertain were referred to the whole team for
further discussion. When quantitative data were unavailable, the
corresponding authors were contacted to request raw data. The
following authors provided relevant data through personal corre-
spondence: Appelhans et al. (2011), Bongers et al. (2013), Cardi
et al. (2013), Cardi et al. (2015), Cardi et al. (unpublished) and Mittal
et al. (2011). References from all relevant articles were inspected
for additional studies not yielded by the initial search. One study
was found using this method.
1.5. Data collection and synthesis
Information regarding: (1) valence of induced mood (i.e. pos-
itive, negative, neutral), (2) mood induction procedure used, (3)
participants mood ratings before and after mood induction, (4)
sample size, (5) means and SDs for the amount of food consumed
during the test meal and (6) types of food on offer (i.e. sweet,
savoury) was extracted from the included papers. The following
method was undertaken to synthesise the data: where studies
included two separate test meals only the test meal that took place
during or immediately after mood induction was included. Studies
were divided into the following groups considering participants
included in the studies: HC, Obese, REs, Clinical (AN, BN, BED, sub-
BED). Two  meta-analyses were conducted comparing: (1) overall
effect of negative vs. neutral mood on food consumption and (2)
overall effect of positive vs. neutral mood on food consumption.
Meta-regressions were calculated to investigate any heterogeneity
arising from the meta-analysis.
1.6. Mood induction procedures
The mood induction methods employed by the studies in the
meta-analysis were grouped as follows:
• Others’ emotional display (OED) that included: excerpts from
movies, TV shows, on purpose made film clips and vignettes,
classical music accompanied by a sad story.
• Guided mood induction (GMI) that consisted of interviewing par-
ticipants or asking them to write about an emotional experience
that they could recall.
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• Social feedback (SF) that included: providing participants with
false, ego-threatening feedback on their performance, facing the
threat of public speaking or being subjected to the Trier Social
Stress Test (Kirschbaum et al., 1993). In the Trier Social Stress
Test three judges trained to maintain a neutral expression request
to subjects to prepare and deliver a brief presentation and to
complete a mental arithmetic task (Kirschbaum et al., 1993).
1.7. Types of food on offer
Studies were categorised in terms of whether they included
offering only sweet, only savoury, both sweet and savoury or a
choice of sweet or savoury foods (i.e. participants were asked to
choose one of the two options before mood induction) during the
test meal (see Table 1). The sweet foods offered included: cook-
ies, chocolate, ice cream, sweet popcorn, chocolate pudding, and
fruit smoothies. The savoury foods offered included: popcorn, sand-
wiches, cheese cubes, crisps, and crackers. The sweet and savoury
foods offered included: chocolate, crisps, cookies, pretzels, crack-
ers, peanuts, fresh fruit and vegetables, sandwiches, entire meals
(e.g. pasta), and a variety of desserts (e.g. cakes). The choice of sweet
or savoury foods offered included: salted popcorn or raisins, crisps
or chocolate.
1.8. Statistical analyses
The analyses were performed using Stata 11.0 (Stata Corpora-
tion, College Station, TX, USA) with the user-contributed commands
metan (Bradburn et al., 1998), metabias, metatrim (Steichen, 1998)
and metareg (Sharp, 1998). Cohen’s d ES (i.e. difference between
two means divided by the pooled standard deviations) and 95%
confidence intervals were reported for all studies. Effect sizes can
be interpreted as: negligible (≥−0.15 and >0.15), small (≥0.15 and
>0.40), medium (≥0.40 and >0.75), large (≥0.75 and >1.10), very
large (≥1.10 and >1.45) and huge (≥1.45). When the amount of
test meal consumed after the negative or positive mood induction
was compared to the amount consumed in the neutral condition, a
positive ES suggested that participants consumed more food in the
experimental condition (negative or positive mood induction). A p
value of ≤0.05 was considered to be significant.
The meta-analysis was conducted using the random-effects
model. The random-effects model assumes that both the within-
group variability of scores and mean ES are caused by differences
between the studies. The homogeneity of the true ES was  assessed
using Cochran’s Q statistic and I2 index (0–1) giving a measure of
the magnitude of heterogeneity in the sample of studies (Higgins
et al., 2003). Meta-regressions were performed to adjust for varia-
tion caused by differences in: (1) methods used to induce negative
and positive mood (OED, GMI, SF), (2) type of negative or positive
mood induced (positive mood or happiness; negative mood, anger,
sadness, anxiety, stress or fear); (3) participant group (HCs, Obese,
REs, Clinical); (4) types of food offered (sweet, savoury, sweet and
savoury, sweet or savoury). Publication bias was  assessed using
Begg’s adjusted rank test (Begg and Mazumdar, 1994) Egger’s test
(Egger et al., 1997) and by observing the funnel plots.
2. Results
2.1. Study characteristics
Table 1 presents a summary of the main characteristics of the
studies included in the meta-analysis. The Cohen’s d in Table 1
indicates the standardised difference in outcome measures in the
different mood conditions.
2.2. Study participants
The total number of participants was  2491, of which 1772 were
HCs, 270 REs, 317 had a diagnosis of EDs (i.e. 33 AN, 23 BN, 156 BED
and 105 Sub-BED) and 132 suffered from obesity. The overall mean
age of the sample was 24.4 years (SD = 5.09) and the overall mean
BMI  was 24.7 kg/m2 (SD = 3.03).
2.3. Mood manipulation outcome
Sixteen studies reported participants’ positive and/or negative
mood ratings before and after mood induction (see Supplemen-
tary figs. 1 and 2). A further 6 studies provided the relevant data
through personal correspondence (see Fig. 1). Eleven studies mea-
sured change in positive mood ratings after negative, positive and
neutral mood induction (see supplementary figure 1). All studies
included a HC group and two studies also included clinical groups
(AN, BN). Findings indicated that positive mood was significantly
reduced after negative mood induction (ES = −0.80, 95% CI −1.08,
−0.52, p < 0.001) and significantly increased after positive mood
induction (ES = 0.52, 95% CI 0.26, 0.79, p < 0.001). As expected no sig-
nificant changes were observed in the neutral condition (ES = 0.082,
95% CI −0.095, 0.260, NS).
Supplementary figure 1 related to this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.neubiorev.2015.
08.011.
Ten studies measured change in negative mood ratings after
negative, positive and neutral mood induction (see supplemen-
tary figure 2). All studies included a HC group and one study
also included a clinical group (AN). The overall findings indicated
that negative mood increased significantly after negative mood
induction (ES = 0.89, 95% CI 0.47, 1.31, p < 0.001). Positive mood
induction had only a modest effect in reducing negative mood
ratings (ES = −0.28, 95% CI −0.58, 0.03, p = 0.073) and the neutral
condition had a small, but significant effect in reducing negative
mood (ES = −0.21, 95% CI −0.32, −0.10, p < 0.001).
Supplementary figure 2 related to this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.neubiorev.2015.
08.011.
2.4. Food intake: negative vs. neutral mood induction
The overall findings indicated that there was  a significant effect
of negative mood on food consumption (ES = 0.260, 95% CI 0.076,
0.444; p = 0.006) with participants consuming more food under this
condition. The heterogeneity of the sample was high (I2 = 89.1%). A
meta-regression was  conducted to further investigate the variance
using the following variables: participant group, mood induc-
tion method, type of mood induced and types of food offered.
The participant group variable significantly explained some of the
variance (Adj. R2 = 21.75%, t = 3.26, p = 0.002, 95% CI 0.122, 0.517)
indicating that the RE, BED and Sub-BED groups consumed sig-
nificantly more food when negative mood was induced compared
with the HC and obese groups. The type of food offered also sig-
nificantly explained a small percentage of the variance observed
(Adj. R2 = 7.88%, t = −2.13, p = 0.039, 95% CI −0.438, −0.118) indicat-
ing that more food was  consumed in the negative mood condition
when participants were offered either sweet or savoury foods than
when they were offered both or a choice of sweet or savoury. There
was no evidence of publication bias (Begg’s test p = 0.487, Egger’s
test p = 0.288). Results are shown in Fig. 2.
2.5. Food intake: positive vs. neutral mood induction
The overall findings showed that significantly more food was
consumed when positive mood was  induced than in the control
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Fig. 2. Amount consumed in the negative vs. neutral mood induction conditions. Forest plot indicating the difference in the amount of food consumed in the negative
compared to the neutral experimental conditions. Studies are grouped by participant group. Information regarding the type of mood induced and whether participants were
offered sweet and savoury, sweet or savoury, only sweet or only savoury foods is presented on the right. (Sweet and savoury: Sw & Sa, sweet or savoury: Sw/Sa, only sweet:
Sw,  only savoury: Sa). Effect size is reported as standard mean difference (SMD). EXPT = experiment.
condition (ES = 0.261, 95% CI 0.053, 0.469; p = 0.014). The hetero-
geneity of the studies was high (I2 = 77.0%). A meta-regression
was run including the following variables: participant group,
mood induction method, type of mood induced and types of food
offered. The types of food offered variable approached significance
explaining some of the variance observed (Adj. R2 = 28.48%, t = 1.91,
p = 0.079, 95% CI −0.022, 0.359). This finding indicates that when
positive mood was induced there was a trend for more food to be
consumed in studies where participants were offered both sweet
and savoury food. There was no evidence of publication bias (Begg’s
test p = 0.843, Egger’s test p = 0.838). Results are shown in Fig. 3.
3. Discussion
The aim of this meta-analysis was to quantify the impact of
induced negative and positive mood on eating behaviour in lab-
oratory, controlled studies in participants on the spectrum ranging
from normal to at risk and clinical eating behaviour. Findings indi-
cated that negative mood induction was significantly associated
with greater food intake across groups, with a more pronounced
effect in restrictive eaters and patients with BED or sub-threshold
BED. Positive mood was  also associated with greater caloric intake
across the limited number of groups studied.
The causal relationship between induced negative mood and
increased food consumption in binge eaters is in line with the
associations found in the literature and confirms the predictions
of theoretical models explaining the onset and maintenance of
bulimic symptoms in eating disorders (Fairburn et al., 2003; Stice
et al., 1998). The mechanism of this effect may be a depletion of
self-regulatory abilities caused by emotional distress (Baumeister
et al., 1993).
Experimental data on the impact of induced positive mood on
eating behaviour in clinical populations were surprisingly limited.
Only 3 studies included participants with AN or BN and found that
a motivational video-clip (Cardi et al., 2013) and positive mood
induction (Cardi et al., 2015; Cardi et al., unpublished) were asso-
ciated with increased calories consumption in AN and reduced
consumption of high palatable, snack foods in BN.
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Fig. 3. Amount consumed in the positive vs. neutral mood induction conditions. Forest plot indicating the difference in the amount of food consumed in the positive compared
to  the neutral experimental conditions. Studies are grouped by participant group. Information regarding the type of mood induced, and whether participants were offered
sweet  and savoury, sweet or savoury, only sweet or only savoury foods is presented on the right. (Sweet and savoury: Sw & Sa, sweet or savoury: Sw/Sa, only sweet: Sw, only
savoury: Sa). Effect size is reported as standard mean difference (SMD). EXPT = experiment.
The finding that positive mood was associated with greater
food consumption in HCs corroborates naturalistic studies in which
healthy people have shown to engage in hedonic eating during
times of joy and happiness (Macht, 1999). Furthermore, exper-
imentally induced positive mood has been shown to increase
experienced pleasantness and taste of chocolate in a laboratory
setting (Macht et al., 2002).
More food was consumed in the positive mood condition when
participants were given both sweet and savoury food to sample,
as expected according to the mechanism of sensory specific satiety
(i.e. decline in satisfaction derived from consuming one type of food
for a long time; Havermans, 2012), Surprisingly, in the negative
mood condition more food was consumed when only savoury or
sweet foods were offered.
3.1. Limitations
The main limitation of this work is that a wide range of out-
come measures (different forms of test meals) and mood induction
procedures have been used. This makes the comparison of find-
ings and their interpretation difficult, particularly as it is known
that the type of food and setting can have a large effect on food
consumption (Wallis and Hetherington, 2009). There have been
surprisingly few studies that have used clinical samples. This
seems to be a missed opportunity for applying an experimental
medicine approach to identify possible novel clinical interven-
tions for eating and weight disorders. The use of standardised
outcomes and experimental procedures can improve research in
this area.
3.2. Implications and future directions
This meta-analysis corroborates the previous literature suggest-
ing a possible role of negative affect as a transdiagnostic causal
risk and maintaining factor for disorders of weight and eating.
It follows that strategies to counteract negative mood (e.g. pos-
itive mood induction procedures) or to develop effective coping
strategies to deal with negative emotions might be useful adjuncts
to treatment for these conditions. The preliminary findings from
3 studies that tested positive mood induction in patients with
AN or BN are promising, however the effect sizes are small for
an individual meal. It would be of interest to know if the effects
could be cumulative, if positive mood induction was repeated over
time.
3.3. Conclusion
A causal relationship between induced negative mood and
abnormal eating behaviour was supported by this meta-analysis.
Strategies to counteract negative mood (e.g. positive mood induc-
tion) or improve emotion regulation might be of benefit in breaking
unhelpful eating habits in people with eating and weight disorders.
However, more standardised experimental studies are needed in
this area.
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A B S T R A C T
Background: People with anorexia nervosa (AN) have diﬃculties in a wide range of social-emotional processes.
Previous work suggests atypical involvement of the prefrontal cortex (PFC), amygdala, insula, and fusiform gyri
during social-emotional processing in AN.
Methods: Twenty women with AN and twenty healthy comparison (HC) women were presented with happy,
fearful, and neutral faces during a functional magnetic resonance imaging study. Group diﬀerences were in-
vestigated in the following regions of interest: lateral PFC, amygdala, insula, and fusiform gyri.
Results: The HC participants showed signiﬁcantly increased recruitment of the ventrolateral PFC and amygdala
in the fearful> neutral contrast relative to the AN participants. The AN participants showed a signiﬁcantly
increased recruitment of a small cluster in the right posterior insula in the happy>neutral contrast.
Conclusions: These ﬁndings are in line with the hypothesis that people with AN have a blunted response to
negative and atypical exaggerated response to positive emotionally provoking stimuli.
1. Introduction
Diﬃculties in social-emotional processing are believed to play an
important role both in the onset and maintenance of anorexia nervosa
(AN) (Treasure, Corﬁeld, & Cardi, 2012; Treasure & Schmidt, 2013). A
wide range of anomalies in social-emotional processing and reactivity
to emotional stimuli have been documented in people with acute AN
(Bora & Köse, 2016; Caglar-Nazali et al., 2014; Davies et al., 2016).
Furthermore, longitudinal cohort studies have reported that diﬃculties
in social cognition and social communication at admission are im-
portant predictors of poor treatment outcome at 3- to 18-year follow-up
(Nielsen et al., 2015; Speranza, Loas, Wallier, & Corcos, 2007). Thus,
these diﬃculties may contribute to the maintenance of the illness and
further understanding of these processes is of importance.
Behavioural studies have documented diﬃculties in a range of dif-
ferent aspects of social-emotional processing in acute AN (Bora & Köse,
2016; Caglar-Nazali et al., 2014; Davies et al., 2016). Some experi-
mental studies have suggested diﬃculties in explicit processing of so-
cial-emotional cues, such as recognition of facial expressions, in AN
(Caglar-Nazali et al., 2014; Oldershaw et al., 2011). However, more
recent studies have suggested that these diﬃculties may be driven by
anomalies in interpretation and reactivity to social-emotional cues in
AN (Ambwani et al., 2015; Dapelo, Surguladze, Morris, & Tchanturia,
2016). Indeed, people with AN perceive emotionally provoking stimuli
to be more negative and colder than healthy comparison (HC) partici-
pants (Ambwani et al., 2015; Cardi et al., 2014). Additionally, relative
to HCs, people with AN display reduced facial aﬀect in response to
emotionally provoking stimuli (Davies et al., 2016). Taken together,
these ﬁndings suggest that there may be speciﬁc anomalies in implicit
processing and reactivity to social-emotional cues in AN and further
exploration of the neural mechanisms that underlie these processes may
be of interest.
Few studies have examined the neural processes that underlie dif-
ﬁculties in social-emotional processing and reactivity to emotional sti-
muli in people with AN. A recent review reported reduced response in
prefrontal regions, including the lateral and medial prefrontal cortex
(PFC), while viewing social behaviour in acute AN (McAdams & Smith,
2015). Further, one of the included studies found that reduced response
in the lateral and medial PFC to social behaviour at admission to
treatment was associated with poorer outcome at discharge (Schulte-
Rüther, Mainz, Fink, Herpertz-Dahlmann, & Konrad, 2012). A recent
study investigating implicit processing of happy faces of increasing
intensity found greater linear increase in activation of the fusiform
gyrus in people with acute AN relative to HCs (Fonville, Giampietro,
http://dx.doi.org/10.1016/j.biopsycho.2017.07.010
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Surguladze, Williams, & Tchanturia, 2014). Another study, using a more
explicit task, found reduced amygdala response in people recovered
from AN relative to HCs in response to negative facial expressions when
the faces were coupled with the congruent emotion label (Bang,
Ro, & Endestad, 2016). Despite the relative paucity of research in this
ﬁeld, these ﬁndings suggest possible anomalies in the recruitment of
frontal, amygdala, and visual attentional regions in social-emotional
processing in AN.
More work has been conducted in anxiety and mood disorders,
which are common comorbid disorders in AN and share similar diﬃ-
culties in social-emotional processing and reactivity to emotional sti-
muli (Davies et al., 2016; Hambrook, Brown, & Tchanturia, 2012;
Treasure, Stein, &Maguire, 2015). A recent meta-analysis found that
relative to HCs, people with depression showed hyperactivation of re-
gions associated with appraisal including amygdala, insula, and fusi-
form gyrus, during implicit processing of negative facial aﬀect
(Groenewold, Opmeer, de Jonge, Aleman, & Costafreda, 2013). Ad-
ditionally, increased activation of these regions was associated with
reduced recruitment of regions associated with emotion down-regula-
tion, including the lateral PFC (Groenewold et al., 2013). Similarly,
people with generalised and social anxiety disorders show reduced
activation of lateral PFC and associated hyperactivation of the amyg-
dala when processing negative emotional stimuli including negative
facial expressions (Mochcovitch, da Rocha Freire, Garcia, & Nardi,
2014). Taken together, these ﬁndings suggest that there may be a
deﬁcit in prefrontal down-regulation and limbic up-regulation of ne-
gative emotion associated with depression and anxiety.
The aim of the current study was to examine the neural substrates
employed during implicit processing of positively and negatively va-
lenced facial expressions in AN and HC participants. Based on the
neuroimaging ﬁndings outlined above, we hypothesised that partici-
pants with AN would have atypical pattern of reduced recruitment of
lateral PFC while processing emotional faces. Further, based on pre-
vious work conducted in mood and anxiety disorders as well as beha-
vioural work in AN, we hypothesise that participants with AN would
show a pattern of activation suggestive of anomalies in emotional re-
activity. Speciﬁcally, we hypothesise that relative to the HCs, partici-
pants with AN would show increased activation in the amygdala, in-
sula, and fusiform gyri while processing the emotional facial
expressions.
2. Materials and methods
2.1. Participants
Forty right-handed females participated in the study. Twenty par-
ticipants had a current DSM-IV diagnosis of AN, which was conﬁrmed
using the Structured Clinical Interview for Diagnosis – Researcher
Version (Spitzer, Williams, Gibbon, & First, 1992). Fifteen participants
with AN were recruited from the community through advertisements
posted on eating disorder charity websites (i.e. BEAT and Succeed). The
AN participants recruited from the community were not receiving
psychological treatment during the time of the study. Five participants
with AN were recruited from the Bethlem Royal Hospital, South London
and Maudsley NHS Trust and were receiving treatment during the
study. 60% of the participants with AN were taking antidepressants
during the time of the study, 45% of the AN participants reported co-
morbid depression and 25% reported comorbid anxiety disorder.
Twenty age-matched HC women of healthy weight were recruited from
the community and amongst King’s College London students and staﬀ.
The exclusion criteria for all participants were a history of head
trauma, hearing or visual impairment, neurological disease, MRI in-
compatibility, acute suicidality, and history of (or current) alcohol or
drug abuse. Additionally, HC participants were screened with the
Structured Clinical Interview for Diagnosis − Researcher Version
(Spitzer et al., 1992) and were excluded if they had current or a history
of psychiatric disorders. HC participants were also excluded if did not
have BMI between 18.5 and 25.0 or were taking psychotropic medi-
cation. All participants gave a written, informed consent prior to taking
part in the study and were compensated for their participation. The
study was approved by a National Research Ethics Service committee
(approval number: 11/LO/0373) and was conducted in accordance
with the latest version of Declaration of Helsinki.
2.2. Questionnaire measures
The eating disorders examination questionnaire (EDEQ)
(Fairburn & Beglin, 1994), a 36-item self-report measure, was used to
assess eating restraint, eating concern, shape concern, and weight
concern over the past 28 days.
The depression, anxiety, and stress scale (DASS)
(Lovibond & Lovibond, 1995), a 21-item self-report measure, was used
to assess depression, anxiety, and stress over the past two weeks.
2.3. Design and procedure
During a 6-min event-related functional magnetic resonance imaging
(fMRI) task participants were presented with black and white images of
faces (Fig. 1). The face stimuli consisted of prototypical happy (intensity:
100%), prototypical fearful (intensity: 100%), and neutral faces. The
stimuli were selected from a standardised set of facial expressions
(Ekman& Friesen, 1976), and consisted of ten diﬀerent adults displaying
each of the selected emotions (5 female and 5 male). Happy and fearful
faces were used as they have previously been found to strongly capture
participants’ attention and produce robust activation of the amygdala,
fusiform gyrus, insula, and prefrontal regions (Fusar-Poli et al., 2009;
Fig. 1. Implicit emotion processing task.
The happy, fearful, and neutral faces were presented one at a time for
2000 milliseconds (ms) during which participants identiﬁed the gender of
each face. Faces were preceded by a ﬁxation cross the presentation of
which was jittered between 1000 and 6000 ms.
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Lundqvist &Ohman, 2005; Williams&Mattingley, 2006). Additionally,
unlike angry or disgusted faces, fearful faces are not considered to be
indicative of direct threat (Hunnius, de Wit, Vrins, & von Hofsten, 2011).
The neutral faces were used as a baseline comparison condition to allow
investigation of neural responses to facial aﬀect.
Twenty happy, fearful, and neutral faces were presented in a
pseudo-randomised order. The faces were presented one at time for
2000 ms followed by an inter-stimulus interval (ISI) ﬁxation cross. The
ISI was varied between 1 and 6 s. To ensure participants were attending
to the stimuli, they were asked to identify the gender of the faces by
pressing the appropriate buttons. This is a paradigm frequently em-
ployed to investigate implicit social-emotional processing (Stuhrmann,
Suslow, & Dannlowski, 2011).
2.4. Image acquisition and pre-processing
Magnetic resonance images were acquired using GE Signa 1.5 T
scanner (GE Medical Systems, Milwaukee, Wisconsin) at the Centre for
Neuroimaging Science, King’s College London. An 8-channel headcoil
was used to transmit and receive the radio frequency signal. T2* –
weighted images depicting blood oxygen level dependent (BOLD) signal
were acquired using an interleaved ascending acquisition order with a
repetition time of 2 s with 40 ms echo time and an 80° ﬂip angle. Whole
brain coverage was acquired in 30 slices with 4 mm slice thickness and
0.4 mm slice gap. 180 T2* – weighted whole brain volumes were ac-
quired with an in-plane resolution of 3.75 mm× 3.75 mm.
Additionally, high-resolution sagittal T1–weighted structural images
(MP-RAGE) were acquired with a repetition time of 8.592 ms. The echo
time was 3.8 ms with an 8° ﬂip angle. Whole brain coverage was ac-
quired in 180 slices with an in-plane resolution of 1.25 mm× 1.25 mm,
and 1.2 mm slice thickness and 1.2 mm slice gap.
Prior to analysis, the fMRI data was pre-processed using SPM8
(Wellcome Department of Cognitive Neurology, Institute of Neurology,
London) implemented in Matlab 2015b (Mathworks, Natick, Mass.).
Pre-processing involved slice-timing and volume-to-volume head mo-
tion correction. The data was then co-registered to a high-resolution
DARTEL template, created out of the participants T1–weighted struc-
tural images (Ashburner, 2007), and normalised to Montreal Neurolo-
gical Institute (MNI) space. The data was spatially smoothed using an
8 mm FWHM three-dimensional isotropic Gaussian kernel.
2.5. Statistical analysis
2.5.1. Questionnaire and behavioural data
Questionnaire and behavioural data were analysed with Stata 14
(StataCorp. 2015, College Station, TX: StataCorp LP.). Due to skewed
nature of the questionnaire data, group diﬀerences were investigated
with nonparametric median Chi2 tests. Prior to analysis, gender iden-
tiﬁcation accuracy data was transformed with arcsine and square root
transformation to allow further analysis under the general linear model
framework. The gender identiﬁcation accuracy and reaction time data
were then analysed with a bootstrapped mixed model (1000 repeti-
tions). Trial (fearful, happy, neutral) and group (AN, HC) were entered
as ﬁxed eﬀects variables with a random intercept. Signiﬁcant eﬀects
and interactions were further investigated by calculating post-hoc
contrasts and pair-wise comparisons. P < 0.05 was considered sig-
niﬁcant.
2.5.2. Neuroimaging data
On subject level, each participant’s fMRI data were analysed under
the general linear model framework in SPM 8. A canonical haemody-
namic response function was used to model the BOLD signal for each of
the following conditions: happy faces, fearful faces, and neutral faces.
The time-series was adjusted for head motion using the Friston 24-
parameter model (Friston, Williams, Howard, Frackowiak, & Turner,
1996) and low-frequency drift was ﬁltered out using high-pass ﬁlter set
to 1/128s. To investigate relative activation or deactivation in response
to fearful and happy facial expressions compared to neutral faces, the
following contrast images were generated for each participant: fear>
neutral and happy>neutral.
Each participant’s contrast images were then entered into group
level analysis, which was conducted with the Robust Regression
toolbox (http://wagerlab.colorado.edu/tools) implemented in Matlab
2015b (Wager, Keller, Lacey, & Jonides, 2005). The Robust Regression
toolbox uses iteratively re-weighted least squares (IRLS) to increase
statistical power and reduce the impact of extreme outliers (Fritsch
et al., 2015; Wager et al., 2005). We chose this method to reduce the
likelihood of false ﬁndings due to presence of extreme outliers that
could arise from head motion, scanner related artefacts, or individual
participants who were substantially diﬀerent from the rest of the
sample during the time of the MRI scan.
The contrast images were ﬁrst entered into region of interest (ROI)
IRLS analyses to test a priori hypotheses. The WFU Pickatlas toolbox in
SPM 8 was used to create the following ROI masks: bilateral amygdala,
bilateral insula, bilateral fusiform gyri, and bilateral lateral PFC. To
investigate group diﬀerences within these regions, group status was
added as a contrast-coded covariate (1,−1: AN, HC). Thus, positive test
statistic indicates greater activation in the AN group relative to the HC
group and negative test statistic indicates greater activation in the HC
group relative to the AN group. The ROI ﬁndings were corrected for
multiple comparisons with a voxel-wise nonparametric permutation
test with 10000 iterations (α < 0.05). The permutation test uses the
max T distribution to generate a new corrected t-threshold each voxel
must reach to be considered signiﬁcant.
We, additionally, explored whether the mean activation in the sig-
niﬁcant ROIs correlated with medication status, BMI, DASS total score,
duration of illness, and eating disorder psychopathology as measured
by EDEQ within the AN group. The correlations were conducted by
extracting mean signal change from the signiﬁcant ROIs in each con-
trast as recommended by Vul, Harris, Winkielman, and Pashler (2009).
Nonparametric Spearman’s rho correlations were then conducted with
Matlab 2015b and p < 0.01 was considered signiﬁcant following
correction for multiple comparisons.
Finally, we also conducted an exploratory whole brain analysis to
investigate if signiﬁcant group diﬀerences were present in any further
regions outside of the a priori ROI masks. As above, the contrast images
were entered into whole brain IRLS analysis with group status was
added as a contrast-coded covariate (1, −1: AN, HC). The whole brain
ﬁndings were corrected for multiple comparisons with voxel level False
Discovery Rate (FDR) set at q < 0.05. Eﬀect size, and lower and upper
bound 99.9% conﬁdence interval maps were generated using the EScalc
toolbox implemented in Matlab 2015b (http://restfmri.net)
(Gao & Zang, 2015).
3. Results
3.1. Clinical characteristics
The socio-demographic and clinical characteristics of the groups are
presented in Table 1. There were no signiﬁcant diﬀerences in age or
years of education between the AN and HC participants. As expected
the participants with AN had signiﬁcantly lower BMI and reported
signiﬁcantly more eating disorder psychopathology, depression, an-
xiety, and stress than the HC participants.
3.2. Gender identiﬁcation
Gender identiﬁcation mean reaction times and accuracy are pre-
sented in Table 2. There was a signiﬁcant diﬀerence between the groups
in gender identiﬁcation RTs, with the HC participants being sig-
niﬁcantly faster to identify the gender of the faces than the participants
with AN.
J. Leppanen et al. %LRORJLFDO3V\FKRORJ\²

In gender identiﬁcation accuracy, there was a signiﬁcant diﬀerence
between trials with all participants being signiﬁcantly more accurate in
the happy trials than fearful or neutral trials (Z = 2.37, p = 0.018, 95%
CI [0.005, 0.05]; Z = 2.73, p = 0.006, 95% CI [0.01, 0.04]). There
were no signiﬁcant diﬀerences in accuracy between neutral and fearful
trials across participants (Z = 0.33, p = 0.742, 95% CI [-0.02, 0.03]).
There was also a signiﬁcant eﬀect of group and a signiﬁcant trial x
group interaction (Table 2). Post-hoc tests revealed that HC participants
were signiﬁcantly more accurate than the participants with AN only in
the fearful trials (Z = 2.64, p = 0.008, 95% CI [0.01, 0.09]), but not in
the happy (Z =−1.42, p = 0.155, 95% CI [-0.04, 0.01]) or neutral
trials (Z = 1.27, p = 0.205,95% CI [-0.01,0.04]).
3.3. Regions of interest ﬁndings
3.3.1. Happy> neutral faces
The ROI ﬁndings are presented in Fig. 2 and Table 3. There was a
signiﬁcant diﬀerence in BOLD signal change between groups in re-
cruitment of the right posterior insula while viewing happy>neutral
faces (Fig. 2A, Table 3). Inspection of the contrast parameter estimates
revealed that there was simultaneous BOLD signal increase in the right
posterior insula in the AN group and BOLD signal decrease in the
posterior insula in the HC group in this contrast (Fig. 2A). No further
signiﬁcant diﬀerences between groups were found in the amygdala,
fusiform gyri, or lateral PFC in this contrast.
Additionally, within the AN group, the mean BOLD signal change in
the insula ROI did not signiﬁcantly correlate with medication status,
duration of illness, psychopathology, or BMI in this contrast
(Supplementary Table 1).
3.3.2. Fearful > neutral faces
The ROI ﬁndings revealed a signiﬁcant diﬀerence between the AN
and HC groups in BOLD signal change in left amygdala in response to
fearful relative to neutral faces. Similarly, there was a signiﬁcant dif-
ference between groups in BOLD signal change in the left VLPFC in this
contrast. Inspection of the peak parameter estimates revealed that there
was a relative increase BOLD signal in the left amygdala and VLPFC in
response to the fearful expressions in the HC group, but not in the AN
group (Fig. 2B,C). No further signiﬁcant diﬀerences between groups
were found in the insula or fusiform gyri in this contrast.
Additionally, within the AN group, the mean BOLD signal change in
the VLPFC or amygdala ROIs did not signiﬁcantly correlate with med-
ication status, duration of illness, psychopathology, or BMI in this
contrast (Supplementary Table 1).
3.4. Whole brain ﬁndings
The exploratory whole brain analysis did not reveal any regions of
signiﬁcant diﬀerences in BOLD signal change between groups within
the happy > neutral or fearful > neutral contrasts. The eﬀect size
maps revealed regions of activation with large eﬀect sizes in response to
fearful > neutral and happy > neutral faces in the AN > HC group
contrast (Supplementary Fig. 1, Supplementary Fig. 2). However, these
regions did not survive whole brain voxel level correction.
4. Discussion
The aim of the current study was to investigate anomalies in the
neural substrates employed during implicit processing of positive and
negative emotional facial expressions in AN. There was a signiﬁcant
diﬀerence between groups in the recruitment of left VLPFC and the
amygdala while processing fearful facial expressions, with the HCs
showing signiﬁcantly increased activation in both of these regions
while the participants with AN did not. Additionally, we found a sig-
niﬁcantly increased activation of the right posterior insula in the AN
group relative to the HC group while viewing happy facial expressions.
No group diﬀerences were found in the fusiform gyri in response to
fearful or happy facial expressions. Similarly, no group diﬀerences were
found in the exploratory whole brain analysis.
The current ﬁndings revealed reduced activation of the left amygdala
in the people with AN relative to the HCs while processing fearful facial
expressions. Regarding the HCs, these ﬁndings are in line with previous
Table 1
Demographic and clinical characteristics.
AN (N = 20) Mean (SD) HC (N = 20) Mean (SD) X2 statistic, p value
Age 28.6 (10.81) 25.75 (3.40) X2 < 0, p = 1.00
Years of education 15.95 (2.56) 16.25 (4.28) X2 = 0.10, p = 0.752
Duration of illness (years) 13.0 (10.1) – –
BMI 15.87 (1.70) 21.15 (2.26) X2 = 27.92, p < 0.001
EDEQ Total 4.16 (0.99) 0.57 (0.54) X2 = 34.11, p < 0.001
EDEQ Restraint 4.20 (1.35) 0.45 (0.53) X2 = 26.95, p < 0.001
EDEQ Eating concern 3.71 (1.06) 0.13 (0.18) X2 = 34.11, p < 0.001
EDEQ Shape concern 4.66 (1.15) 1.05 (0.98) X2 = 26.95, p < 0.001
EDEQ Weight concern 4.07 (1.51) 0.65 (0.70) X2 = 20.63, p < 0.001
DASS Total 70.32 (22.56) 12.30 (13.01) X2 = 27.92, p < 0.001
DASS Anxiety 17.79 (7.54) 1.80 (3.11) X2 = 16.01, p < 0.001
DASS Depression 25.47 (11.03) 2.90 (4.38) X2 = 21.55, p < 0.001
DASS Stress 27.05 (8.34) 7.60 (7.13) X2 = 16.01, p < 0.001
AN = anorexia nervosa; HC = healthy comparison; BMI = body mass index; EDEQ= Eating Disorder Examination Questionnaire; DASS = Depression, Anxiety, and Stress Scale.
Table 2
Gender identiﬁcation mean reaction times and accuracy.
Trial AN (N = 20) Mean (SD) HC (N = 20) Mean (SD) Χ2 statistic, p value
Reaction time (ms) Fearful faces 934.13 (208.12) 812.78 (143.66) Trial: Χ2 = 2.09, p = 0.352
Happy faces 956.15 (227.28) 827.10 (122.32) Group: Χ2 = 64.94, p < 0.001
Neutral faces 951.20 (204.50) 783.80 (100.98) Trial x Group: Χ2 = 2.11, p = 0.348
Accuracy (%) Fearful faces 85.50 (5.60) 89.00 (5.76) Trial: Χ2 = 10.15, p = 0.006
Happy faces 89.75 (3.02) 88.75 (3.58) Group: Χ2 = 4.10, p = 0.043
Neutral faces 87.13 (4.08) 88.38 (2.84) Trial x Group: Χ2 = 10.56, p = 0.005
AN = anorexia nervosa; HC = healthy comparison; ms = milliseconds.
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work showing that healthy individuals show an elevated amygdala re-
sponse to negative emotional facial expressions during both implicit and
explicit tasks (Fitzgerald, Angstadt, Jelsone, Nathan, & Phan, 2006; Hung
et al., 2010; Sato, Yoshikawa, Kochiyama, &Matsumura, 2004). Ad-
ditionally, previous studies in AN have reported reduced recruitment of
the amygdala in people who had recovered from AN relative to HC
participants in an explicit facial emotion processing task (Bang et al.,
2016). Thus, these ﬁndings suggest that blunted amygdala response to
negative facial aﬀect in AN may be trait-like anomaly that persist after
recovery.
The current ﬁndings also showed reduced recruitment of the left
VLPFC in participants with AN relative to the HCs, in response to fearful
facial expressions. Increased activation of the VLPFC in healthy in-
dividuals has been found in studies where participants are presented with
negative facial expression or neutral facial expressions in negative context
(Kim et al., 2004; Marumo, Takizawa, Kawakubo, Onitsuka, &Kasai,
2009; Taylor, Eisenberger, Saxbe, Lehman, & Lieberman, 2006). In AN,
reduced frontal response to emotional facial expression has been
previously reported in an EEG study, which found reduced frontal P300,
while viewing negative facial expressions (Pollatos, Herbert,
Schandry, &Gramann, 2008). Additionally, reduced activation of lateral
and medial PFC regions has been reported in AN while viewing positive
and negative social behaviour (McAdams& Smith, 2015). Such reduced
PFC reactivity has also been associated with poorer general clinical out-
come at 1-year follow-up (Schulte-Rüther et al., 2012). These ﬁndings
highlight the importance of atypical activation of these regions in acute
AN and suggest that this could contribute to illness maintenance.
A possible interpretation of these ﬁndings is that unlike in depres-
sion and anxiety disorders (Groenewold et al., 2013; Mochcovitch et al.,
2014), people with acute AN may show generally blunted reactivity to
negative social-emotional stimuli. This interpretation is supported by
behavioural work that has found that relative to HCs, people with acute
AN display less negative facial aﬀect while viewing negative ﬁlm sti-
muli (Davies, Schmidt, & Tchanturia, 2013; Davies et al., 2016). People
with AN also tend react in an emotionally cold and detached manner to
negative emotionally provoking stimuli relative to HCs (Ambwani et al.,
Fig. 2. Regions of interest ﬁndings in AN and HC participants.
A.) Diﬀerences in signal change between the AN and HC participants in the right posterior insula in the happy> neutral contrast; B.) Diﬀerences in signal change between the AN and HC
participants in the left amygdala in the fear> neutral contrast; C.) Diﬀerences in signal change between the AN and HC participants in the left VLPFC in the fear>neutral contrast. The
bar plots indicate group means and the error bars represent the 95% conﬁdence intervals for the mean. The overlaid violin plots provide an indication of the density and distribution of the
data and the circles inside the violin plots indicate weighted individual data points. Black circles indicate weight of 1, white circles indicate weight of 0, and grey circles indicate reduced
weights. AN = anorexia nervosa; HC = healthy comparison; VLPFC = ventrolateral prefrontal cortex.
Table 3
Regions of interest ﬁndings in AN and HC participants.
Contrast Peak MNI Coordinates Contrast signal change
x y z AN Mean (SE) HC Mean (SE) Max T p value k ROI
Happy>Neutral 38 −16 21 0.26 (0.12) −0.42 (0.10) 4.68 0.0001 14 Insula
Fearful>Neutral −24 −8 −16 −0.08 (0.13) 0.60 (0.14) −3.55 0.001 10 Amygdala
−45 20 9 −0.19 (0.17) 0.90 (0.15) −4.21 < 0.0001 16 VLPFC
Voxel size 1.5 mm× 1.5 mm× 1.5 mm. AN = anorexia nervosa; HC = healthy comparison; MNI = Montreal Neurological Institute; SE = standard error of the mean; k = number of
voxels; ROI = region of interest; VLPFC = ventrolateral prefrontal cortex.
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2015). Taken together these ﬁnding suggest that people with AN may
have atypical blunted response to negative social-emotional cues.
The present study also found a signiﬁcant increased activation of the
right posterior insula in the AN group relative to the HCs while viewing
happy facial expressions. A recent meta-analysis found increased acti-
vation of the posterior insula in people with AN relative to HC parti-
cipants when processing stimuli depicting bodies using a variety of
paradigms, including comparing own body to images of slim bodies
(Zhu et al., 2012). Among healthy individuals, such increased activa-
tion of the bilateral posterior insula has previously been associated with
perception and experience of emotions, particularly negative emotions
(Duerden, Arsalidou, Lee, & Taylor, 2013; Grecucci, Giorgetta, van't
Wout, Bonini, & Sanfey, 2013; Waugh et al., 2016). Furthermore,
healthy individuals show increased activation of the posterior insula in
response to a task involving up-regulation of others’ negative intentions
(Grecucci et al., 2013).
The above ﬁndings suggest that people with AN may exhibit aty-
pical reactivity to positive social-emotional stimuli that is similar to
that seen in healthy individuals in response to negative stimuli. This
interpretation is supported by previous behavioural work showing that
people with AN have a tendency to avoid positive emotions (Lampard,
Byrne, McLean, & Fursland, 2011). Additionally, when presented with
positive ﬁlm clips people with AN display fewer reciprocal positive
facial expressions, and report less positive subjective positive aﬀect and
more negative positive aﬀect than HC participants (Cardi et al., 2015;
Davies et al., 2011; Davies et al., 2016; Lang et al., 2016). Additionally,
people with AN report greater social anhedonia and general diﬃculties
deriving pleasure from social interactions (Tchanturia et al., 2012).
Taken together, these ﬁndings suggest that people with AN may have an
atypical reaction to positive social-emotional stimuli.
4.1. Clinical implications
The present ﬁndings diﬀer from what is seen in depression and
anxiety disorders, and suggest that a generally blunted response to
negative and atypical response to positive social-emotional information
in acute AN. When taken together with recent ﬁndings in people who
have recovered from AN (Bang et al., 2016), the ﬁndings suggest that a
blunted response to negatively valenced stimuli may persist after re-
covery. Reduced reactivity to emotional stimuli has been suggested to
have negative aﬀective and social consequences, including elevated
negative mood, negative social evaluation by others, and increased
isolation (Butler, Lee, & Gross, 2009; Gross, 2002; Szczurek et al.,
2012). Furthermore, atypical emotional reactivity in AN also has ne-
gative impact on carers and has been associated with increased anxiety
and anger in the family (Treasure et al., 2012). Thus, these social-
emotional processing diﬃculties in AN are important targets for inter-
ventions.
4.2. Limitations
The main limitation of the current study was the relatively small
sample size limiting the exploration of potential confounding eﬀects of
AN subtypes, inpatient treatment, and medication. However, we took
steps to combat this by exploring the eﬀects of eating disorder psy-
chopathology and medication status on the present ﬁndings in post-hoc
correlational analyses. Additionally, since we did not include weight
restored AN participants or people recovered from AN, it is also not
possible to ascertain to what extent the present ﬁndings are due to
malnutrition. Therefore, future studies with larger and balanced sam-
ples are required to replicate and further explore the impact of medi-
cation on neural correlates of social-emotional processing in AN.
Future, studies would also beneﬁt from further exploring the neural
correlates of social-emotional processing diﬃculties across age and
duration of illness.
Although the present study explored the impact of self-reported
eating pathology and medication status on the ﬁndings in correlational
analyses, we did not examine the impact of comorbid disorders.
Previous studies have reported that people with AN report higher levels
of a number of comorbidities that could impact social-emotional pro-
cessing, such as autistic symptoms and alexithymia (Caglar-Nazali
et al., 2014; Doris, Westwood, Mandy, & Tchanturia, 2014; Westwood
et al., 2016).Future studies would beneﬁt from investigating the impact
of autistic symptoms and alexithymia on neural processes recruited
during social processing in AN.
Finally, the current study only used happy and fearful facial ex-
pressions. Utilising a wider range of emotional facial expressions, in-
cluding disgust, anger and sadness would be of interest. Furthermore,
the current study also only used static images without context. Future
studies would beneﬁt from using more ecologically relevant designs
that include dynamic facial expressions with contextual information.
5. Conclusions
The current study investigated neural mechanisms that underlie
processing of fearful and happy facial expressions in AN. The ROI
ﬁndings revealed decreased BOLD signal in the left amygdala and
VLPFC while processing fearful facial expressions in the AN participants
compared to HC. Additionally, we found a cluster in the right posterior
insula with a relative increase in the BOLD signal while processing
happy facial expressions in AN, but not in the HC participants. These
ﬁndings go some way to support the social-emotional elements of the
cognitive-interpersonal maintenance model and calls for interventions
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Difficulties in social–emotional processing have been proposed to play an important
role in the development and maintenance of anorexia nervosa (AN). Few studies,
thus far, have investigated neural processes that underlie these difficulties, including
processing emotional facial expressions. However, the majority of these studies have
investigated neural responses to adult emotional display, which may be confounded by
elevated sensitivity to social rank and threat in AN. Therefore, the aim of this study
was to investigate the neural processes underlying implicit processing of positively
and negatively valenced infant emotional display in AN. Twenty-one adult women with
AN and twenty-six healthy comparison (HC) women were presented with images of
positively valenced, negatively valenced, and neutral infant faces during a fMRI scan.
Significant differences between the groups in positive > neutral and negative > neutral
contrasts were investigated in a priori regions of interest, including the bilateral
amygdala, insula, and lateral prefrontal cortex (PFC). The findings revealed that the AN
participants showed relatively increased recruitment while the HC participants showed
relatively reduced recruitment of the bilateral amygdala and the right dorsolateral PFC
in the positive > neutral contrast. In the negative > neutral contrast, the AN group
showed relatively increased recruitment of the left posterior insula while the HC groups
showed relatively reduced recruitment of this region. These findings suggest that people
with AN may engage in implicit prefrontal down-regulation of elevated limbic reactivity to
positively social–emotional stimuli.
Keywords: eating disorders, anorexia nervosa, fMRI, emotional infant faces, implicit
INTRODUCTION
Recent large scale meta-analyses and systematic reviews have found that people with anorexia
nervosa (AN) have di culties in various aspects of social–emotional processing, including theory
of mind and accurate interpretation of emotions (Caglar-Nazali et al., 2014; Bora and Köse, 2016).
Another recent meta-analysis also found that people with AN show a behavioral pattern of reduced
expression of emotions when viewing both positive and negative emotionally provoking stimuli
(Davies et al., 2016). Additionally, behavioral studies have reported that people with AN also
show greater attentional bias toward threatening emotional facial expressions, such as rejecting
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and angry faces, and attentional avoidance of positive facial
expressions, such as accepting and happy faces (Harrison
et al., 2010; Cardi et al., 2013, 2015). Furthermore, people
with AN show elevated sensitivity to social rank, and report
more submissive behavior and feelings of shame (Troop
and Baker, 2008; Cardi et al., 2014b; Troop, 2016). These
di culties have been proposed to play an important role in
the development and maintenance of disordered eating in AN,
increasing isolation and negative mood (Treasure and Schmidt,
2013). Further investigation of the underlying mechanisms is of
interest.
Few studies to date have investigated the neural mechanisms
that underlie these di culties in social–emotional processing
in AN. A recent systematic review of the literature found that
relative to healthy comparison (HC) participants, people with
AN show atypical, reduced recruitment in regions such as
lateral and medial prefrontal cortex (PFC) in response to social–
emotional behavior (McAdams and Smith, 2015). Additionally,
a prospective study by Schulte-Rüther et al. (2012) found
that reduced recruitment of the prefrontal regions in response
to social–emotional behavior at admission to hospital was
associated with poorer outcome. Interestingly, other studies have
found that when asked to select negatively valenced social words
or view provoking stimuli, such as food images, people with
AN show greater recruitment of cortical regions, including the
dorsolateral PFC and insula, relative to healthy control (HC)
participants (Brooks et al., 2011, 2012a; Miyake et al., 2012;
Brooks, 2016). Additionally, a recent study by Fonville et al.
(2014) investigated neural response to positive facial expressions
in acute AN and found a linear increase in neural activation in
the right fusiform gyrus, which was greater in the AN group than
the HC group. Taken together, these findings suggest that atypical
recruitment of lateral prefrontal, insular, and visual attention
regions may underlie di culties in social–emotional processing
in AN.
The above mentioned studies have largely focused on
investigating atypical emotional processing in the context of peer,
adult social–emotional display, which may be confounded by
elevated sensitivity to social rank and threat in AN. It would
be of interest to explore whether atypical emotional processing
extends across lifespan to, for example pre-language infant
emotional display. Adults in general are uniquely attuned to
social–emotional signaling from infant faces due to absence of
language (Brosch et al., 2007; Parsons et al., 2011; Thompson-
Booth et al., 2014). Additionally, relative to adult faces infant
faces have been found to be perceived as less threatening,
more helpless, and evoke caregiving responses in adults (Berry
and McArthur, 1985, 1986; Parsons et al., 2011; Senese et al.,
2013). Neuroimaging studies have found that relative to adult
faces infant faces strongly activate regions involved in social–
emotional processing including the lateral PFC and insula, and
regions involved in visual attention, such the fusiform gyrus
(Caria et al., 2012; Rocchetti et al., 2014). Furthermore, emotional
infant faces have been found to strongly recruit limbic regions
including the amygdala, as well as multiple areas in the frontal
cortex, including the lateral PFC, in healthy adults (Baeken et al.,
2009; Montoya et al., 2012).
A study by Cardi et al. (2014a) found that people with eating
disorders (EDs) show anomalies in processing infant emotional
display. Interestingly, unlike with emotional adult faces, Cardi
et al. (2014a) found no significant di erences between the people
with EDs and HC participants in attentional bias toward positive
and negatively valenced emotional infant faces (Cardi et al.,
2015). However, relative to HC participants, people with EDs
interpreted the positively valenced infant stimuli to be less
positive and reported more subjective negative a ect in response
to negative infant display (Cardi et al., 2014a). Additionally, the
participants with EDs displayed fewer positive facial expressions
while viewing a positively valenced infant display (Cardi et al.,
2014a). These findings suggest that people with EDs may have
a tendency to interpret emotional stimuli in a negative way and
display reduced facial a ect, which are not restricted to peer,
other-adult emotional displays, but extends to less threatening
and motivationally salient infant emotional expression. However,
to our knowledge no studies to date have investigated the neural
responses to infant emotional expression in EDs, which could
shed light on the mechanisms that may underlie these atypical
responses.
Few studies in mood and anxiety disorders, common co-
morbid disorders in AN, have investigated neural responses to
motivationally salient emotional infant stimuli (Baeken et al.,
2010; Schechter et al., 2012; Wonch et al., 2016). A study
investigating neural responses to emotional infant stimuli among
people with melancholic depression found increased activation
in regions including the ventrolateral PFC (VLPFC) and inferior
occipital cortex, while viewing positively valenced infant faces
relative to scrambled stimuli (Baeken et al., 2010). Another
study found that relative to healthy mothers, mothers with
postnatal depression showed greater amygdala response to
unfamiliar positively valenced infant faces (Wonch et al., 2016).
The authors also found that mothers with postnatal depression
showed reduced functional connectivity between the amygdala
and insula while viewing positively valenced infant stimuli
(Wonch et al., 2016). Additionally, previous work has found
that mothers with interpersonal trauma related post-traumatic
stress disorder (PTSD) showed increased recruitment of regions
involved in emotion processing and regulation, including the
posterior insula, amygdala, and dorsolateral PFC (DLPFC), while
viewing distressed unfamiliar infants relative to content infants
(Schechter et al., 2012). Taken together, these findings suggest
that there may be deficits in elevated insular and limbic reactivity,
and prefrontal down-regulation in response to motivationally
salient infant emotion in these disorders.
The aim of the current study was to investigate the neural
correlates that underlie implicit processing of infant emotion
in people with AN relative to HC participants. Based on the
previous findings from studies investigating neural response to
social–emotional stimuli in people with AN outlined above, we
hypothesized that we would find atypical increased recruitment
of regions involved in emotion down-regulation, namely the
bilateral lateral PFC, in response to emotional infant faces.
Additionally, based on previous neuroimaging work among
people with anxiety and mood disorders we hypothesized that
the AN group would show atypical elevated neural response
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to emotional infant faces in regions associated with emotional
processing, including the bilateral amygdala and insula. These
hypotheses were investigated with regions of interest approach.
MATERIALS AND METHODS
Participants
Forty-seven adult women took part in the study. Twenty-one
women had a current DSM-5 diagnosis of AN. Fifteen women
with AN were recruited through advertisements placed on EDs
charities websites (BEAT and Succeed) and six women with
AN were recruited from the South London and Maudsley NHS
Foundation Trust inpatient unit. All AN participants recruited
from the inpatient unit were receiving treatment at the time of
the study. Twenty-six HCs with a BMI between 18.5 and 25
and no history of psychiatric disorders were recruited amongst
King’s College London students and sta  who responded to
advertisements placed on the university’s website. The Structured
Clinical Interview for DSM-5 was used to confirm AN diagnosis,
and to screen for psychiatric disorders in the HC group (First
et al., 2015). Both groups were matched for age and level
of education. Participants were excluded from the study if
they were left handed or reported a history of head trauma,
neurological disease, uncorrected hearing or visual impairment,
acute suicidality, history of or current alcohol or drug abuse, or
MRI incompatibility (i.e., implanted medical devices of any kind,
history of accidents involving metal, any metal in or on the body
that cannot be removed, claustrophobia, pregnancy). Additional
exclusion criteria for the AN group included psychotropic
medication other than selective serotonin reuptake inhibitors
(SSRIs). Prior to taking part in the study, all participants were
asked to give written informed consent, and were compensated
for their time. The study was conducted in accordance with the
latest version of the Declaration of Helsinki (1975, as revised
in 2008) and was approved by a local National Research Ethics
Service (NRES) committee (11/LO/0373).
Clinical and Questionnaire Measures
The Eating Disorder Examination Questionnaire (EDEQ), a 36-
item self-report measure, was used to assess ED behaviors and
attitudes over the past 28 days (Fairburn and Beglin, 1994). In
the current study, internal consistency of EDEQ was high, with
Cronbach’s alpha of 0.90.
The Depression, Anxiety, and Stress scale (DASS) is a 21-item
self-report measure assessing severity of depression, anxiety, and
stress over the past week (Lovibond and Lovibond, 1995). In the
current study, internal consistency of the DASS was high, with
Cronbach’s alpha of 0.97.
Functional Magnetic Resonance Imaging
(fMRI) Procedure
Participants were presented with black and white photographs of
prototypical positively valenced (smiling), prototypical negatively
valenced (crying), and neutral infant faces during a 12-min
fMRI scanning session. The images were matched for physical
FIGURE 1 | Implicit emotion processing task. The positively valenced,
negatively valenced, and neutral infant faces were presented one at a time for
2000 ms during which time participants identified the gender of each face.
Faces were preceded by a fixation cross the presentation of which was jittered
between 1000 and 6000 ms.
properties, including size, contrast, and luminosity. The stimuli
were acquired from a validated set of infant emotional facial
expressions and composed of ten di erent babies (five female,
five male) (Kringelbach et al., 2008). The images were used with
approval from the authors.
The task employed an event-related design, in which the
faces were presented one at a time for 2000 ms separated by a
fixation cross (Figure 1). Ten positively valenced, ten negatively
valenced, and ten neutral infant faces were presented in a
pseudorandomized order to avoid learning e ects and avoid
positive and negative faces following one another. The fixation
cross inter-stimulus interval was jittered to vary between 1 and
6 s (mean 3.0 s) in order to prevent participants from being
able to predict the onset of the trials. While viewing the faces
participants were asked to indicate the gender of the faces using
the control pad to ensure that they paid attention to the stimuli.
The participants were told that the gender identification task
would be di cult, to not think about their answers toomuch, and
give their best guess. They were informed that the main goal was
to attend to the stimuli and were not given feedback regarding
their performance during the task.
Data Acquisition
TheGE Signa 1.5 Tesla scanner (GEMedical Systems,Milwaukee,
WI, USA) was used to acquire the magnetic resonance images
at the King’s College London, Centre for Neuroimaging Sciences
(CNS). An 8-channel radiofrequency birdcage head coil was
used to transmit and receive the signal. High resolution T1-
weighted magnetization-prepared rapid gradient echo (MP-
RAGE) structural images were acquired with a repetition
time (TR) of 8.592 ms, and 1.2 mm slice gap, and 1.2 mm
slice thickness. One hundred and eighty slices were used to
achieve whole brain coverage with an in-plane resolution of
1.25 mm ⇥ 1.25 mm. Following the structural scan, a functional
blood oxygen level dependent (BOLD) signal was acquired using
interleaved T2⇤ weighted echo planar imaging (EPI) with TR
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of 2 s, and 0.4 mm slice gap, and 4 mm slice thickness. Thirty
slices were used to achieve whole brain coverage with in-plane
resolution of 3.75mm⇥ 3.75mm. Data quality was assured using
an automated quality control procedure (Simmons et al., 1999).
Statistical Analysis
Behavioral and Self-report Data
Behavioral and self-report questionnaire data were analyzed
with Stata 14 (StataCorp. 2015, College Station, TX, USA:
StataCorp LP.). Group di erences in demographic variables
and questionnaire responses were investigated using non-
parametric median Chi2 tests. The behavioral data from the
gender identification task was analyzed with 2 ⇥ 3 linear
mixed models with group (AN, HC) and valence (positive,
negative, neutral) entered as fixed e ects and a random intercept.
Significant interactions were explored with post hoc contrasts and
pairwise comparisons. P-values of 0.05 or lower were considered
significant.
Functional Neuroimaging Data
FMRI data pre-processing was conducted using SPM8
(Wellcome Department of Cognitive Neurology, Institute
of Neurology, London) implemented in MATLAB, version
8.2.0 (Mathworks, Natick, MA, USA). The functional data was
corrected for slice-timing and volume-to-volume head motion.
The functional data was re-sliced and following re-slicing
the voxel size was 1.5 mm ⇥ 1.5 mm ⇥ 1.5 mm. Following
correction the functional images were co-registered to a T1-
weighted DARTEL template created from each participant’s
high resolution MP-RAGE structural image (Ashburner, 2007).
The images were smoothed with an 8 mm FWHM three-
dimensional isotropic Gaussian Kernel and normalized to
Montreal Neurological institute (MNI) space.
At subject level, the data was modeled using the general linear
model framework implemented in SPM8. The BOLD signal was
modeled using a single canonical HRF, and the predicted BOLD
response was modeled for each of the following conditions:
positively valenced faces, negative valenced faces, and neutral
faces. Twenty four motion parameters were calculated and used
to adjust the time series data for head motion (Friston et al.,
1996). Low frequency drift was filtered out of the data using a
high-pass filter set to 1/128 s. The subject level model produced
the following contrast images: positive faces > neutral faces, and
negative faces> neutral faces.
The robust regression toolbox (Wager et al., 2005)1
implemented in Matlab 2016b was used to conduct group
level random e ects analysis. The robust regression toolbox uses
iteratively re-weighted least squares (IRLS), which identifies
and outweighs influential, extreme outliers. Thus, the IRLS
analysis minimizes the impact of extreme outliers and reduces
the likelihood of false positive and negative findings with no
reduction in power (Wager et al., 2005; Fritsch et al., 2015). We
chose this approach to avoid false findings arising from head
motion, scanner-related artifacts, or individual participants who
were particularly depressed, anxious, stressed, or otherwise vastly
1https://github.com/canlab/RobustToolbox
di ered from the rest of the sample during the MRI scan, which
could have led them to process the social–emotional stimuli in a
di erent way (Leppänen et al., 2004; Wager et al., 2005; Kircanski
et al., 2014).
The contrast images were first entered into region of interest
(ROI) analyses to investigate a priori hypothesis within the
following bilateral regions: amygdala, insula, and lateral PFC.
Anatomical masks of these regions were created using the
WFU Pickatlas implemented in SPM8. In the IRLS analysis
group was added as a contrast coded covariate (1,  1: AN,
HC) with positive test statistics indicating relatively increased
activation in the AN group and negative test statistics indicating
relatively increased activation in the HC group. The ROI findings
were corrected for multiple comparisons with a voxel-wise
non-parametric permutation test as recommended by Eklund
et al. (2016) (a < 0.05). The permutation test uses the max T
distribution to identity a critical threshold to control for family-
wise error rate. The permutation test was conducted with 10000
iterations.
Where significant group di erences were present, mean signal
change data was extracted from the clusters. The data was entered
into further analysis to investigate if the atypical activation
within the AN group correlated with BMI, duration of illness,
medication status, DASS total score, or EDEQ total score. The
correlational analyses were conducted using Spearman’s rho in
Matlab 2016b.
Whole brain exploratory analysis was conducted to investigate
brain responses to positive and negative infant faces in
AN. As above, in order to explore di erences in brain
responses between AN and HC groups, group was added as
a contrast coded covariate (1,  1: AN, HC) in the IRLS
analyses. The following contrasts were included in the whole
brain analysis: positive faces > neutral faces and negative
faces > neutral faces. The whole brain analysis was corrected
with voxel-wise False Discovery Rate (FDR) thresholded at
q < 0.05. E ect size, and lower and upper bound 99.9%
confidence interval maps for the whole brain analyses were
generated using the EScalc toolbox implemented in Matlab2
(Gao and Zang, 2015), and are presented in Supplementary




Demographic and clinical characteristics of both groups are
presented in Table 1. Participants did not di er significantly in
age or level of education. However, as expected, the AN group
had significantly lower BMI and reported higher depression,
anxiety, stress, and ED psychopathology than the HC group.
Medication status provides the number and the percentage
of AN participants taking SSRIs during the time of the
study.
2http://restfmri.net
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TABLE 1 | Sample clinical and demographic characteristics.
AN (N = 21) Median [Q1, Q3] HC (N = 26) Median [Q1, Q3] X2 (DF) statistic, p-value
Age 25.00 [20.00, 34.50] 25.50 [23.00, 28.00] X2 (1) = 0.001, p = 0.969
Level of education (years) 16.00 [14.00, 17.00] 17.00 [14.00, 20.00] X2 (1) = 0.09, p = 0.766
BMI 15.84 [14.8, 16.76] 19.90 [19.38, 21.88] X2 (1) = 24.68, p < 0.001
Medication status N (%) 12 (57%) – –
EDEQ total 3.87 [3.41, 5.02] 0.31 [0.14, 0.58] X2 (1) = 34.04, p < 0.001
EDEQ restraint 4.20 [3.60, 5.20] 0.20 [0.00, 0.60] X2 (1) = 30.39, p < 0.001
EDEQ eating concern 3.90 [3.20, 4.40] 0.00 [0.00, 0.20] X2 (1) = 37.38, p < 0.001
EDEQ weight concern 3.80 [3.00, 5.50] 0.40 [0.00, 0.60] X2 (1) = 27.40, p < 0.001
EDEQ Shape concern 4.75 [3.44, 5.69] 0.63 [0.25, 1.13] X2 (1) = 37.38, p < 0.001
DASS total 67.00 [54.00, 88.00] 9.00 [4.00, 12.00] X2 (1) = 31.93, p < 0.001
DASS anxiety 19.00 [13.00, 23.00] 0.00 [0.00, 2.00] X2 (1) = 25.57, p < 0.001
DASS depression 24.00 [18.00, 35.00] 2.00 [0.00, 4.00] X2 (1) = 25.57, p < 0.001
DASS stress 28.00 [19.00, 34.00] 4.00 [2.00, 10.00] X2 (1) = 25.57, p < 0.001
AN, anorexia nervosa; HC, healthy comparison; BMI, body mass index; EDEQ, Eating Disorder Examination Questionnaire; DASS, Depression, Anxiety, and Stress Scale;
Medication status, percentage of AN participants taking anti-depressants; Q1, first quartile, Q3, third quartile, DF, degrees of freedom.
Task Performance
The gender identification task performance in the AN and
HC groups is presented in Table 2. Regarding accuracy, the
mixed e ects model revealed a significant e ect of trial with
participants performing better in the neutral trials than positive
trials (Z = 24.97, p < 0.001, 95% CI [0.43, 0.50]) or negative
trials (Z = 24.32, p < 0.001, 95% CI [0.44, 0.52]). There were
no significant di erences between participants performance on
the positive and negative trials (Z =  0.95, p = 0.340, 95% CI
[ 0.06, 0.02]).
Similarly, the mixed e ects model also revealed a significant
e ect of trial in participants’ reaction times (Table 2). Participants
were significantly faster in the neutral trials than positive trials
(Z =  3.59, p < 0.001, 95% CI [ 125.03,  36.75]) and
positive trials than negative trials (Z =  2.62, p = 0.009, 95%
CI [ 117.78,  17.01]). There were no significant di erences
between participants reaction times in the neutral and negative
trials (Z = 0.61, p= 0.540, 95% CI [ 56.68, 29.69]). There was
also a significant e ect of group in participants’ reaction times
(Table 2), with HC participants responding significantly faster
than AN participants across trials (Z =  3.70, p < 0.001, 95%
CI [ 158.04, 48.55]).
Regions of Interest Findings
We conducted ROI IRLS analyses to investigate group di erences
in activation in response to positively valenced and negatively
valenced infant faces within the following masks: amygdala,
insula, and lateral PFC. The ROI findings for group di erences
are presented in Figure 2 and Table 3.
Positive > Neutral
The ROI findings revealed a significant di erence between the
groups in recruitment of a very small cluster in the right DLPFC
in the positive > neutral contrast (Table 3). Exploration of the
mean contrast signal change suggested that the group di erences
in the DLPFC was driven by relatively increase in recruitment
in the AN group in this contrast (Figure 2A). Similarly, a
significant di erence between the groups in recruitment of
the bilateral amygdala in the positive > neutral contrast was
observed (Table 3). Exploration of the mean contrast signal
change suggested that the group di erence observed in the
amygdala was driven by relatively increased recruitment in the
AN group and reduced recruitment in the HC group in this
contrast (Figures 2B,C).
Post hoc correlational analysis within the AN group revealed
that the mean contrast signal change in the DLPFC and amygdala
ROIs did not significantly correlate with psychopathology,
medication status, BMI, or duration of illness in this contrast
(Supplementary Table S1).
Negative > Neutral
There was a significant di erence between the AN and HC
groups in recruitment of the left posterior insula in the
negative > neutral contrast (Table 3). Exploration of the mean
contrast signal change revealed that the group di erence was
brought on by relatively increased recruitment in the AN group
and reduced recruitment in the HC group in this contrast
(Figure 2D).
Post hoc correlational analysis within the AN group revealed
that the mean contrast signal change in the insula ROI did not
significantly correlate with psychopathology, medication status,
BMI, or duration of illness in this contrast (Supplementary
Table S1).
Whole Brain Findings
The positively valenced faces > neutral faces and negatively
valenced faces > neutral faces contrasts did not yield areas
of significant group di erences in the whole brain exploratory
search.
DISCUSSION
The aim of the current study was to investigate di erences
in neural mechanisms that underlie implicit processing of
Frontiers in Psychology | www.frontiersin.org 5 May 2017 | Volume 8 | Article 780
fpsyg-08-00780 May 15, 2017 Time: 17:32 # 6
Leppanen et al. Infant Emotion in Anorexia Nervosa
TABLE 2 | Gender identification task performance in the AN and HC groups.
Trial AN (N = 21) HC (N = 26) X2 (DF) statistic, p-value
Accuracy (%) Positive 27.50 (9.80) 30.19 (8.42) Group: X2 (1) = 0.13, p = 0.717
Negative 28.00 (7.68) 27.50 (7.78) Trial: X2 (2) = 832.59, p < 0.001
Neutral 73.55 (7.61) 72.73 (5.29) Group ⇥ Trial: X2 (2) = 0.85, p = 0.653
RT (ms) Positive 1197.72 (433.12) 1094.15 (182.48) Group: X2 (1) = 13.68, p = 0.0002
Negative 1254.36 (352.47) 1172.30 (190.39) Trial: X2 (2) = 13.29, p = 0.001
Neutral 1194.57 (392.48) 1070.32 (154.87) Group ⇥ Trial: X2 (2) = 0.94, p = 0.624
AN, anorexia nervosa; HC, healthy comparison; RT, reaction time, DF, degrees of freedom.
FIGURE 2 | Regions of interest findings in AN and HC participants. (A) Statistical parametric map of the right lateral PFC ROI with parameter estimate bar plot
showing mean activation in the right DLPFC cluster in the positive > neutral contrast. (B) Statistical parametric map of the bilateral amygdala ROI with parameter
estimate bar plot showing mean activation in the right amygdala cluster in the positive > neutral contrast (C) Statistical parametric map of the bilateral amygdala ROI
with parameter estimate bar plot showing mean activation in the left amygdala cluster in the positive > neutral contrast. (D) Statistical parametric map of the bilateral
insula ROI with parameter estimate bar plot showing mean activation in the left posterior insula cluster in the negative > neutral contrast. The Y-axis shows mean
contrast signal change.
emotional infant faces between AN and HC participants. As
hypothesized, group di erences emerged in the recruitment of
the left posterior insula, bilateral amygdala, and the right DLPFC
between the AN and HC groups. A very small cluster in the
right DLPFC showed increased recruitment in the AN group,
but not the HC group, while viewing positively valenced infant
TABLE 3 | Regions of interest findings in AN and HC participants.
Peak MNI coordinates Contrast signal change
Contrast x y z AN Mean (SE) HC Mean (SE) Max T statistic, p-value k ROI
Positive > Neutral  18  3  14 0.10 (0.07)  0.27 (0.10) t = 3.85, p = 0.0008 24 Amygdala
20 3  17 0.09 (0.08)  0.60 (0.15) t = 3.54, p = 0.0002 14 Amygdala
36 2 38 0.30 (0.06)  0.15 (0.07) t = 4.17, p < 0.0001 4 DLPFC
Negative > Neutral  41  11  5 0.20 (0.11)  0.58 (0.17) t = 4.18, p = 0.0001 24 Insula
AN, anorexia nervosa; HC, healthy comparison; ROI, region of interest; MNI, Montreal Neurological Institute; DLPFC, dorsolateral prefrontal cortex; SE, standard error of
mean; k, number of voxels; voxel size 1.5 mm ⇥ 1.5 mm ⇥ 1.5 mm.
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faces relative to neutral faces. Interestingly, the bilateral amygdala
showed relatively reduced recruitment in the HC group, but
not the AN group, in this contrast. While viewing negatively
valenced faces relative to neutral faces, the AN groups showed
increased recruitment of the left posterior insula, while the HC
group showed relatively reduced recruitment of this region. The
whole brain analysis did not reveal any further regions showing
significant di erences between the groups in either contrast.
The present ROI findings revealed increased recruitment of a
very small cluster in the right DLPFC in the AN group relative
to the HC group when viewing images of positively valenced
infant faces. Similar increased recruitment of the lateral PFC
has also been found in women with melancholic depression
while viewing positively valenced infant faces (Baeken et al.,
2010). Increased recruitment of the right DLPFC has also been
found among people with depression while viewing salient,
positive emotional stimuli, including smiling faces (Jaworska
et al., 2015). Further, one study reported a positive correlation
between recruitment of the right DLPFC and valence rating
of emotional stimuli among people with depression, whereas
an inverse correlation was observed among healthy individuals
(Grimm et al., 2008). Indeed, increased recruitment of the right
DLPFC is often reported among healthy participants during
working memory tasks, and while processing negative emotional
stimuli particularly when explicitly asked to down-regulate
subjective negative emotional responses to intense distressing
stimuli (Goldin et al., 2008; Wager et al., 2008; Ochsner et al.,
2012; Criaud and Boulinguez, 2013). Similarly, increased lateral
and medial prefrontal activation has been reported among
healthy women in response to negatively valenced infant stimuli,
including images of distressed infants and the sound of infant cry
(Baeken et al., 2009; Montoya et al., 2012). Thus it appears that
in the healthy population the DLPFC activation is as associated
with a form of top-down control to regulate emotional responses
to negative stimuli. However, it seems that in AN as well as
depression this mechanism may be activated in response to
positive emotional stimuli. Still, it is of importance to note that
the cluster in the right DLPFC in the present study was very
small and replication of these findings is necessary before firm
conclusions can be drawn.
The present study also found relatively reduced recruitment
of the bilateral amygdala among HC participants, but not among
AN participants, while viewing positively valenced infant faces.
Reduced recruitment of the bilateral amygdala has also previously
been found among healthy individuals while processing positive
emotional adult faces (Cowdrey et al., 2012). Interestingly, similar
reduced recruitment of the amygdala in response to positive facial
expressions has also been reported in people who have recovered
fromAN (Cowdrey et al., 2012). Additionally, relatively increased
recruitment of the amygdala has been found previously among
mothers with postnatal depression while viewing positive infant
stimuli (Wonch et al., 2016). Furthermore, a number of studies
have found that in addition to increased recruitment of the
right DLPFC, people with depression show relatively increased
recruitment of the amygdala while processing salient, positive
emotional stimuli (Jaworska et al., 2015). One study also reported
correlated increase in the recruitment of the bilateral amygdala
and right DLPFC in people with depression while processing
positive emotional facial expressions (Liao et al., 2012).Moreover,
as with people recovered from AN, a few studies investigating
di erences in neural activation in response to positive social–
emotional stimuli between people recovered from depression and
HC participants have reported no significant di erences in the
recruitment of the amygdala (Dutra, 2012; Kerestes et al., 2012).
Taken together these findings suggest that atypical activation of
the bilateral amygdala while processing salient positive social–
emotional stimuli may be related to acute state of illness in AN
and depression.
A possible interpretation of the above findings is that people
with acute ANmay engage in implicit prefrontal down-regulation
of elevated amygdala reactivity to positively valenced infant
stimuli. Indeed, the wealth of previous work in depression has
suggested that increased recruitment of the DLPFC and the
amygdala in response to positive emotional stimuli to be linked
with attempts to down-regulate positive mood (Kupfer et al.,
2012). Previous studies have also found that people with AN
show greater implicit cognitive control relative to HC during
working memory tasks demonstrated by equivalent behavioral
performance, but elevated DLPFC activation (Brooks et al.,
2012b; Brooks, 2016). This interpretation would be in line with
findings from previous behavioral studies reporting reduced
facial expressivity in people with ANwhile viewing positive infant
stimuli (Cardi et al., 2014a). Furthermore, these findings are
also supported by the steady accumulation of studies reporting
reduced facial expressivity in response to general emotionally
provoking positive films among people with AN (Davies et al.,
2016). Positive facial expressivity has also been found to correlate
positively with BMI and negatively with ED psychopathology
among people with acute AN (Dapelo et al., 2016; Lang et al.,
2016). People recovered from AN, on the other hand, do
not display similar reduced facial expressivity to emotionally
provoking positive stimuli (Davies et al., 2013). However, as the
cluster in the right DLPFC in the present study was very small,
replication of these findings with a larger sample is necessary
before firm conclusions can be drawn.
The present findings also revealed relatively increased
recruitment of the left posterior insula in the AN group and
relatively reduced recruitment of this region in the HC group
when viewing negatively valenced infant faces. Similar pattern
of increased recruitment of the left posterior insula has been
seen in mothers with interpersonal trauma related PTSD while
viewing videos of distressed unfamiliar infants (Schechter et al.,
2012). The increased recruitment of the posterior insula was also
associated with increased levels of subjective distress as reported
by these mothers, which has been speculated to indicate emotion
dysregulation and di culties in down-regulating subjective
negative emotions such as feelings of distress and helplessness
(Schechter et al., 2012). Furthermore, increased recruitment
of posterior insula has been previously found in response to
intense sadness and distress in healthy and depressed individuals,
with recovery from depression being marked by decreased
recruitment of the posterior insula (Mayberg et al., 1999).
Thus, a possible interpretation of this finding is that people
with ANmay experience greater subjective distress while viewing
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salient, negative infant stimuli. Indeed, the posterior insula
has been suggested to play an important role in processing of
emotional salience and interoceptive awareness (Craig, 2009;
Menon and Uddin, 2010; Duerden et al., 2013). Hyperactivation
of this region in response to negative emotional stimuli has been
associated with subjective feelings of distress among healthy and
clinical populations (Mayberg et al., 1999; Schechter et al., 2012).
This would be in line with behavioral studies showing that people
with AN report generally elevated social anxiety and distress, and
report more subjective negative a ect in response to emotionally
provoking negative stimuli (Gilboa-Schechtman et al., 2006; Lang
et al., 2016). Furthermore, one study found that subjective distress
significantly mediated di culties in emotional awareness and
attention toward emotions in AN (Gilboa-Schechtman et al.,
2006). Taken together, these findings suggest that posterior insula
may play an important role in processing negative emotional
information in AN and further exploration of this regions in
context of subjective negative a ect would be of interest.
Clinical Implications
The current findings are in line with previous behavioral studies
suggesting that people with AN may engage in implicit down-
regulation of emotions and report elevated subjective distress
while viewing particularly salient positive and negative stimuli,
respectively (Cardi et al., 2014a; Davies et al., 2016). Suppression
of emotional responses can have generally negative emotional
and social consequences, including elevated negative mood and
social isolation (Gross, 2002; Szczurek et al., 2012). Furthermore,
reduced emotional expression in response to infant emotional
display can have profoundly disruptive e ect on the infant
as demonstrated with the still face paradigm (Weinberg and
Tronick, 1994) and this may ultimately impact the development
of the children of mothers with AN (Micali et al., 2014). Thus,
these findings further highlight the need for interventions that
target atypical social–emotional processing, including down-
regulation of positive emotions and elevated subjective distress,
in AN. Pending replication, the present findings may serve as
useful targets to assess e ectiveness of such interventions.
Limitations
The main limitation of this study was the gender identification
task chosen to ensure that participants paid attention to the
stimuli and allow exploration of neural mechanisms underlying
implicit emotion processing. Although this task has been
previously used successfully with images of adult faces (Fonville
et al., 2014), in the present study both groups exhibited poor
accuracy in identifying the infants’ gender in the emotional
context. Tasks that the participants find too di cult can lead
to increased recruitment of other regions in order to try and
cope with the task demands or, in some cases, participants
may “give up” leading to less time spent on task (Bookheimer,
2000; Huddleston and DeYoe, 2008; Pressman and Gitelman,
2012). Additionally, increasing task demands can influence
the processing of social–emotional stimuli leading to reduced
recruitment of regions typically involved in emotion processing,
such as the amygdala (Blair et al., 2007). Although, in the
current study both groups performed equally poorly and they
were not given feedback regarding their performance, it is not 
possible to ascertain that the group di erences observed were 
not partly due to the AN participants feeling guilty about their 
poor performance. Before firm conclusions can be drawn from 
the present findings, these results must be replicated with an 
alternative task and future research should use alternative tasks 
to further investigate implicit emotion processing.
  Although the aim of the present study was to investigate 
the neural mechanisms that underlie implicit processing of 
infant emotional display, it would have been of interest to also 
investigate neural processes that underlie explicit recognition 
of emotions in infant faces. There is behavioral evidence that 
people with EDs show negative bias when interpreting infant 
emotional displays (Cardi et al., 2014a). Therefore, future studies 
may benefit from further exploration of the neural processes that 
underlie such interpretation bias.
  Although, emotional infant stimuli have been found to be 
e ective in eliciting strong emotional responses in adults, another 
limitation of the current study was that we did not evaluate 
participants’ interest in or experiences with infants, which could 
influence responses to emotional infant stimuli. For example it 
has been found that people who are interested in infants display 
attentional bias toward infant faces over adult faces and are 
more motivated to view images of infants than those who are 
not interested in infants (Cárdenas et al., 2013; Charles et al., 
2013). Future studies may benefit from assessing participants 
interest in and experiences with infants with self-report measures, 
such as the Interest in Infants Inventory (Goldberg et al., 1982;
Maestripieri and Pelka, 2002).
  Another limitation of the study was small sample size and 
lack of IQ or cognitive assessment. The small sample size 
prevented us from exploring further di erences between AN 
participants who were taking SSRIs during the time of the 
study and those AN participants who were free of psychotropic 
medication. Additionally, a small number of the AN participants 
were receiving inpatient treatment during the study, whereas the 
majority of the group were volunteers and not in treatment for 
their ED. Therefore, the impact of SSRI medication and treatment 
on the group di erences observed cannot be ruled out. Similarly, 
we did not conduct formal IQ or cognitive assessment, which 
could have impacted the findings. However, the AN and HC 
groups were matched for level of education and the task did 
not have a strong cognitive component. Still future studies may 
benefit from including larger samples and assessing the impact of 
the above-mentioned factors.
Finally, the AN participants in the current study were 
not weight recovered and therefore, it cannot be ruled out 
that the group di erences were due to state of malnutrition. 
Malnutrition can, thus pose di culties in trying to explore the 
neural mechanisms that underlie social–emotional processing 
in AN. On the other hand, including only weight recovered 
AN participants is not without di culties. Di erent stages 
of illness and recovery are often associated with di erent 
challenges (Kordy et al., 2002; Treasure et al., 2015), making 
it di cult to generalize findings from studies including only 
weight recovered AN participants to people in the acute state 
of illness. Thus future studies may benefit from exploring the
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neural processes that underlie di culties in social–emotional
functioning across di erent stages of illness.
CONCLUSION
The aim of the current study was to investigate di erences
in neural mechanisms that underlie implicit processing of
emotional infant faces between AN and HC participants. The
results revealed increased recruitment of the bilateral amygdala
and a very small cluster in the right DLPFC in the AN group
relative to the HC group while viewing positively valenced
infant stimuli. Additionally, relative to the HC group, the AN
participants showed increased recruitment of the left posterior
insula while viewing negatively valenced infant stimuli. These
findings suggest that people with AN may engage in increased
prefrontal down-regulation of elevated limbic response to
salient positive social–emotional stimuli, and may experience
elevated subjective distress while viewing salient negative social–
emotional stimuli. These neural processes may serve as useful
targets for future interventions in AN, although replication of
these findings with a larger sample size and an alternative task
is necessary before firm conclusions can be drawn.
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FIGURE S1 | (A) Effect size (Hedges’ g) map of the positively valenced > neutral
infant faces contrast. Positive effect sizes indicate larger mean contrast signal
change in the AN group relative to the HC group. Negative effect sizes indicate
larger mean contrast signal change in the HC group relative to the AN group.
(B) 99.9% confidence interval lower bound. (C) 99.9% confidence interval upper
bound. Red to white colors indicate positive figures, blue to green colors indicate
negative figures.
FIGURE S2 | (A) Effect size (Hedges’ g) map of the negatively valenced > neutral
infant faces contrast. Positive effect sizes indicate larger mean contrast signal
change in the AN group relative to the HC group. Negative effect sizes indicate
larger mean contrast signal change in the HC group relative to the AN group.
(B) 99.9% confidence interval lower bound. (C) 99.9% confidence interval upper
bound. Red to white colors indicate positive figures, blue to green colors indicate
negative figures.
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a  b  s  t  r  a  c  t
Background:  Anorexia  nervosa  (AN)  is  characterised  by severe  malnutrition  as  well  as  intense  fear  and
anxiety  around  food  and  eating  with  associated  anomalies  in information  processing.  Previous  studies
have  found  that the  neuropeptide,  oxytocin,  can  influence  eating  behaviour,  lower  the neurobiological
stress  response  and  anxiety  among  clinical  populations,  and  alter  attentional  processing  of food  and
eating  related  images  in  AN.
Methodology:  Thirty  adult  women  with  AN  and  twenty-nine  healthy  comparison  (HC)  women  took  part
in  the  current  study.  The  study  used  double  blind,  placebo  controlled,  crossover  design  to  investigate
the  effects  of  a single  dose  of intranasal  oxytocin  (40 IU)  on a standard  laboratory  smoothie  challenge,
and  on salivary  cortisol,  anxiety,  and  attentional  bias  towards  food  images  before  and  after  the  smoothie
challenge  in AN  and  HC participants.  Attentional  bias  was  assessed  using  a visual  probe  task.
Results:  Relative  to  placebo  intranasal  oxytocin  reduced  salivary  cortisol  and  altered  anomalies  in  atten-
tional  bias  towards  food  images  in the  AN  group  only.  The  oxytocin-induced  reduction  in attentional
avoidance  of food  images  correlated  with  oxytocin  induced  reduction  in  salivary  cortisol  in  the AN  group
before  the  smoothie  challenge.  Intranasal  oxytocin  did not  significantly  alter  subjective  feelings  of  anxiety
or  intake  during  the  smoothie  challenge  in  the  AN  or HC  groups.
Conclusions:  Intranasal  oxytocin  may  moderate  the  automated  information  processing  biases in AN  and
reduce neurobiological  stress.  Further  investigation  of the  effects  of repeated  administration  of oxytocin
on  these  processes  as  well  as  on  eating  behaviour  and  subjective  anxiety  would  be of interest.
©  2017  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Anorexia nervosa (AN) is characterised by an intense fear of food
and eating with associated avoidance behaviours and severe mal-
nourishment (American Psychiatric Association, 2013). Over time
these associations become stronger and cues related to food and
eating become linked to changes in brain function and information
processing biases begin to develop (Schmidt and Treasure, 2006;
Treasure et al., 2012; Yackobovitch-Gavan et al., 2009). To date,
a number of studies have demonstrated that relative to healthy
individuals, people with AN have elevated plasma and salivary
∗ Corresponding author.
E-mail address: jenni.leppanen@kcl.ac.uk (J. Leppanen).
cortisol levels, which suggests a dysregulation of the hypothalamic-
pituitary-adrenal (HPA) axis (Bailer and Kaye, 2003; Connan et al.,
2003; Lawson et al., 2013b; Licinio et al., 1996). Furthermore,
behavioural studies have found that people with AN have ele-
vated autonomic responses to illness-related stimuli, such as food
(Léonard et al., 1998; Rigaud et al., 2007; Soussignan et al., 2011;
Uher et al., 2004). A study investigating the effect of a blind gastric
load of 0, 300, or 700 calories on endocrine responses in AN found
that the cortisol response increased with the calorie content of the
gastric load in the AN participants (Rigaud et al., 2007). Further
work has also demonstrated that relative to healthy participants,
people with AN report greater fear and disgust in response to food
stimuli, and have elevated corrugator facial EMG  (i.e. frowning) and
physiological arousal response to food images and when confronted
http://dx.doi.org/10.1016/j.psyneuen.2017.01.017
0306-4530/© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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with a test meal (Léonard et al., 1998; Soussignan et al., 2011; Uher
et al., 2004).
In addition to elevated anxiety and stress around eating, peo-
ple with AN also have anomalies in attention towards food (Brooks
et al., 2011). A meta-analysis found that people with AN show an
increased attentional bias (AB) towards food images (Brooks et al.,
2011). Another study utilising eye-tracking methodology found
that relative to healthy participants, people with AN showed early
AB towards food images, but later avoidance of food images (Giel
et al., 2011). Similarly, electroencephalogram (EEG) and magne-
toencephalography (MEG) studies have found elevated early and
reduced later posterior activation in people with AN compared to
healthy individuals in response to food stimuli (Godier et al., 2016;
Wolz et al., 2015). Interestingly, a study by Cardi et al. (2013) inves-
tigated AB towards food images before and after a standard test
meal challenge and found that inpatients with AN showed greater
AB towards food images following exposure to a test meal chal-
lenge. Thus, taken together, these findings suggest that anomalies
in AB towards food images is a prominent feature of AN and is likely
fuelled by stress and anxiety around food and eating.
Animal studies have demonstrated that the neuropeptide oxy-
tocin is involved in many regulatory functions in the central
nervous system including stress response and food intake (Cochran
et al., 2013; Olszewski et al., 2010). A recent meta-analysis found
that intranasal oxytocin significantly reduced cortisol response to
stressful stimuli among clinical populations of people suffering
from a range of disorders, including depression, substance depen-
dence, fragile X syndrome and borderline personality disorder,
characterised by a chronic dysregulated and hyperactivated HPA
axis (Cardoso et al., 2014). Additionally, emerging evidence from
animal studies has demonstrated that central administration of an
oxytocin receptor agonist can normalise novelty-induced decrease
in food intake in mice, suggesting that oxytocin may  play a role in
moderating the influence of stress and anxiety on eating (Olszewski
et al., 2014). Thus intranasal oxytocin may  be helpful facilitating
exposure treatment for food restriction fuelled by anxiety.
There has been increasing interest in the possibility that oxy-
tocin may  be involved in the pathophysiology of eating disorders
(Maguire et al., 2013). A recent meta-analysis reported that periph-
eral and cerebrospinal fluid (CSF) levels of endogenous oxytocin
were significantly lower in AN relative to normal weight controls,
which the authors suggested is likely associated with dysregula-
tion of the HPA axis (Rutigliano et al., 2016). Additionally, another
study has reported atypical, elevated oxytocin response to food
intake in AN, which was associated with pre-meal hypoactivation
of the hypothalamus, orbitofrontal cortex, insula, and amygdala
in response to food images in AN relative to healthy participants
(Lawson et al., 2013b; Lawson et al., 2012). Moreover, a recent proof
of concept study found that a single dose of 40IU of intranasal oxy-
tocin reduced anomalies in AB towards images of food, eating, and
negative body shape in people with AN (Kim et al., 2014a). The
authors also found that intranasal oxytocin led to a reduction in
caloric intake in the 24 h following administration in participants
with bulimia nervosa (Kim et al., 2015). These findings suggest that
intranasal oxytocin can alter anomalies in attentional processes to
specific and general aversive stimuli in AN and may  alter eating
behaviour.
The aim of the current study was to examine the impact of a sin-
gle dose of intranasal oxytocin on a standard smoothie challenge,
as well as neurobiological stress and AB towards food images, as
measured with a visual probe task, before and after the smoothie
challenge in adult women with AN and gender and age matched
healthy control (HC) participants. Based on previous findings out-
lined above, we hypothesised that relative to HCs, participants with
AN would consume less during the smoothie challenge, have ele-
vated anxiety and salivary cortisol, and anomalies in AB towards
food images before and after the smoothie challenge. Additionally,
we hypothesised that oxytocin administration would decrease anx-
iety, increase smoothie intake, reduce cortisol and alter anomalies
in AB towards food images in participants with AN.
2. Methods and materials
2.1. Participants
Fifty-nine women participated in the study. Thirty women met
the DSM-5 criteria for AN, with mean BMI  of 16.30 (SD = 2.04) and
age of 26.20 (SD = 6.82). Diagnosis was confirmed using the Struc-
tured Clinical Interview for DSM-5 (First et al., 2015). Fifteen of the
AN participants were recruited from the South London and Maud-
sley NHS Foundation Trust inpatient unit and were in treatment.
The other fifteen AN participants were recruited through ED char-
ities (BEAT, Succeed). Fifteen of the AN participants were taking
medication (anti-depressants) during the study.
The HC participants (N = 29), with mean BMI  of 23.25 (SD = 3.65)
and age of 26.83 (SD = 8.54), were recruited from the community
and amongst King’s College London students and staff. HC partic-
ipants were of normal weight and were screened for current or
past psychiatric disorders, and alcohol or drug misuse with the
Structured Clinical Interview for DSM-5 (First et al., 2015). Partic-
ipants were excluded from the study if they reported medical or
psychiatric problems, a history of or current alcohol or drug abuse,
current impairments in cardiovascular functioning, pregnancy or
plans to become pregnant during the study. Prior to participating in
the study, all participants gave a written informed consent. Ethical
approval for the study was  obtained from National Research Ethics
Service (NRES) committee (14/LO/0128) and all procedures were
conducted in accordance with the latest declaration of Helsinki
(2008).
The sample size was based on power analysis conducted with
G*Power for a repeated measures design (Faul et al., 2007). To
ensure adequate power (0.80) to detect an effect in the mixed
model, the total recommended sample size was 60 participants.
2.2. Experimental design
The study employed a double blind, placebo controlled, within
subjects, crossover design. All participants received a single dose
of both oxytocin and placebo in separate sessions. The treatment
order was  pseudo-randomised so that half of the AN participants
and half of the HC participants received oxytocin in the first session
and the other half of the AN and HC participants received oxytocin
in the second session. Only the Maudsley pharmacy, responsible
for dispensing the compounds were aware of the order in which
each participant received the compounds. The experimenter and
the participants were both blind to treatment order.
The study flow chart is presented in Supplementary Fig. S1 . Prior
to administration of the compounds participants were asked to
provide a saliva sample for cortisol analysis, and to provide a base-
line rating of anxiety on a visual analogue scale (VAS) (for further
details see Supplementary information). The intranasal oxytocin
and the placebo were self-administered by the participants in ten
sprays, five sprays in each nostril every 45 s (for further details
see Supplementary information). Fifty minutes after administra-
tion, participants gave the second saliva sample and VAS anxiety
rating. The first visual probe task was then administered approx-
imately 55 min  after administration of the compound (T1; for
further details see Supplementary information). This was followed
by the smoothie challenge consisting of a 250 ml  fruit smoothie
(a choice from 3 Innocent smoothie flavours: strawberries and
bananas, mangoes and passion fruits, and kiwis, apples and limes).
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All labels were kept on the bottles and this contained the calorie
content and nutritional information. The participantswere encour-
aged to consume as much of the smoothie as they liked under
non-supervised conditions and were left for 15min to do this. If
participants refused to have a smoothie they were informed that
they did not have to have it, but were encouraged to try it and
left with the smoothie for the duration of the challenge. Following
this, participants gave a third VAS anxiety rating and the second
visual probe task was administered, approximately 75min after
administration of the compound (T2; for further details see Supple-
mentary information). Finally, the third saliva samplewas collected
approximately 80min after administration. The timing was based
on previouswork investigating the effects of intranasal oxytocin on
AB in eating disorders and on cerebral blood flow among healthy
individuals (Kim et al., 2014a; Paloyelis et al., 2016).
The two sessions were scheduled a minimum of one day and
maximum of five days apart. All HC and AN participants who were
menstruating regularly during the studywere testedduring the fol-
licular phase, 1–15days following the onset of a menstrual cycle.
All participantswere asked to refrain fromconsuming any alcoholic
or caffeinated beverages twelve hours prior to the sessions. Addi-
tionally, the participants were asked to not consume any food two
hours prior to the sessions, in order to minimise effects of fullness
and hunger on the tasks.
2.3. Visual probe task
Avisual probedetection taskwasused to investigateAB towards
and away from food and neutral, non-food images in AN. The task
was amended from that used in a previous study (Cardi et al.,
2013), and the food images were acquired from a standardised
set of images and depicted a variety of savoury and sweet food
items on a blue background (Uher et al., 2004). The food images
depicted highly palatable food, andwerematched for size and calo-
rie content. The non-food images consisted of neutral images of
furniture. In the visual probe detection task participants were pre-
sented with two images simultaneously on a computer screen side
by side for 500ms. One of the images then revealed one of two
visual probes underneath them and participants were instructed
to press specific keys on the keyboard to indicate which probe they
saw. The probe was presented until participants responded. The
task was presented with E-prime software (Psychology Software
Tools, Sharpsburg, USA) and consisted of 96 trials. The task lasted
approximately 3min. Further details regarding the visual probe
task are presented in Supplementary information.
2.4. Statistical analysis
All data was analysed using Stata 14 (StataCorp, 2015) and
p<0.05 was considered significant. The self-report questionnaire
data were analysed with non-parametric two-sample median Chi2
tests. Effect sizes were estimated with Cramer’s !, which can be
interpreted as small (0.10), medium (0.30), or large (0.50) (Cohen,
1988).
Due to thehighly skewednature of the smoothie data, logarithm
10 transformation was performed prior to analysis. Group differ-
ences in smoothie intake in millilitres (ml) consumed as well as
the effect of oxytocin/placebo on consumption were then analysed
with a bootstrapped mixed linear model with 1000 repetitions
using the bootstrap andmixed functions in Stata (StataCorp, 2015).
Significant interactions were further investigated by computing
post-hoc contrasts and pairwise comparisons.
TheABdatawas analysed separately for the 500msand1250ms
ITI blockswith a 2×2×2mixed linearmodel using themixed func-
tion with bootstrapping (1000 repetitions) in Stata 14 (StataCorp,
2015). Drug (oxytocin, placebo), time (before smoothie challenge,
after smoothie challenge), andgroup (AN,HC)were enteredasfixed
effects with a random intercept and random slope on drug. Sim-
ilarly, the VAS anxiety and salivary cortisol data were analysed
with a 2×3×2 bootstrapped mixed model with drug (oxytocin,
placebo), time (baseline, before smoothie challenge, after smoothie
challenge), and group (AN, HC) and a random intercept and ran-
dom slope on drug. Significant interactions were explored further
by calculating contrasts and pairwise post-hoc comparisons using
the contrast and pwcompare functions (StataCorp, 2015).
We additionally explored whether oxytocin induced changes in
AB scores correlatedwith oxytocin induced changes in VAS anxiety
ratings andsalivary cortisol before andafter the smoothie challenge
within theANgroup. ABdelta scoreswere calculated byfirst adding
a constant to all AB data to ensure no AB scores were negative. The
AB scores from the placebo session were then subtracted from the
ABscores fromtheoxytocin session. Thus, negative scores indicated
greater AB towards food images in the placebo session and positive
scores indicated greater AB towards food images in the oxytocin
session. VAS anxiety and salivary cortisol delta scores were calcu-
lated in a similar manner. We then conducted correlation analyses
to investigate significant correlations between the deltas in Stata
using the spearman function (StataCorp, 2015).
Effects of medication status on AB, salivary cortisol, and VAS
anxiety ratings as well as on the effects of oxytocin are presented
in Supplementary information.
3. Results
3.1. Demographic and clinical characteristics
The clinical and self-report questionnaire data is presented in
Table 1 and was corrected for multiple comparisons with the false
discovery rate set at q <0.05 (Benjamini and Hochberg, 1995). Fol-
lowing correction, p <0.04 was considered significant. The AN and
HC groups were matched for age, and as expected the AN group
had lower BMI than the HC group. The AN group also scored higher
on the EDEQ reporting higher levels of restraint, eating concern,
weight concern, and shape concern compared to the HC group.
Additionally, the AN group scored higher on the DASS reporting
elevated levels of depression, anxiety, and stress relative to the HC
group.
3.2. Smoothie intake
Smoothie intake in the oxytocin and placebo conditions are
summarised separately for each group in Table 2 (see Supplemen-
tary Fig. S2). Themixedmodel revealed a significant effect of Group,
with HC participants consuming significantly more smoothie dur-
ing the challenge thanANparticipants across conditions. Therewas
no significant effect of Drug or Drug x Group interaction. Eleven AN
participants did not consume any of the smoothie in the placebo
condition, and nine of these eleven AN participants also did not
consume any smoothie in the oxytocin condition.
3.3. AB: 500ms ITI blocks
The AB scores in the 500ms ITI blocks among the AN and HC
groups following oxytocin and placebo administration are pre-
sented in Table 3 (see Supplementary Fig. S3A,B). P-values were
corrected formultiple comparisonswith the false discovery rate set
at q <0.05 (Benjamini and Hochberg, 1995). Following correction,
p <0.02 was considered significant.
The mixed model revealed a significant Drug x Time x Group
interactions (Table 3). The 3-way interaction was further investi-
gated in three ways. First we explored the Drug x Time interaction
separately within the AN and HC groups. The results revealed
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Table 1
Clinical and demographic sample characteristics.
AN (N=30) HC (N=29) AN vs HC
Median Q1 Q3 Median Q1 Q3 X2 statistic, p value Cramer’s !
BMI 16.13 14.56 18.14 22.21 20.78 25.51 X2 =35.55, p <0.001 0.78
Age 24.50 22.00 28.25 25.00 23.00 27.50 X2 =0.02, p =0.875 0.02
EDEQ total 4.13 3.00 5.13 0.59 0.34 1.00 X2 =35.27, p <0.001 0.77
EDEQ restraint 3.70 2.60 5.05 0.60 0.00 1.70 X2 =20.79, p <0.001 0.59
EDEQ weight concern 4.20 2.70 5.65 0.60 0.30 1.40 X2 =31.38, p <0.001 0.73
EDEQ shape concern 4.86 3.56 5.91 0.75 0.38 1.38 X2 =41.67, p <0.001 0.84
EDEQ eating concern 4.10 2.90 4.80 0.20 0.00 0.40 X2 =41.67, p <0.001 0.84
DASS Total 63.00 40.00 86.00 4.00 1.00 10.00 X2 =37.49, p <0.001 0.80
DASS Depression 21.00 13.50 32.00 0.00 0.00 2.00 X2 =26.61, p <0.001 0.67
DASS Anxiety 12.00 6.00 21.00 0.00 0.00 2.00 X2 =29.07, p <0.001 0.70
DASS Stress 25.00 17.50 31.00 2.00 0.00 7.00 X2 =37.49, p <0.001 0.80
AN=anorexia nervosa, HC=healthy comparison, BMI =Body mass index, EDEQ=Eating Disorder Examination Questionnaire, DASS=Depression, Anxiety, and Stress Scale.
Table 2
Smoothie intake in millilitres (ml) in the AN and HC groups in the oxytocin and placebo conditions.
Drug AN (N=30) Mean (SD) HC (N=29) Mean (SD) X2 statistic, p value
Oxytocin 113.10 (102.94) 224.24 (47.58) Drug:X2=1.39,p=0.239
Group:X2=131.66,p<0.001
DrugxGroup:X2<0.01,p=0.975
Placebo 99.07 (102.16) 237.52 (30.29)
AN=anorexia nervosa, HC=healthy comparison.
Table 3
AB towards food images before and after the test meal in the AN and HC groups.
ITI Time Drug AN (N=30) Mean (SD) HC (N=29) Mean (SD) X2 statistic, p value
500ms Before test meal Oxytocin −2.66 (33.57) 2.52 (36.79)
Placebo −13.69 (29.27) 13.86 (42.70)
After test meal Oxytocin −13.64 (38.78) 0.41 (43.66)
Placebo 10.64 (34.42) −2.99 (42.55)















Placebo 2.64 (34.08) −4.53 (35.44)
After test meal Oxytocin −6.78 (48.86) −5.24 (67.38)
Placebo −8.13 (41.65) −13.95 (44.29)
AN=anorexia nervosa, HC=healthy comparison, AB=Attentional bias, ITI = inter-trial interval.
that the Drug x Time interaction was significant within the AN
group (X2 =7.78, p =0.005), but not within the HC group (X2 =0.94,
p =0.333). The interaction was then further investigated within
the AN group by exploring the effects of Drug at T1 and T2. The
results revealed that oxytocin administration significantly reduced
AB towards food images in the AN group at T2, after the smoothie
challenge, (Z =−2.72, p =0.007, 95% CI [−41.78, −6.78]), but not
at T1, before the smoothie challenge al, (Z =1.38, p =0.168, 95% CI
[−4.66, 26.72]).
Finally, we explored the Group x Time interaction separately in
the oxytocin and placebo conditions. The results revealed a sig-
nificant Group x Time interaction only in the placebo condition
(X2 =10.03, p =0.002), but not in the oxytocin condition (X2 =0.38,
p =0.540). When group differences were explored further, the
results revealed that AN participants showed significantly more
AB away from food images than HC participants at T1, before the
smoothie challenge, (Z =−3.08, p =0.002, 95% CI [−45.09,−10.02]),
but not at T2, after the smoothie challenge, (Z =1.56, p =0.118, 95%
CI [−3.46, 30.71]).
We then explored the Group x Drug interaction separately at
T1 and T2, which revealed no significant interaction at T1, before
the smoothie challenge (X2 =3.06, p =0.080), or at T2, after the
smoothie challenge (X2 =4.13, p =0.042).
3.4. AB: 1250ms ITI blocks
The attentional bias scores in the 1250ms ITI blocks among the
AN and HC groups following oxytocin and placebo administration
are presented in Supplementary Fig. S4A,B. The drug x time x group
mixed model revealed no significant effects or interactions in the
1250ms ITI blocks (Supplementary Table S1).
3.5. Salivary cortisol
Mean salivary cortisol levels are presented separately for each
group in the oxytocin and placebo conditions in Table 4 (see Sup-
plementary Fig. S5). The mixed model revealed a significant effect
of Group, with AN participants having significantly higher corti-
sol levels than HC participants across conditions and time points
(Table 4).
The mixed model additionally revealed a significant Drug x
Group interaction. The interaction was further explored by explor-
ing the effect of Drug on salivary cortisol separately in each
group. The results revealed a significant effect of Drug in the
AN group (Z=−1.99, p =0.046, 95% CI [−1.30, −0.01]), with AN
participants having lower salivary cortisol levels in the oxytocin
condition. There was no significant difference between oxytocin
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Table 4
Salivary cortisol at each time point in the AN and HC groups.
Time Drug AN (N=30) Mean (SD) HC (N=29) Mean (SD) X2 statistic, p value
Baseline Oxytocin 5.35 (5.66) 3.71 (3.68) Drug: X2 =0.37, p =0.542
Time: X2 =6.91, p =0.032
Group: X2 =179.21, p <0.001
Drug x Time: X2 =1.46, p =0.482
Drug x Group: X2 =7.22, p =0.007
Time x Group: X2 =4.33, p =0.115
Drug x Time x Group: X2 =1.38, p =0.502
Placebo 5.35 (3.31) 3.18 (2.67)
Before smoothie challenge Oxytocin 4.81 (3.35) 2.57 (2.10)
Placebo 5.54 (4.04) 2.24 (1.75)
After smoothie challenge Oxytocin 4.69 (3.14) 2.59 (1.92)
Placebo 5.93 (4.48) 2.09 (1.57)
AN=anorexia nervosa, HC=healthy comparison.
and placebo in the HC group (Z=1.94, p =0.052, 95% CI [−0.004,
0.84]).
3.6. Self-reported VAS anxiety ratings
Mean VAS anxiety ratings are presented separately for each
group in the oxytocin andplacebo conditions in Supplementary Fig.
S6 . The mixed model exploring group differences in anxiety rat-
ings at different time points in the oxytocin and placebo conditions
revealed a significant effect of Time (Supplementary Table S2). VAS
anxiety ratings were significantly higher after the smoothie chal-
lenge than before the smoothie challenge across groups (Z =3.62,
p <0.001, 95% CI [0.03, 0.09]). There were no significant differences
in self-reported anxiety at baseline and before the smoothie chal-
lenge (Z =−1.85, p =0.064, 95% CI [−0.07, 0.002]) or at baseline
and after the smoothie challenge (Z =1.21, p =0.224, 95% CI [−0.01,
0.06]).
3.7. Correlations between oxytocin-induced changes in AB,
anxiety, and salivary cortisol
The correlational analysis revealed a significant inverse corre-
lation between salivary cortisol delta scores and oxytocin-induced
changes in AB before the smoothie challenge ("=−0.41, p =0.026).
Inverse correlation between VAS anxiety delta scores and oxy-
tocin induced changes in AB before the smoothie challenge also
approached significance ("=−0.31, p =0.097). There were no sig-
nificant correlations between oxytocin-induced changes in AB and
cortisol delta scores ("=−0.11, p =0.574), anxiety delta scores
("=−0.08, p =0.692) after the smoothie challenge, or BMI (before
smoothie challenge: "=0.09, p =0.631, after smoothie challenge:
"=0.06, p =0.752).
4. Discussion
The aim of the current study was to examine the effects of
a single dose of intranasal oxytocin on smoothie intake during a
standard smoothie challenge as well as on salivary cortisol and AB
towards food images before and after the smoothie challenge. As
hypothesised, relative to HCs, the majority of the AN participants
consumed less smoothie during the smoothie challenge and had
elevated anxiety and salivary cortisol levels, and showed anoma-
lies in AB towards food images. Contrary towhatwas hypothesised,
oxytocin administration did not significantly influence smoothie
intake among the AN or HC participants nor did it moderate sub-
jective anxiety. However as postulated, oxytocin administration
significantly reduced salivary cortisol and reduced the anomalies
in AB towards food images in peoplewith AN. Additionally, correla-
tional analysis revealed an association between oxytocin-induced
reduction in salivary cortisol and attentional avoidance of food
images before the smoothie challenge.
The current findings revealed that relative to the HC group,
the AN participants had significantly higher salivary cortisol, and
intranasal oxytocin reduced salivary cortisol levels across time
points in the AN group only. This supports findings from a recent
6-week pilot trial that reported reductions in salivary cortisol lev-
els and anticipatory cortisol response to an afternoon snack among
inpatients with AN following repeated twice-daily administration
of 18IU of intranasal oxytocin (Russell et al., 2013). This is also con-
sistentwith findings from a recentmeta-analysis, which found that
intranasal oxytocin reduced the cortisol response to stressful stim-
uli among clinical populations, with conditions characterised by
dysregulation of the HPA axis (Cardoso et al., 2014). These find-
ings suggest that oxytocin is able to moderate both acute and
chronic stress response among clinical populations. Previous work
has suggested that increased availability of another hypothalamic
neuropeptide, vasopressin, plays an important role in dysregulated
and elevated neurobiological stress response in AN (Connan et al.,
2003).Oxytocinmaymoderate this systemby reducingvasopressin
availability, thus, reducing elevated stress response (Heinrichs and
Domes, 2008; Heinrichs et al., 2009). Another possibility is that
the dysregulation of the HPA axis and associated elevated stress
response are due to a failure in the stress-induced up-regulation of
endogenous oxytocin (Zheng et al., 2010). Intranasal oxytocin may
then moderate the stress response by regulating HPA axis activity
(Neumann and Slattery, 2016). Although the exact mechanism of
the effects of oxytocin on neurobiological stress is still not clear
and need further exploration, these findings raise the possibility
that oxytocin might have a role as a neuroenhancer that facilitates
extinction learning as has been proposed based on recent findings
from animal studies (Eckstein et al., 2015; Hofmann et al., 2015;
Stockhorst and Antov, 2016).
Thecurrent studyalso found that relative toHCs,ANparticipants
had anomalies in AB towards food images, showing greater avoid-
ance of food images before the smoothie challenge and greater bias
towards food images after the smoothie challenge, although this
failed to reach significance. Oxytocin administration altered these
anomalies significantly reducing bias towards food images after
the smoothie challenge in the AN group. The moderation of the
anomalies in AB toward food are in keeping with previous work
exploring the effects of intranasal oxytocin on attentional process-
ing inAN (Kimet al., 2014a; Kimet al., 2014b). The authors reported
that intranasal oxytocin significantly reduced bias towards illness-
related stimuli, including images of food, eating, fat body shape,
and disgusted faces in AN (Kim et al., 2014a; Kim et al., 2014b).
Thesefindings suggest that intranasal oxytocin can alter automated
attentional processing of illness-related stimuli, which would oth-
erwise be difficult to target through talking therapies. Additionally,
it has recently been suggested that oxytocin may be a useful sup-
plement to treatment as usual in eating disorders (Maguire et al.,
2013; Treasure et al., 2015).
The current study also attempted to explore the mech-
anism of the effects of oxytocin on attentional processes.
The findings revealed a significant inverse correlation between
oxytocin-induced reduction in AB away from food images and
oxytocin-induced reduction in salivary cortisol before the smoothie
challenge. These findings suggest that as intranasal oxytocin
reduced salivary cortisol, it also reduced attentional avoidance
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of food images before the smoothie challenge. This is in accor-
dancewithfindings fromanimal studiesdemonstrating that central
oxytocin release reduces neurobiological stress and stress-related
behaviours, such as hiding during an open field test and periods
of immobility during forced swimming test (Chaviaras et al., 2010;
Zheng et al., 2010). These findings are also supported by a pre-
vious functional neuroimaging study, which found that intranasal
oxytocin normalises anxiety-induced amygdala hyper-reactivity to
threatening, illness related stimuli in generalised social anxiety
disorder (Labuschagne et al., 2010). Furthermore, among people
with fragile X syndrome, characterised by autism-like difficul-
ties in social processing, intranasal oxytocin has been shown to
reduce salivary cortisol and improve eye gaze during social inter-
action (Hall et al., 2012). However, it is of note that in the current
study we were not able to find a significant correlation between
oxytocin-induced changes in AB towards food images and salivary
cortisol or self-reported anxiety, which may have been due to tim-
ing of the final saliva sample collected after the smoothie challenge
(Hellhammer et al., 2009). Therefore, further research using func-
tional neuroimaging techniques are needed to further examine the
mechanism through which intranasal oxytocin alters attentional
processes in AN.
Oxytocin administration did not significantly alter smoothie
intake in either the AN or HC group in the current study. Previ-
ous findings from studies investigating the effects of a single dose
of intranasal oxytocin on eating behaviour in humans are variable
(Olszewski et al., 2016). One study reported that intranasal oxy-
tocin reduced food intake during a buffet test meal in healthy men
following an overnight fast (Lawson et al., 2015). On the other hand,
another study failed to find significant oxytocin-induced reduc-
tion in food intake during a buffet breakfast following an overnight
fast (Ott et al., 2013). Instead the authors reported that intranasal
oxytocin reduced hedonic snacking two hours after the test meal
(Ott et al., 2013). Interestingly, the buffet test meal in the Lawson
et al. (2015) had more variety and contained more options than
that in the Ott et al. (2013) study. Variety has been shown to be
an important factor increasing hedonic value of food and intake
during buffet test meals (Brondel et al., 2009; Hetherington et al.,
2006). The current study conducted in the afternoon and partici-
pants had not consumed any food for at least three hours by the
time they were introduced to the test meal consisting of a single
fruit smoothie. It is probable that clinical status, hedonic hunger,
and the context of the testmealmay influence the effect of oxytocin
on eating.
Considering the important role that chronic neurobiological
stress and informationprocessingbiases play in themaintenance of
disordered eating, it was perhaps surprising that oxytocin-induced
reduction in salivary cortisol and in automated AB towards food
images did not translate into greater intake during the smoothie
challenge and less anxiety throughout the session. It is possible
that a testmeal disguised as a “taste test”might be amore sensitive
outcome as it would allow a covert assessment of intake of various
different types of food andmicronutrients. Additionally, using eco-
logically valid assessments such as 24-h food diaries could help to
further investigate the effects of intranasal oxytocin on food intake
under naturalistic settings. Indeed, a recent proof of concept study
by Kim et al. (2015), which used 24-h food diaries, found that a sin-
gledoseof intranasal oxytocin reduced caloric intake amongpeople
with bulimia nervosa. The authors did not find any increase in
caloric intake among peoplewith AN (Kim et al., 2015). However, it
is of not that the AN participants in the Kim et al. (2015) studywere
all inpatients undergoing treatment. Thus, further investigation of
the effects of intranasal oxytocin on food intake among peoplewith
ANunder naturalistic conditionswould benecessary before recom-
mendations regarding its potential as an add-on treatment can be
made.
Finally, the demographic data, including questionnaire
responses, age, and BMI, in the current study was skewed.
However this is not unusual with questionnaire and other mea-
sures that contain natural boundaries, below or above which the
data can’t reach (Diez et al., 2015). For instance, the age data is
skewed because in the current study we only recruited adults over
the age of 18. Therefore, we have a natural boundary at 18 years
and for this reason the data has a right skew. Similarly, a person’s
BMI cannot be below a certain point, but there is no clear upper
limit, meaning that the data has a natural right skew.
4.1. Limitations
One of the limitations of the current study was the smoothie
challenge used in the current study, which differed from test meal
challenges employed in other studies (Khalsa et al., 2015; Lawson
et al., 2013a; Steinglass et al., 2014). The fruit smoothies are mar-
keted as healthy and previous studies found them to be acceptable
for the AN participants (Cardi et al., 2013). However, the smoothie
challenge consisted of a single 250ml smoothie, which in some
cases led to ceiling effects. Future studiesmaybenefit fromemploy-
ing test meals that include both high and low calorie options.
Additionally, since the smoothie options varied slightly in their
calorie content (range: 126–140Kcal), we were not able to validly
analyse the data in calories consumed during the challenge. Future
studies using similar smoothie challenge paradigm may benefit
from matching the smoothies offered for caloric content.
Additionally, the type of visual probe task used to measure
attention in the current study precluded the measurement of
timing related changes in AB. Future research may benefit from
exploring the effects of oxytocin on early and late attentional
processes in AN using eye tracking and functional neuroimaging
techniques such as EEG andMEG. Furthermore, the neutral images
consisted of pictures of furniture and rooms, which were not simi-
larly standardised as the food images. Although, prior to the study,
effort was taken to ensure the images were as visually appealing
as the food images, in terms of colour and contrast, this may have
added noise to the data. It has also been recently proposed that
standardised images should be used in order to improve compa-
rability of studies and increase replicability and reproducibility of
findings (Blechert et al., 2014).
Further, the sessions were very close together. Although, this
was unlikely to influence the results of the rapid behavioural task
and biologicalmeasures, it would be beneficial for the current find-
ings to be replicated with a larger study using a longer period
between the sessions.
Finally, salivary cortisol measures were taken only at three dif-
ferent time points. It is possible that we did not find a correlation
between oxytocin-induced changes in salivary cortisol andAB after
the smoothie challenge because the saliva sample was taken too
soon after the challenge. It has been suggested that relative to psy-
chological responses, there can be considerable lag in the cortisol
response to stressful, anxiety-provoking stimuli (Hellhammeret al.,
2009). Future research would benefits from building on these find-
ings and further investigating the timeline of the effects of oxytocin
on stress in AN and how these effects may correlate with psycho-
logical responses.
5. Conclusions
The current study examined the effects of a single dose of
intranasal oxytocin on a smoothie challenge, salivary cortisol, and
AB towards food images inAN. Thefindings revealed that intranasal
oxytocin did not significantly increase smoothie intake during the
smoothie challenge, but did significantly reduce salivary cortisol in
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the AN group. Oxytocin did influence food-related attentional bias,
which correlatedwithoxytocin-induced reduction in salivary corti-
sol in the AN group. Taken together, these findings suggest that the
oxytocinmay be helpful in altering automatic information process-
ing biases and inhibiting the hyperactivation of the HPA axis and
may enhance the therapeutic benefits of food exposure paradigms
in anorexia nervosa. Still, it will be necessary to further examine
the exact mechanism through which oxytocin exerts its effects in
AN aswell as the effects of chronic administration on illness related
processes and eating behaviours over the long term, before any rec-
ommendation can be made regarding whether intranasal oxytocin
could be introduced into treatment of AN.
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challenge,	 in	 500ms	 ITI	 blocks.	 B.)	 AB	 scores	 for	 AN	 and	 HC	 groups	 in	 the	 placebo	 and	 oxytocin	
conditions	at	T2,	after	smoothie	challenge,	in	500ms	ITI	blocks.	Positive	scores	indicate	AB	towards	



































































































Median	[Q1,	Q3]	 Median	[Q1,	Q3]	 X2	statistic,	p	value	 Cramer’s	ϕ	
BMI	 17.63	[15.20,	18.51]	 14.67	[14.37,	16.61]	 X2	=	2.13,	p=	0.144	 0.27	
Age	 25.00	[22.00,	27.00]	 24.00	[21.00,	29.00]	 X2	=	0.00,	p=	1.000	 0.00	
EDEQ	total	 4.49	[4.21,	5.50]	 3.68	[2.66,	4.06]	 X2	=	19.27,	p<	0.001	 0.80	
EDEQ	restraint	 4.40	[2.60,	5.20]	 3.40	[1.40,	4.80]	 X2	=	0.07,	p=	0.796	 0.04	
EDEQ	 weight	
concern	 5.60	[3.80,	6.00]	 3.00	[2.00,	4.60]	 X2	=	5.40,	p=	0.020	 0.42	
EDEQ	 shape	
concern	 5.88	[5.38,	6.00]	 4.25	[2.75,	4.75]	 X2	=	19.27,	p<	0.001	 0.80	
EDEQ	 eating	
concern	 4.40	[3.20,	4.80]	 3.6	[2.60,	4.40]	 X2	=	5.40,	p=	0.020	 0.42	
DASS	Total	 72.00	[54.00,	88.00]	 46.00	[26.00,	86.00]	 X2	=	6.67,	p=	0.010	 0.47	
DASS	
Depression	 30.00	[20.00,	40.00]	 18.00	[10.00,	26.00]	 X2	=	6.67,	p=	0.010	 0.47	
DASS	Anxiety	 18.00	[10.00,	26.00]	 8.00	[2.00,	20.00]	 X2	=	4.29,	p=	0.038	 0.38	
DASS	Stress	 26.00	[24.00,	30.00]	 18.00	[14.00,	34.00]	 X2	=	0.27,	p=	0.606	 0.09	
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Altered social-emotional functioning is considered to play an important role in the development
and maintenance of anorexia nervosa (AN). Recently, there has been increasing interest in inves-
tigating the role of intranasal oxytocin in social-emotional processing. The present study aimed
to investigate the effects of intranasal oxytocin on the interpretation and expression of emo-
tions among people with AN. Thirty women with AN and 29 age-matched healthy women took
part in the present study, which used a double-blind, placebo-controlled, cross-over design. The
participants received a single dose of 40 IU of intranasal oxytocin in one session and a placebo
spray in the other. Fifteen minutes after administration, the participants completed the Reading
the Mind in the Eyes Test to assess the interpretation of complex emotions and mental states
followed by a video task, which assessed expressions of facial affect when they were viewing
humorous and sad film clips. The intranasal oxytocin did not significantly influence the expres-
sion or interpretation of emotions in the AN or healthy comparison groups. The AN group
expressed significantly less positive emotion, spent more time looking away and reported experi-
encing a significantly more negative affect in response to the film clips. The finding that intra-
nasal oxytocin had little to no effect on the interpretation or expression of emotions in either
group supports the notion that the effects of oxytocin on social-emotional processing are not
straightforward and may depend on individual and environmental differences, as well as the
emotion being processed. Replication of these findings is necessary to explore the effect of tim-
ing on the effects of oxytocin before firm conclusions can be drawn. Nonetheless, these findings
add to the steady accumulation of evidence that people with AN have reduced emotional
expression and avoidance of emotionally provoking stimuli.
Key words: oxytocin, anorexia nervosa, social-emotional functioning, facial expressions, positive
affect, negative affect
doi: 10.1111/jne.12458
Current models of anorexia nervosa (AN) postulate that altered
social cognition and difficulties in social-emotional functioning
contribute to the development and maintenance of AN (1,2). Robust
evidence from recent meta-analyses shows that people with AN
have difficulties in a wide range of social-emotional domains,
including the accurate interpretation and appropriate expression of
emotions. Appropriate facial expression and mimicry increase proso-
cial behaviour and aid the accurate interpretation of emotions,
whereas an inappropriate or blunted expression of emotions has
been found to give rise to negative judgements and elicit a desire
for increased social distance (3–5). In eating disorders, it has been
suggested that problems in social communication contribute to the
maintenance of disordered eating by causing interpersonal difficul-
ties and increasing isolation (1,2). Thus, treatments targeting these
interpersonal problems may be beneficial for people with AN.
Behavioural studies have demonstrated that people with AN have
particular difficulties with accurately interpreting positive and nega-
tive emotions in faces, as well as tone of voice (6). People with AN
also have difficulties with accurately interpreting complex emotions
and mental states in tasks such as the Reading the Mind in the
Eyes Test (RMET) and other theory of mind tasks (6). Furthermore, a
recent meta-analysis showed that people with AN, depression and
autism display fewer positive and negative facial expressions when
viewing positive and negative emotional film clips (7). Interestingly,
people who have recovered from AN do not show similar difficul-
ties in the interpretation and expression of emotions (6–9). Thus,
these difficulties are possible secondary consequences of malnutri-
tion; however, the exact mechanisms underlying difficulties in
social-emotional processing in AN are still unclear.
The neuropeptide oxytocin is considered to pay a key role in
social-emotional functioning (10,11). A recent review has docu-
mented a range of abnormalities in oxytocin functioning in acute
AN (12). Additionally, another recent meta-analysis found that
people with AN have significantly lower peripheral endogenous oxy-
tocin levels than healthy individuals (13). Moreover, preliminary
proof of concept studies have found that a single dose of intrana-
sal oxytocin influences certain aspects of social-emotional process-
ing in eating disorders (14,15). Among people with AN, a single
dose of intranasal oxytocin attenuated attentional bias towards dis-
gusted faces (15), although it did not increase sensitivity to recog-
nise basic emotions, whereas, in people with bulimia nervosa and
healthy comparison (HC) participants, intranasal oxytocin increased
sensitivity to detect emotions (14). These mixed findings suggest
that further exploration of the effects of a single dose of intranasal
oxytocin on social-emotional functioning is still necessary.
A single dose of intranasal oxytocin has also been reported to
improve the interpretation of complex emotional states in a number
of different paradigms, including the RMET and the awareness of
social inference test, among healthy individuals (16–18). Addition-
ally, a single dose has been reported to further improve the inter-
pretation of complex emotions among those healthy individuals
who report difficulties in identifying and describing emotions (19).
Among clinical populations, a single dose of intranasal oxytocin has
been reported to improve the interpretation of complex emotions
among people with schizophrenia and depression, comprising disor-
ders characterised by difficulties in the interpretation of emotions
(16,20). Thus, these findings suggest that a single dose of intranasal
oxytocin may increase attention social-emotional cues particularly
among those individuals who have difficulties with such social-
emotional processes. However, to our knowledge, no studies to date
have investigated the effects of a single dose of intranasal oxytocin
on the interpretation of complex emotions in AN.
A single dose of intranasal oxytocin has also been found to
increase emotional empathy and cooperation among healthy indi-
viduals particularly when social information regarding the other
person was present (21,22). Additionally, recent studies have found
that a single dose of intranasal oxytocin can increase cooperation
and normalise the avoidant, flattened arousal responses to human
social sounds in autism spectrum disorder (23,24). Thus, oxytocin
may be a facilitator of social communication, including facial
expression of emotion. Few studies thus far have investigated the
effects of a single dose of oxytocin on emotion expression (25,26).
Among healthy populations, a single dose of intranasal oxytocin
has been reported to increase spontaneous facial mimicry in
response to emotionally provoking videos, as well as increase facial
expressivity during the instructed production of facial expressions
(25,26). Among clinical populations, a single dose of intranasal oxy-
tocin has been reported to increase facial expressivity in response
to emotionally provoking images among people with schizophrenia
and to reduce avoidant behaviours during a clinical interview in
people with borderline personality disorder (27,28). However, to our
knowledge, no studies to date have investigated the effects of
intranasal oxytocin on evoked emotional facial expressions and the
interpretation of complex emotions in AN.
The present study aimed to investigate the effects of a single
dose of intranasal oxytocin on the interpretation and expression of
emotions in people with AN and healthy control (HC) participants.
Based on the previous work outlined above, we hypothesised that
participants with AN would have anomalies in the interpretation
and expression of emotions and that oxytocin administration would
alleviate these anomalies. Additionally, we explored correlations
between oxytocin-induced changes in the interpretation and
expression of emotions and depression, autistic traits, and body
mass index (BMI) within the AN group. Finally, we also explored
differences in the interpretation and expression of emotions, as well
as the effects of oxytocin, between AN participants who were tak-
ing antidepressants during the study and those AN participants
who were free of psychotropic medication.
Materials and methods
Participants
Thirty women with AN were recruited to take part in the present study. The AN
participants were recruited through South London and Maudsley National
Health Service (NHS) Trust and eating disorder charity websites (BEAT https://
www.b-eat.co.uk/ and Succeed www.succeed-foundation.org). All interested
AN participants were included in the study if they were female, aged 16–
65 years, met the DSM-5 criteria for AN assessed with the Structured Clinical
Interview for DSM-5 (29) and did not meet any of the exclusion criteria for all
participants. Fifteen of the AN participants were receiving psychotropic medi-
cation during the study. Twenty-nine HC women were recruited to take part in
the study as a comparison group. The HC participants were recruited through
King’s College London circulars and notice boards in the local community. All
HC participants were screened for past and current psychiatric disorders with
the Structured Clinical Interview for DSM-5 (29) and excluded if they reported
any current or history of mental health difficulties or suicidality. Additionally,
participants were excluded if they met any of the overall exclusion criteria for
all participants, which included being pregnant, a history of (or current) alcohol
or drug abuse/misuse, hormonal disturbance not as a result of low weight
among the AN participants, current impairments in cardiovascular functioning,
and any regular medication excluding psychotropic medication among the AN
participants. Five HC participants reported taking the contraceptive pill and
were asked to take a break from the pill and wait for the onset of their next
menstrual cycle before taking part. Prior to taking part in the study, all partici-
pants provided their written, informed consent. The study was approved by the
National Health System Research Ethics Committee (14/LO/0128) and was con-
ducted in accordance with the Helsinki Declaration of 1975 (revised in 2008).
The sample size was based on an a priori power analysis conducted with
G*Power, which indicated that, altogether, 60 participants would be needed
to have sufficient statistical power (0.8) to detect significant effects (30).
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Self-report measures
The Eating Disorder Examination Questionnaire (EDEQ) was used to obtain
an assessment of eating disorder psychopathology with the subscales:
restraint, eating concern, weight concern and shape concern (31). The relia-
bility of the EDEQ was high in the present study (Cronbach’s a = 0.98).
Assessments of depression, anxiety and stress were obtained using the
Depression, Anxiety and Stress Scale (DASS) (32). The reliability of the DASS
was high in the present study (Cronbach’s a = 0.98).
Autism Spectrum Quotient (AQ-10) is a short 10-item assessment of
autistic traits with high positive predictive value at clinical cut-off of 6 (33).
The reliability of the AQ-10 was acceptable in the present study (Cronbach’s
a = 0.70).
Design and procedure
The present study used a within subjects, placebo-controlled, double-blind
AB/BA cross-over design to explore the effects of intranasal oxytocin on
evoked facial expressions in AN. The study consisted of two sessions. In one
session, participants were asked to self-administer 10 puffs (five in each nos-
tril) of a nasal spray containing 40 IU of synthetic oxytocin (Syntocinon;
Novartis Pharmaceutical, Basel, Switzerland). In the other session, participants
were asked to self-administer 10 puffs (five in each nostril) of a placebo (pla-
cebo) nasal spray. The dose was based on previous work investigating the
effects of a single dose of intranasal oxytocin in eating disorders
(14,15,34,35). The placebo nasal spray was custom made to be identical to
the oxytocin spray minus the active ingredient. The order in which partici-
pants received oxytocin and placebo was counterbalanced and randomised.
All HCs, and AN participants if menstruating, were tested during the first 1–
10 days of the menstrual cycle. Additionally, the participants were asked not
to consume any food 2 h before the sessions and to refrain from smoking or
drinking alcoholic or caffeinated drinks 12 h before the sessions.
Fifteen minutes after administration, the participants were asked to com-
plete a computerised version of the RMET (36) presented with EPRIME, version
2.0 (Psychology Software Tools, Inc., Sharpsburg, PA, USA). The RMET con-
sists of a short practice trial and an experimental trial. In the practice trial,
participants were presented with 10 images of eyes and were asked to iden-
tify whether the eyes were male or female. In the experimental trial, partici-
pants are presented 36 pictures of eyes (18 male and 18 female) depicting
complex emotions. In this part of the task, participants are asked to identify
the emotion that the eyes are conveying by selecting one of four options
presented in each corner of the screen. The pictures were presented in a
randomised order in each session. In the present study, participants were
given infinite time to respond to each trial before moving onto the next.
Participants’ reaction times and accuracy were recorded.
Twenty-five minutes after administration, the participants were asked to
watch two short video clips, each lasting 2–2.5 min, during which they were
filmed. The two clips were chosen to evoke positive and negative emotions
in the participants. The first film clip (henceforth Film 1) was a humorous
scene from the film Four Weddings and a Funeral (1994), which has been
previously successfully been used in a number of studies to evoke positive
emotions (9,37–39). The second film clip (henceforth Film 2) was a sad
scene chosen from the film Shadowlands (1999), which has also been previ-
ously successfully used to evoke negative emotions in the studies listed
above (9,37–39). The same film clips were presented in both sessions in a
fixed order with a short clip of computer simulated waves presented before
each clip. This was performed to avoid carry-over effects from emotions
experienced before the task started, as well as to avoid carry-over effects
from the first film clip onto the second film clip.
After viewing each clip, participants were asked to rate how they were
feeling on the Positive and Negative Affect Schedule (PANAS) (40). The
PANAS consist of 20 emotion words and participants were asked to rate to
what extent they were experiencing each emotion on a scale of 1 (very
slightly or not at all) to 5 (extremely). The PANAS ratings were then anal-
ysed to establish participants self-reported positive and negative affect
scores in response to Film 1 and Film 2.
Noldus FACEREADER
Noldus FACEREADER (Noldus Information Technology BV, Wageningen, The
Netherlands) comprises facial expression analysis software that has been
developed to identify six basic emotions: happiness, sadness, fear, anger,
surprise and disgust. The software also detects neutral expressions. FACEREADER
reports the intensity to which each of the six basic emotions are expressed
in each frame on a scale of 0 to 1, where 0 indicates that the emotion is
not present and 1 indicates that the emotion is fully present. FACEREADER has
been validated using manual emotion coding systems and facial electromyo-
graphy (41–43). The present study focused on exploring expressions of hap-
piness and sadness.
Looking away
Looking away was analysed manually. The total number of seconds partici-
pants looked away from the film stimuli was recorded and analysed.
Statistical analysis
All data were analysed using STATA, version 14 (StataCorp, College Station,
TX, USA). Differences in clinical and demographic self-report measures
between the groups were analysed using a nonparametric median chi-
squared test.
As a result of the highly skewed nature of the data, the PANAS ratings
were transformed with square root transformation prior to analysis. Group
differences and effects of oxytocin/placebo on the expression of emotions,
PANAS ratings and looking away were explored with bootstrapped mixed
linear models with 1000 bootstrap replications. Drug (oxytocin, placebo),
Film (Film 1, Film 2), Group (AN, HC) and session (session 1, session 2) were
entered as fixed effects with a random intercept. Technical difficulties with
the video camera SD card led to loss of data from one AN participant and
three HC participants.
As described above, group differences and the effect of drug on the
interpretation of emotions on the RMET were examined using a boot-
strapped mixed linear model (1000 replications) with Drug (oxytocin, pla-
cebo), Group (AN, HC) and Session (session 1, session 2) entered as fixed
effects and a random intercept. As a result of the close proximity of the
sessions (1–5 days apart), we included Session as a fixed effect to control
for familiarity with the RMET and film stimuli. Significant interactions were
further explored by investigating post-hoc contrasts and pairwise compar-
isons. We additionally conducted further post-hoc analysis investigating the
effects of oxytocin on easy and difficult items between the two groups. We
used a median split to divide items into easy (accuracy > 75.42%) and diffi-
cult (accuracy < 75.42%) groups based on total sample accuracy. These
results are presented in the Supporting information (Doc S1, Table S2).
Additionally, we explored differences in the effects of intranasal oxytocin
between AN participants taking antidepressants during the time of the study
and those free of psychotropic medication in the above measures. As above,
the effects of drug on the interpretation and expression of emotions, PANAS
ratings and looking away were explored with similar 2 9 2 9 2 9 2 and
2 9 2 9 2 bootstrapped mixed linear models with 1000 bootstrap replica-
tions. The results are presented in the Supporting information (Doc. S1, Table
S3–S6, Figure S1–S2).
Within the AN group, relationships between oxytocin-induced changes in
the interpretation and expression of emotions, and depression (DASS:
© 2017 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd
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depression subscale), autistic features (AQ-10) and BMI were analysed with
Spearman’s rho correlation. Prior to correlation analysis, oxytocin-induced
changes in the interpretation and expression of emotions were calculated by
subtracting the interpretation accuracy and facial expression scores in the
placebo condition from those in the oxytocin condition. Thus, positive scores
indicated greater accuracy and facial expressivity in the oxytocin condition,
whereas negative scores indicated greater accuracy and facial expressivity in
the placebo session. The results are presented in the Supporting information
(Doc S1, Table S6).
Results
Clinical and demographic characteristics
The clinical characteristics of the sample are presented in Table 1.
The AN and HC groups were matched for age. The AN group
had a significantly lower BMI than the HC group. Additionally,
the AN group a reported significantly higher incidence of eating
disorder psychopathology as measured on the EDEQ, and reported
higher restraint, eating concern, shape concern and weight con-
cern. Furthermore, the AN group scored higher on the DASS,
reporting more depression, anxiety and stress than the HC group.
Finally, there was a significant difference between the two groups
on level of education, with HC participants reporting a higher
level of education than the AN participants, 90% of whom
reported having taken time off from education as a result of
their illness.
There were no significant differences in age or BMI between
those AN participants taking antidepressants during the study and
those AN participants who were free of psychotropic medication
(Table 1). The medicated AN participants did report a higher
incidence of eating disorder symptomatology as measured on the
EDEQ, scoring higher on the eating concern, weight concern and
shape concern subscales than those free of medication. Addition-
ally, the medicated AN participants scored higher on the DASS,
Table 1. Clinical and Demographic Sample Characteristics.







non-medicated AN HC (n = 29) AN versus HC
Median (Q1, Q3) Median (Q1, Q3) Median (Q1, Q3)
v2,
P value Median (Q1, Q3)
v2,
P value
BMI 16.13 (14.56, 18.14) 17.63 (15.20, 18.51) 14.67 (14.37, 16.61) 2.13,
0.144
22.21 (20.78, 25.51) 35.55,
< 0.001
Age 24.50 (22.00, 28.25) 25.00 (22.00, 27.00) 24.00 (21.00, 29.00) 0.00,
1.000
25.00 (23.00, 27.50) 0.02,
0.875
Level of education 3.00 (1.00, 3.00) 3.00 (1.00, 3.00) 3.00 (1.00, 3.50) 0.00,
1.000
3.00 (3.00, 4.00) 12.34,
< 0.001
Time off education
as a result of
AN (years)
1.00 (0.69, 2.00) 1.50 (0.92, 2.50) 0.67 (0.25, 0.1.25) 2.17,
0.141
– –
EDEQ total 4.13 (3.00, 5.13) 4.49 (4.21, 5.50) 3.68 (2.66, 4.06) 19.27,
< 0.001
0.59 (0.34, 1.00) 35.27,
< 0.001
EDEQ restraint 3.70 (2.60, 5.05) 4.40 (2.60, 5.20) 3.40 (1.40, 4.80) 0.07,
0.796
0.60 (0.00, 1.70) 20.79,
< 0.001
EDEQ weight concern 4.20 (2.70, 5.65) 5.60 (3.80, 6.00) 3.00 (2.00, 4.60) 5.40,
0.020
0.60 (0.30, 1.40) 31.38,
< 0.001
EDEQ shape concern 4.86 (3.56, 5.91) 5.88 (5.38, 6.00) 4.25 (2.75, 4.75) 19.27,
< 0.001
0.75 (0.38, 1.38) 41.67,
< 0.001
EDEQ eating concern 4.10 (2.90, 4.80) 4.40 (3.20, 4.80) 3.6 (2.60, 4.40) 5.40,
0.020
0.20 (0.00, 0.40) 41.67,
< 0.001
DASS Total 63.00 (40.00, 86.00) 72.00 (54.00, 88.00) 46.00 (26.00, 86.00) 6.67,
0.010
4.00 (1.00, 10.00) 37.49,
< 0.001
DASS Depression 21.00 (13.50, 32.00) 30.00 (20.00, 40.00) 18.00 (10.00, 26.00) 6.67,
0.010
0.00 (0.00, 2.00) 26.61,
< 0.001
DASS Anxiety 12.00 (6.00, 21.00) 18.00 (10.00, 26.00) 8.00 (2.00, 20.00) 4.29,
0.038
0.00 (0.00, 2.00) 29.07,
< 0.001
DASS Stress 25.00 (17.50, 31.00) 26.00 (24.00, 30.00) 18.00 (14.00, 34.00) 0.27,
0.606
2.00 (0.00, 7.00) 37.49,
< 0.001
AQ 3.00 (4.00, 1.00) 2.00 (4.00, 1.00) 3.00 (4.00, 1.00) 0.17,
0.680
2.00 (3.00, 1.00) 1.38,
0.502
AN, anorexia nervosa; HC, healthy comparison; BMI, body mass index; EDEQ, Eating Disorder Examination Questionnaire; DASS, Depression, Anxiety and Stress
Scale; AQ, Autism quotient; Level of education: 1 = A-level/National Vocational Qualification, 2 = Diploma, 3 = Undergraduate degree, 4 = Postgraduate
degree.
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reporting more depression and anxiety but not stress than the non-
medicated AN participants (Table 1).
Performance on the RMET
Interpretation accuracy and reaction times (RT) in the AN and HC
groups following both oxytocin and placebo administration are pre-
sented in Fig. 1(A,B). The mixed model revealed a significant differ-
ence between groups, with the AN participants being significantly
more accurate than the HC participants (Table 2). There was also a
significant effect of session, with all participants being significantly
more accurate in session 2 than session 1 [Z = 2.39, P = 0.017,
95% confidence interval (CI) = 0.01–0.12]. There were no other sig-
nificant effects or interactions influencing accuracy.
In terms of RT, the mixed model revealed a significant effect of
session, with all participants responding faster in session 2 than
session 1 (Z = !3.86, P < 0.001, 95% CI = !1211.80 to !395.67).
There was also a significant Drug 9 Group 9 Session interaction
(Table 2). The interaction was first explored by investigating the
Drug 9 Group interaction within each session. The results revealed
that there was a significant Drug 9 Group interaction in session 2
(v2 = 12.53, P = 0.0004) but not in session 1 (v2 = 2.70,
P = 0.1006). The effect of drug was then investigated within each
group in session 2. The results revealed that oxytocin led to a sig-
nificantly slower RT in the AN group in (Z = 2.32, P = 0.020, 95%
CI = 157.26–1871.20) and a faster RT in the HC group in session 2
(Z = !2.62, P = 0.009, 95% CI = !2059.48 to !269.17).
We also explored the Group 9 Session within placebo and
oxytocin conditions. The post-hoc contrasts revealed a significant
Group 9 Session interaction following both placebo (v2 = 6.83,
P = 0.009) and oxytocin administration (v2 = 6.49, P = 0.011). The
pairwise comparisons revealed that HC participants were signifi-
cantly faster than the AN participants in session 2 (Z = !2.59,
P = 0.010, 95% CI = !1912.21 to !263.49) but not in session 1
(Z = 1.13, P = 0.259, 95% CI = !431.42 to 1602.88) following
oxytocin administration. Following placebo administration, the HC
participants were significantly slower than the AN participants in
session 2 (Z = 2.45, P = 0.014, 95% CI = 222.32–1986.10) but not
in session 1 (Z = !1.19, P = 0.235, 95% CI = !1293.64–317.61)
(Table 2).
Because 17 of the AN participants had completed the RMET
before, we also explored differences between the groups on task
performance without these participants to examine their impact.
These findings are presented in the Supporting information (Doc
S1). The results revealed that, although the AN participants were
still on average more accurate than the HC participants, this differ-
ence no longer reached significance (see Supporting information,
Table S1). As above, there was a significant effect of session sug-
gesting that participants were more accurate in session 1 than in
session 2.
Regarding RT, the results revealed a significant effect of ses-
sion, with all participants being faster in session 2, and a signifi-
cant Drug 9 Group interaction (see Supporting information,
Table S1). Further exploration of the interaction revealed that the
AN participants who had not completed the RMET before were
significantly slower in the oxytocin than placebo condition
(Z = 2.70, P = 0.007, 95% CI = 165.63–1045.27). A similar effect
was not present in the HC group (Z = !0.56, P = 0.576, 95%
CI = !503.51 to 280.00).
Expressions of happiness and sadness, and looking away
The intensity of expression of sadness and happiness in response to
Film 1 and Film 2 following placebo and oxytocin administration is
summarised for the AN and HC groups in Fig. 2(A,B) for Film 1 and
Fig. 2(C,D) for Film 2. The P-value was adjusted for multiple post-
hoc comparisons using the false discovery rate and was set at
P < 0.003 (44). As expected, the mixed model revealed a significant
effect of Film, with all participants across groups and sessions
expressing more happiness when viewing Film 1 than Film 2. The
results also revealed a significant effect of Group, with HC partici-
pants expressing more positive facial expressions than AN partici-
pants across films and sessions (Table 3). The model also revealed a
significant Film 9 Group and Drug 9 Film 9 Group 9 Session
interactions.
The Film 9 Group interaction was investigated further by explor-
ing the difference between the groups at the two levels of Film.
The post-hoc test revealed that the HC participants expressed sig-
nificantly more happiness than the AN participants when viewing




























Fig. 1. Percentage accuracy (A) and reaction times (B) on the Reading the Mind in the Eyes (RMET) in the anorexia nervosa (AN) and healthy comparison (HC)
groups in the oxytocin and placebo conditions. Grey dots represent individual data points; the box plot represents the median, interquartile range, and the
maximum and minimum of the data. RT, reaction time; ms, milliseconds.
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significant differences between the groups in expressions of happi-
ness when viewing Film 2 (Z = !1.34, P = 0.181, 95%
CI = !0.10–0.02).
The four-way interaction was first investigated by exploring the
Drug 9 Film 9 Group interaction within session 1 (v2 = 3.84,
P = 0.05) and session 2 (v2 = 1.02, P = 0.314), which did not yield
significant results. Next, the Drug 9 Film 9 Session interaction
was explored within the HC (v2 = 2.23, P = 0.135) and AN groups
(v2 = 1.85, P = 0.173), which did not yield significant results.
Finally, the Drug 9 Session 9 Group interaction was explored
within Film 1 (v2 = 4.06, P = 0.044) and Film 2 (v2 = 1.07,
P = 0.301), which also did not yield significant results. There were
no other significant effects or interactions influencing expressions
of happiness.
Regarding the expression of sadness, as above, the mixed model
revealed a significant effect of Film, with all participants across
Table 2. Performance on the Reading the Mind in the Eyes Test (RMET) in Anorexia Nervosa (AN) and Healthy Comparison (HC) Groups Following Oxytocin
and Placebo.
Drug AN (n = 30), mean " SD HC (n = 29), mean " SD v2, P value
Accuracy (%) Oxytocin 81.77 " 10.67 69.83 " 12.35 Drug: 0.27, 0.604
Session: 5.69, 0.017
Group: 31.25, < 0.001
Drug 9 Session: 2.86, 0.091
Drug 9 Group: 1.33, 0.250
Session 9 Group: 0.71, 0.400
Drug 9 Session 9 Group: 0.72, 0.397
Placebo 78.83 " 13.74 71.79 " 9.63
RT Oxytocin 5379.72 " 1802.67 5158.24 " 2671.37 Drug: 0.65, 0.420
Session: 14.90, < 0.001
Group: 0.01, 0.909
Drug 9 Session: 0.97, 0.324
Drug 9 Group: 1.84, 0.175
Session 9 Group: 0.01, 0.920
Drug 9 Session 9 Group: 11.31, 0.001
Placebo 4929.32 " 1600.89 5241.59 " 2282.45
RT, reaction time.
0.6
Film 1 Film 1












































Fig. 2. Intensity of expressions of sadness and happiness in response to Film 1 and Film 2 in the anorexia nervosa (AN) and healthy comparison (HC) groups
in oxytocin and placebo conditions. (A) Expressions of happiness in response Film 1, (B) expressions of sadness in response to Film 1, (C) expressions of happi-
ness in response to Film 2, (D) expressions of sadness in response to Film 2. Grey dots represent individual data points; the box plot represents the median,
interquartile range, and the maximum and minimum of the data. Film 1, humorous film clip; Film 2, sad film clip.
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groups and sessions expressing more sadness when viewing Film 2
than Film 1. There were no other significant effects or interactions
influencing expressions of sadness.
The total time (s) that participants looked away from the film stim-
uli is presented in Table 3. The mixed model revealed a significant
effect of group, with AN participants looking away more than HC par-
ticipants. There was also a significant effect of film and session, with
all participants spending more time looking away from Film 2 than
Film 1, and looking away more during session 2 than session 1. There
were no other significant effects or interactions (Table 3).
Subjective PANAS ratings
Ratings of subjective positive and negative affect following Film 1
and Film 2 in the AN and HC groups are presented in Table 4.
The P-value was adjusted for multiple post-hoc comparisons using
Table 3. Expressions of Happiness and Sadness, and Looking Away in Anorexia Nervosa (AN) and Healthy Comparison (HC) Groups During Film 1 and Film 2.
Film Drug AN (n = 30), mean " SD HC (n = 29), mean " SD v2, P value
Expressions of happiness Film 1 Oxytocin 0.15 " 0.16 0.27 " 0.18 Drug: 0.47, 0.494
Film: 134.66, < 0.001
Group: 5.81, 0.016
Session: 0.20, 0.592
Drug 9 Film: 0.12, 0.727
Drug 9 Group: 1.63, 0.202
Film 9 Group: 14.29, < 0.001
Drug 9 Session: 0.05, 0.818
Film 9 Session: 2.08, 0.149
Group 9 Session: 1.11, 0.293
Drug 9 Film 9 Group: 0.29, 0.592
Drug 9 Film 9 Session: 0.03, 0.857
Drug 9 Group 9 Session: 0.94, 0.857
Film 9 Group 9 Session: 0.01, 0.905
Drug 9 Film 9 Group 9 Session: 4.07, 0.044
Placebo 0.16 " 0.17 0.22 " 0.16
Film 2 Oxytocin 0.05 " 0.09 0.03 " 0.04
Placebo 0.05 " 0.10 0.02 " 0.03




Drug 9 Film: 0.76, 0.384
Drug 9 Group: 0.73, 0.392
Film 9 Group: 1.30, 0.254
Drug 9 Session: 0.06, 0.801
Film 9 Session: 0.57, 0.451
Group 9 Session: 0.34, 0.559
Drug 9 Film 9 Group: 1.13, 0.289
Drug 9 Film 9 Session: 0.64, 0.422
Drug 9 Group 9 Session: 0.71, 0.398
Film 9 Group 9 Session: 0.23, 0.631
Drug 9 Film 9 Group 9 Session: 0.48, 0.488
Placebo 0.004 " 0.006 0.02 " 0.07
Film 2 Oxytocin 0.01 " 0.01 0.01 " 0.02
Placebo 0.03 " 0.05 0.03 " 0.08
Looking away (s) Film 1 Oxytocin 1.28 " 2.49 0.23 " 0.51 Drug: < 0.01, 0.948
Film: 8.58, 0.003
Group: 18.05, < 0.001
Session: 7.97, 0.005
Drug 9 Film: 0.07, 0.797
Drug 9 Group: 0.72, 0.397
Film 9 Group: 1.87, 0.172
Drug 9 Session: 3.11, 0.078
Film 9 Session: 0.09, 0.762
Group 9 Session: 3.31, 0.069
Drug 9 Film 9 Group: 0.12, 0.728
Drug 9 Film 9 Session: 0.09, 0.767
Drug 9 Group 9 Session: 1.98, 0.160
Film 9 Group 9 Session: 0.04, 0.841
Drug 9 Film 9 Group 9 Session: 2.59, 0.107
Placebo 1.00 " 1.93 0.31 " 0.74
Film 2 Oxytocin 2.72 " 3.72 0.65 " 2.08
Placebo 2.38 " 4.69 1.08 " 2.35
Film 1, humorous film clip; Film 2, sad film clip.
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the false discovery rate and was set at P < 0.004 (44). The mixed
model exploring ratings of positive affect on the PANAS revealed
a significant effect of group in ratings of positive affect, with the
HC participants reporting a more subjective positive affect relative
to the AN participants (Table 4). There was also a significant
effect of Film, with all participants reporting more positive affects
following Film 1 than Film 2, and a significant effect of session,
with participants reporting a more positive affect in session 1
than session 2.
The mixed model exploring ratings of subjective positive affect
also revealed significant Film 9 Session and Drug 9 Film 9 Ses-
sion interactions (Table 4). The three-way interaction was first
explored by investigating the Drug 9 Film interaction in session 1
and session 2, which revealed no significant interactions (session 1:
v2 = 2.53, P = 0.112; session 2: v2 = 4.04, P = 0.044). The three-
way interaction was then explored by investigating the Ses-
sion 9 Drug interaction in the two levels of film, which revealed
no significant interactions (Film 1: v2 = 5.24, P = 0.023; Film 2:
v2 = 1.34, P = 0.247). Finally, the three-way interaction was
explored by investigating the Film 9 Session interaction at the
two levels of drug, which revealed a significant interaction in the
oxytocin (v2 = 11.19, P = 0.001) but not placebo session
(v2 < 0.01, P = 0.980). Further pairwise comparison revealed that
participants who received oxytocin in the first session and those
who received it in the second session reported a more subjective
positive affect in response to Film 1 than Film 2 (session 1;
Z = !7.55, P < 0.001, 95% CI = !11.42 to !6.71; session 2:
Z = !2.16, P = 0.031, 95% CI = !5.00 to !0.24). There was
also a significant Group 9 Session interaction (Table 4), with HC
participants reporting a significantly more positive affect in ses-
sion 1 than 2 (Z = !3.84, P < 0.001, 95% CI = !4.21 to
!1.36). There was no significant differences between the session
within the AN group (Z = !0.84, P = 0.399, 95% CI = !2.14 to
0.86).
The mixed model exploring ratings of negative affect revealed a
significant effect of Film, with all participants reporting significantly
more negative affect in response to Film 2 than Film 1. There was
also a significant difference between groups in ratings of negative
affect, with AN participants reporting a more negative affect than
the HC participants (Table 4).
Table 4. Positive and Negative Affect Schedule (PANAS) Rating Following Film 1 and Film 2 in Anorexia Nervosa (AN) and Healthy Comparison (HC) Groups.
PANAS Film Drug AN (n = 30), mean " SD HC (n = 29), mean " SD v2, P value
Positive affect Film 1 Oxytocin 11.00 " 4.67 14.36 " 7.16 Drug: 1.30, 0.254
Film: 131.20, < 0.001
Group: 58.09,< 0.001
Session: 10.66, 0.001
Drug 9 Film: 0.05, 0.829
Drug 9 Group: 0.29, 0.587
Film 9 Group: 0.02, 0.879
Drug 9 Session: 1.09, 0.297
Film 9 Session: 6.38, 0.012
Group 9 Session: 4.10, 0.043
Drug 9 Film 9 Group: 0.07, 0.789
Drug 9 Film 9 Session: 4.54, 0.032
Drug 9 Group 9 Session: 0.02, 0.882
Film 9 Group 9 Session: 2.53, 0.111
Drug 9 Film 9 Group 9 Session: 0.43, 0.512
Placebo 11.72 " 5.71 15.84 " 6.04
Film 2 Oxytocin 5.21 " 4.29 8.72 " 7.27
Placebo 5.57 " 4.61 9.60 " 6.51
Negative affect Film 1 Oxytocin 5.07 " 6.08 0.88 " 1.69 Drug: 0.64, 0.425
Film: 33.10, < 0.001
Group: 69.99, < 0.001
Session: 0.05, 0.824
Drug 9 Film: < 0.01, 0.950
Drug 9 Group: 0.05, 0.820
Film 9 Group: 1.32, 0.251
Drug 9 Session: 1.14, 0.285
Film 9 Session: 0.29, 0.592
Group 9 Session: 0.41, 0.521
Drug 9 Film 9 Group: 0.28, 0.599
Drug 9 Film 9 Session: 0.10, 0.750
Drug 9 Group 9 Session: 1.54, 0.215
Film 9 Group 9 Session: 0.03, 0.872
Drug 9 Film 9 Group 9 Session: 0.18, 0.673
Placebo 4.28 " 4.57 0.88 " 1.45
Film 2 Oxytocin 8.82 " 6.78 3.68 " 5.37
Placebo 8.57 " 5.49 3.08 " 3.30
Film 1, humorous film clip; Film 2, sad film clip.
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Discussion
The present study aimed to investigate the effects of a single dose
of intranasal oxytocin on the interpretation and expression of emo-
tions in people with AN and HC participants. By contrast to what
was hypothesised based on the previous literature, oxytocin admin-
istration did not have a significant impact on the interpretation or
expression of emotions in either group. However, as hypothesised,
the present findings replicated previous work demonstrating
that, relative to HC, people with AN display a less positive facial
affect, spend more time looking away from the emotional stimuli,
and report a less subjective positive affect when viewing emotional
film stimuli. Surprisingly, the AN participants were significantly
more accurate with respect to interpreting complex emotions in the
RMET than the HC participants. Finally, we found that AN partici-
pants who were taking antidepressants during the study expressed
a less positive facial affect when viewing the humorous film and
were less accurate with respect to interpreting complex emotions
relative to non-medicated AN participants.
By contrast to what was hypothesised, we did not find signifi-
cant effects of intranasal oxytocin on the expression of facial
affect. These findings were somewhat surprising considering that
previous studies have reported a significant effect of oxytocin on
expression of emotions among healthy and clinical populations
(25–27). The discrepancy could arise from the fact that previous
studies have largely utilised different kinds of emotionally
provoking stimuli, including threatening social and nonsocial stimuli
(25–27). Indeed, Korb and Malsert (25) found no changes in the
expression of facial affect in response to positive facial expressions,
although they did find changes in frowning in response to angry
faces. Furthermore, intranasal oxytocin may differentially influence
spontaneous facial expression, instructed production of facial
expression (26) and facial mimicry during an emotion identification
task (25). However, in a recent meta-analysis and systematic review
conducted by our group, we found that oxytocin did not have a
significant effect on emotion expression (J. Leppanen, K. W. Ng, K.
Tchanturia and J. Treasure, unpublished data).
Additionally, we found no significant effects of oxytocin adminis-
tration on the accuracy of complex emotion interpretation in the
AN or HC groups. In part, these findings support a recent proof of
concept study, which found that intranasal oxytocin did not
improve sensitivity to recognise basic emotions in AN (14). How-
ever, the previous study used a different task to assess interpreta-
tion of emotions and found that intranasal oxytocin improved
emotion recognition sensitivity in HC participants and people with
bulimia nervosa (14). Similarly, other previous studies have reported
that a single dose of intranasal oxytocin significantly improved
recognition of complex emotions on the RMET among healthy indi-
viduals (17,18). However, recently, there have also been some failed
replications of these findings suggesting that the effects of intrana-
sal oxytocin on social-emotional processing are likely to more com-
plex than previously anticipated (45–47). Furthermore, in our recent
meta-analysis and systematic review, we found that, when fourteen
previous studies were pooled together, a single dose on intranasal
oxytocin did not have a significant impact on any theory of mind
measures, including RMET (J. Leppanen, K. W. Ng, K. Tchanturia and
J. Treasure, unpublished data). However, in a simpler test of recog-
nition of basic emotions, a single dose of oxytocin improved recog-
nition of fear and increased sensitivity to recognise anger in
healthy individuals only (J. Leppanen, K. W. Ng, K. Tchanturia and J.
Treasure, unpublished data).
Indeed, a systematic review has reported that almost half of
studies investigating the effects of intranasal oxytocin on social-
emotional processing did not report significant effects of oxytocin.
Furthermore, where significant effects were found, 63% of the time,
the effects were moderated by environmental factors or individual
differences (10). Additionally, a more recent systematic review has
suggested that the varied effects of oxytocin on social-emotional
processing may be moderated by social boundaries, such that
oxytocin not only increases social-affiliative behaviour within an
‘in-group’, but also increases distrust and desire to punish strangers
and ‘out-group’ members (48). This notion is supported by a recent
study reporting that oxytocin-induced noncooperation in the pris-
oner’s dilemma, a trust game, was influenced by fear (49). It was
suggested that oxytocin may have increased sensitivity fear-indu-
cing social stimuli leading to noncooperation (49). Thus, it may be
that the previously seen effects of oxytocin on social-emotional
processing are a by-product of its effects on feelings of belonging-
ness. Further exploration of the effects of oxytocin on expression of
emotions in different social boundary conditions may be of interest
with respect to evaluating its therapeutic potential.
When viewing the humorous film clip, the AN participants
expressed significantly less positive facial affect than the HC partic-
ipants, although there were no significant differences between the
groups when viewing the sad film clip. Relative to the HC group,
the AN participants also spend more time looking away from both
emotional film clips, and reported experiencing a less positive affect
and a more negative affect in response to the humorous and sad
film clips. The present findings add to the steady accumulation of
evidence indicating that the AN group has difficulties expressing
positive emotions and also has a tendency to avoid emotional stim-
uli (7,37–39,50). Furthermore, previous studies have shown that,
relative to HC women, adolescents and adult women with AN do
not display more negative facial expressions in response to negative
film stimuli despite reporting a more negative affect (38,51). Taken
together, these findings suggest that there may be a general dis-
connect between subjective experience and external display of emo-
tions and a tendency to avoid emotional engagement. Such
difficulties have important affective and social consequences (4,52)
and are thus important targets for interventions.
By contrast to what we expected, AN participants were signifi-
cantly more accurate than the HC participants with respect to
interpreting complex emotions in the RMET. This finding is in direct
contrast with previous work showing that AN participants have dif-
ficulties with accurately interpreting complex emotions in the RMET
(53–55). However, upon closer inspection, on average, the AN par-
ticipants in the present study did not appear to outperform those
in some previous studies (53,55). The HC participants, on the other
hand, were less accurate than those in previous case–control stud-
ies and large sample validation studies (53–57). Although, it is
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difficult to know what led to these unexpected findings, it is unli-
kely to be a result of the HC group having general difficulties with
understanding the task. Had that been the case, we would have
expected there to be significant differences between the groups in
accuracy and response times, which did not occur in the present
study. Additionally, the majority of the AN participants (57%) were
more familiar with the RMET than HC participants, having com-
pleted it before as part of other studies, and some of them per-
formed unexpectedly well on the task, with accuracy percentages
of up to 100%. Indeed, once these participants were removed, the
differences between the AN and HC groups did not reach signifi-
cance. However, there still remained a small difference between the
groups, with AN participants being more accurate.
Interestingly, we also found significant differences in accuracy
and reaction times between sessions 1 and 2 on the RMET across
groups, with all participants becoming more accurate and faster in
session 2 even though no feedback on performance was given.
These findings appear surprising considering that previous test–ret-
est reliability studies have found no such effects in the RMET
among healthy populations (58,59). However, it is of note that, in
these studies, a minimum of 2 weeks fell between the first admin-
istration of the task and the retest (58,59), whereas, in the present
study, the two sessions were only 1–5 days apart. Other studies
that have used shorter intervals between test and retest, ranging
from 1 h to 1 week, have found improvements in accuracy and
response times in a range of social-emotional tasks (60,61). Fur-
thermore, a few studies have found implicit learning effects over
the course an emotion recognition task in healthy and other clinical
populations, including people with depression and borderline per-
sonality disorder (62,63). Therefore, it is possible that, because the
two sessions in the present study were so close, participants
became familiarised with the stimuli, leading to a significant
improvement in task performance.
The present study also explored differences between participants
taking antidepressants and those free of psychotropic medication.
As might be expected, those taking antidepressants reported signif-
icantly more eating disorder psychopathology, depression and anxi-
ety than those free of psychotropic medication, suggesting that
medicated AN participants were more severe. However, when these
confounding factors were accounted for, the medicated AN partici-
pants remained significantly less accurate with respect to interpret-
ing emotions, and were less expressive and reported a less positive
affect when watching the humorous Film 1 than the non-medi-
cated AN group. Although, it is possible that additional con-
founders were not accounted for, a recent study investigating
facial expressivity among people with AN also reported a reduced
expression of positive facial affect among AN participants taking
antidepressants (9). Further exploration of the effects of antide-
pressants on social-emotional processing in people with acute AN
may be of interest.
Clinical implications
The present findings add further evidence to the wealth of research
suggesting that people with AN may have a general disconnect
between subjective experience and expression of emotions (38,51).
Appropriate expression of emotions is one of the corner stones of
social interaction and a blunted facial affect can have profound
affective and social consequences (4,52). Behavioural studies have
found that inhibiting the expression of facial affect in response to
emotionally provoking stimuli is associated with increases in blood
pressure and reductions in subjective enjoyment (52,64). Additionally,
when viewing videos of people displaying either appropriate, inappro-
priate or blunted reactions to emotional stimuli, participants rated
those people who displayed a blunted response to positive emotional
stimuli more negatively and expressed a greater desire for increased
social distance from these individuals (4). Thus, these problems with
social communication may contribute to the elevated negative mood,
isolation and loneliness that are common features of AN (65).
Limitations
The main limitation of the present study was the relatively short
interval between the administration of oxytocin and the first task.
However, there are previous studies that have used a similar short
interval between administration and the task and have reported
significant differences in social-emotional processing between oxy-
tocin and placebo sessions (66). However, it is not possible to
determine whether the lack of oxytocin-induced effects in the
RMET in the present study was not at least partly a result of this
short interval. Still, previous work investigating the temporal profile
of another neuropeptide similar to oxytocin (i.e. vasopressin) has
found that significant effects occur within 10 min of administration
(67). Nonetheless, replication of the present findings with a longer
interval between administration and tasks is necessary.
Although the sad film has been successfully used in many previ-
ous studies (37–39), in the present study, we found that the major-
ity of the participants were not familiar with the film Shadowlands
(1999) and did not understand it. Thus, most of the participants
were not sufficiently affected by the film and did not express a
sufficient negative facial affect to be detected by FACEREADER, which
provides a mean valence score for the duration of the film. If par-
ticipants expressed a negative facial affect on only couple of occa-
sions during the film but were otherwise neutral during the
majority of the film, those short expressions would be averaged out
in the mean valence score. A previous study used clips from differ-
ent films tailored specifically for younger participants and found
robust results showing reduced facial expressivity in young people
with AN when viewing both happy and sad film clips (51). Future
research may benefit from tailoring the clips for the participant
group to ensure they are sufficiently familiar with the story to
engage with the clips.
Compared to previous work (37,38,53,54), the present study
employed a modified procedure in which the experimenter stayed
in the room during all tasks. Although this allowed the experi-
menter to tackle some practical difficulties (e.g. a participant mov-
ing outside of camera range or watching the clips in a different
order), it may have led the participants to feel less able to engage
and become involved with the film clips during the film task. Future
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studies may benefit from finding alternative ways to combat non-
compliance, at the same time as giving participants sufficient pri-
vacy to engage with the films.
Finally, the present study did not assess participants IQ, which
can impact task performance. This is a limitation when comparing
the performance of the two groups on the RMET, which requires
an understanding of adjectives describing complex emotions.
Although this did not directly impact the investigation of the
effects of oxytocin in the cross-over study, future work should con-
duct a full IQ assessment when attempting to compare the perfor-
mance of two or more groups on a similar neuropsychological test.
Conclusions
The present study aimed to investigate the effects of a single dose of
intranasal oxytocin on difficulties in the interpretation and expression
of emotions in AN. The findings revealed that oxytocin did not signifi-
cantly influence the interpretation of complex emotions or facial
expressivity in response to positive or sad emotional stimuli in AN.
These findings are supported by recent work showing that intranasal
oxytocin does not improve emotion recognition sensitivity in people
with AN and selectively improves the expression of negative emotions
in response to threatening stimuli (14,25–27). However, replication of
these findings with different intervals between oxytocin administra-
tion and the task is necessary before firm conclusions can be drawn.
Taken together, these findings suggest that there may be anomalies
present in social-emotional processing in people with AN that are not
resolved with a single dose of intranasal oxytocin.
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A B S T R A C T
Background: Heightened threat sensitivity is a transdiagnostic feature in several psychiatric disorders. The
neuropeptide oxytocin has been shown to reduce fear related behaviours and facilitated fear extinction in an-
imals. These ﬁndings have led to increasing interest to explore the eﬀects of intranasal oxytocin on threat
processing in humans.
Methods: The review included 26 studies (N = 1173), nine of which included clinical populations (N = 234).
The clinical groups included were people with borderline personality disorder (BPD), anorexia nervosa, bulimia
nervosa, depression, anxiety, and alcohol dependence disorder. We examined the eﬀects of a single dose of
intranasal oxytocin on startle response, attentional responses, and behavioural responses to threat.
Results: A single dose of intranasal oxytocin signiﬁcantly increased the physiological startle response to threat in
healthy people with a small eﬀect size. However, oxytocin did not have signiﬁcant eﬀects on attentional bias
towards social or disorder-speciﬁc threat, ﬁxation towards threatening stimuli among healthy or clinical po-
pulations, or on threat related behavioural approach or avoidance responses.
Limitations: No studies investigated the eﬀects of oxytocin on the startle response to threat among clinical po-
pulations. Additionally, only one of the reviewed studies had suﬃcient power to detect at least a moderate eﬀect
of oxytocin according to our criterion.
Discussion: The synthesis of literature suggest that oxytocin may inﬂuence the salience of threatening stimuli
among healthy individuals, increasing the startle response to threat. It would be of interest to investigate the
eﬀects of oxytocin on the startle response to threat among clinical populations.
1. Introduction
Threat processing is vital for the survival of an organism or species
(Öhman, 2005, 2007). Potential threats are rapidly recognised and
activate a number of subcortical structures including the amygdala and
the hypothalamic-pituitary-adrenal (HPA) axis, which initiate protec-
tive fear responses (Öhman, 2005). Physiological responses, such as
increased skin conductance, behavioural approach and avoidance re-
sponses, such as ﬁght or ﬂight responses, and attentional responses,
such as active attending to the source of fear also occur (Misslin, 2003).
However, hypersensitivity of this system and maladaptive fear learning
can have negative consequences (Ozawa and Johansen, 2014). Such
maladaptive processes are believed to contribute to the development
and maintenance of number of psychiatric disorders, such as eating
disorders (ED), anxiety disorders, obsessive-compulsive disorder (OCD),
and post-traumatic stress disorder (PTSD) (Britton et al., 2011; Ozawa
and Johansen, 2014; Strober et al., 2007).
Behavioural studies have demonstrated that people with PTSD,
OCD, and ED show anomalies in physiological responses to threat. For
example, there is an exaggerated physiological startle response to an-
ticipation and viewing of disorder-speciﬁc, potentially threatening sti-
muli, such as images of trauma, contamination, or food (Altman et al.,
2013; Mauler et al., 2006; Pitman et al., 2012; Simon et al., 2013).
Additionally, a number of reviews have reported atypical attentional
bias towards disorder speciﬁc stimuli (Bar-Haim et al., 2007; Brooks
et al., 2011; Cisler and Koster, 2010). Furthermore, disorder speciﬁc
stimuli have been found to elicit negative facial expressions and sub-
jective feelings of fear and disgust (Broderick et al., 2013; Soussignan
http://dx.doi.org/10.1016/j.jad.2017.08.041
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et al., 2011; Uher et al., 2004). Taken together these ﬁndings suggest
that treatments targeting this hypersensitivity and maladaptive fear
learning may be of beneﬁt in these disorders.
The neuropeptide, oxytocin, has been found to play an important
regulatory role in human and animal studies (Neumann and Slattery,
2016; Onaka et al., 2012; Zheng et al., 2010). Animal studies have
demonstrated that oxytocin plays an important role in lowering the
physiological stress and anxiety response by activating a negative
feedback loop (Onaka et al., 2012; Zheng et al., 2010). Elevated oxy-
tocin secretion from the paraventricular nucleus of the hypothalamus
following a stressful event is believed to lead to increased availability of
gamma-aminobutyric acid (GABA), which in turn is believed to inhibit
the HPA axis and amygdala activation (Onaka et al., 2012; Zheng et al.,
2010). Indeed, a recent study found that marmoset monkeys treated
with an oxytocin receptor antagonist had elevated glucocorticoid levels
in response to the stressor and showed a greater tendency to engage in
maladaptive fear-related behaviour such as isolation (Cavanaugh et al.,
2016). These ﬁndings have sparked increasing interest in exploring the
role of oxytocin in threat processing, particularly in fear responses and
extinction learning.
Preclinical studies have demonstrated that exogenous intravenous
and intranasal oxytocin can inﬂuence fear related responses in rodents
and monkeys respectively, reducing hiding behaviour during an open
ﬁeld test and attentional bias towards threatening facial expressions
(Parr et al., 2013; Rotzinger et al., 2010). Additionally, a recent sys-
tematic review explored the role of the oxytocin system in fear ex-
tinction in rodents (Neumann and Slattery, 2016). The ﬁndings re-
vealed that oxytocin reduced fear related behaviours and facilitated
fear extinction in rodents, particularly when the exogenous oxytocin or
oxytocin agonists were administered to the infralimbic cortex
(Neumann and Slattery, 2016). The infralimbic cortex has inhibitory
projections to a number of subcortical regions in the rodent brain in-
cluding the amygdala and activation of this region has been docu-
mented to be associated with fear extinction in rodents and humans
(Quirk and Beer, 2006). These ﬁndings suggest that oxytocin may re-
duce fear and facilitate extinction possibly by reducing stress and an-
xiety around the source of potential threat. Thus, these ﬁndings have
led to increasing interest to investigate the role oxytocin plays in threat
processing and fear extinction in humans as well as its therapeutic
potential in disorders characterised by elevated threat sensitivity and
resistance to natural extinction.
A few studies have begun to explore the eﬀects of intranasal oxy-
tocin on threat processing and the physiological stress and anxiety re-
sponse in humans. For example a recent meta-analysis found that a
single dose of intranasal oxytocin lowered cortisol in clinical popula-
tions characterised by dysregulation of the HPA axis, but did not sig-
niﬁcantly inﬂuence the cortisol response to stressful stimuli in healthy
individuals (Cardoso et al., 2014). Since many psychiatric disorders,
including ED, PTSD, and anxiety disorders, are characterised by dys-
regulation of the HPA axis (Connan et al., 2007; Ehlert et al., 2001; Lo
Sauro et al., 2008), there has been increasing interest in further ex-
ploration of the potential anti-stress and anxiolytic eﬀects of intranasal
oxytocin. To our knowledge, no systematic reviews have thus far in-
vestigated the eﬀects of single dose of intranasal oxytocin on diﬀerent
aspects of threat processing in healthy and clinical populations more
broadly.
The aim of the current systematic review and meta-analyses was to
build on previous literature and synthesise studies examining the eﬀects
of a single dose of intranasal oxytocin on threat processing among in
humans. The objective was to investigate the eﬀects of oxytocin on the
physiological startle response, behavioural approach and avoidance
responses, and attentional responses, including attentional bias and
ﬁxation, towards generally threatening stimuli as well as towards dis-
order related threatening stimuli among clinical populations. Based on
ﬁndings outlined above, we hypothesised that a single dose of in-
tranasal oxytocin would reduce these anomalous threat responses in
clinical populations characterised by elevated threat sensitivity.
2. Methodology
2.1. Literature search
In accordance with the PRISMA guidelines (Moher et al., 2009),
electronic databases, including OVID (PsycINFO, PsycARTICLES, Med-
line, ARGIS), Web of Knowledge core collection, and Pubmed, were
searched April 2017. The search terms included oxytocin AND (threat
OR fear OR anxiety OR avoidance OR attention OR bias OR startle OR
approach OR ﬁxation OR gaze). Furthermore, bibliographies of included
studies were inspected to look for further studies not yielded by the
initial search.
2.2. Inclusion criteria
In order to be included in the systematic reviews and meta-analyses
studies were required to meet the following inclusion criteria: 1) in-
vestigate physiological response, behavioural approach and avoidance
response, attention, or ﬁxation towards threatening or feared stimuli; 2)
investigate the eﬀects of a single dose of intranasal oxytocin on these
measures; 3) compare the eﬀects of intranasal oxytocin against in-
tranasal placebo; 4) include healthy adult participants and/or adult
clinical populations; 5) random allocation of participants to receive
intranasal oxytocin or placebo in studies using between subjects design;
6) randomisation of treatment order in studies using within subjects
design; 7) be published in English in a peer reviewed journal. In order
to reduce heterogeneity, long trials in which participants received more
than one dose of oxytocin or in which eﬀects of oxytocin were in-
vestigated the following day or later were not included.
2.3. Study selection
The search ﬂow diagram is presented in Fig. 1. The literature search
and initial screening based on title and abstract was conducted by the
ﬁrst author. The full text articles identiﬁed in the initial search and
screening were examined for eligibility by two authors in conjunction
(J.L. and K.W.N.). Studies were then included in the systematic review
and meta-analyses if both authors agreed they met the inclusion cri-
teria. If there was any uncertainty regarding eligibility of a paper it was
referred to the rest of team for further discussion.
2.4. Data collection and synthesis
We conducted three separate meta-analyses investigating the eﬀects
of a single dose of intranasal oxytocin on the physiological response,
behavioural approach and avoidance response, attention, and ﬁxation
towards threatening stimuli. To conduct these meta-analyses informa-
tion regarding means, standard deviations, and sample size were ex-
tracted from the included articles. Where standard errors of the mean
(SE) were reported instead of standard deviations, these were converted
with the following formula: =SD SE N* . Fourteen studies did report
the data in the article or in Supplementary Materials, or reported the
data in ﬁgures only. In order to acquire the required data, the corre-
sponding authors of these papers were contacted by one of the authors.
The relevant data was obtained from the following studies via personal
communication: Acheson et al. (2013); Bertsch et al. (2013); Eckstein
et al. (2015); Eckstein et al. (2016); Hubble et al. (2017); Kim et al., In
prep; Leknes et al. (2013); Preckel et al. (2014); Striepens et al. (2012).
Despite contacting corresponding authors, we were unable to gain ac-
cess to the relevant data from eight studies.
In addition to healthy individuals, clinical populations included in
the study consisted of people with anorexia nervosa (AN), bulimia
nervosa (BN), depression, and BPD. Information regarding participants’
age, dose of oxytocin (in international units), the type of task used, the
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stimulus presentation time in milliseconds (ms), the study design (be-
tween subjects, within subjects), and the proportion of female partici-
pants in the study, was also extracted from the articles for the purposes
of meta-regression.
Where appropriate, information regarding psychopathology was
extracted from the studies. This information was extracted from the
three studies that investigated the eﬀects of a single dose of intranasal
oxytocin on attentional bias to disorder-speciﬁc stimuli. This informa-
tion consisted of self-reported anxiety measured with the Depression,
Anxiety and Stress Scale (DASS) and Spielberger State and the Trait
Anxiety Inventory (STAI), self-reported depression measured with the
DASS and Beck Depression Inventory (BDI), and self-reported ED psy-
chopathology measured with the Eating Disorder Examination
Questionnaire. Self-reported anxiety and depression scores were con-
verted to standardised z-scores prior to being included in the meta-re-
gression.
Finally, we also conducted a systematic review of studies in-
vestigating the eﬀects of a single dose of oxytocin on behavioural ap-
proach and avoidance. We were not able to conduct a meta-analysis due
to a small number of studies and diﬀerences in outcome measures used.
2.5. Tasks used to examine threat processing
2.5.1. Startle response
Seven studies investigated the eﬀects of a single dose of intranasal
oxytocin on the physiological response to general threat and learned
threat (Table 1). Four studies used generally threatening stimuli, in-
cluding angry faces, images of threatening scenes, and predictable and
unpredictable electric shocks (Grillon et al., 2013; Leknes et al., 2013;
Prehn et al., 2013; Striepens et al., 2012). Three studies investigated the
eﬀects of oxytocin on startle response to learned threat cues after
conditioning and on learned threat following extinction (Acheson et al.,
2013; Eckstein et al., 2015, 2016). The outcomes measures included eye
blink magnitude, skin conductance response, pupil dilation, and facial
electromyography (EMG). All studies included only healthy individuals.
One study reported data separately for male and female participants
(Grillon et al., 2013).
2.5.2. Approach and avoidance responses
Five studies investigated the eﬀects of a single dose of intranasal
oxytocin on approach and avoidance responses to threatening images
including angry faces and general negative stimuli (Table 1). In this
experimental paradigm participants are presented with threatening and
neutral stimuli one at a time and asked to respond either by pulling or
pushing a lever as quickly as possible. Pushing the lever shrinks the
stimulus on the screen indicating avoidance of the stimulus, whereas
pulling the lever zooms in on the stimulus on the screen indicating
approach towards the stimulus. One study reported approach reaction
times (Preckel et al., 2014) and another study reported reaction times
for both approach and avoidance responses (Radke et al., 2017). Two
other studies reported approach-avoidance bias scores (Mitchell et al.,
2016; Radke et al., 2013). Positive bias scores indicated approach and
negative bias scores indicated avoidance. Finally, one study did not
report the relevant data but provided test statistics (Theodoridou et al.,
2013). Four of the studies only included healthy individuals, one in-
cluded people with alcohol dependence disorder, and one explored the
eﬀects of oxytocin in low and highly anxious people. Eﬀect sizes and
conﬁdence intervals are reported for the four studies that provided the
relevant data.
2.5.3. Attentional responses
Two methods were used to investigate the eﬀects of a single dose of
intranasal oxytocin on attentional responses to threat: attentional bias
towards threatening images relative to neutral images and ﬁxation to-
wards regions of interest within threatening images (Table 1). Seven
studies investigated the eﬀects of a single dose of intranasal oxytocin on
attentional bias towards social threat, namely images of angry and
disgusted faces. Six of the studies examined attentional bias using the
dot-probe paradigm and one used a spatial cueing task. In these tasks
participants are initially presented with a ﬁxation cross followed by the
presentation of a threatening stimulus either alone on one side of a
computer screen or in combination with a neutral stimulus on opposite
sides of the screen. After the threatening stimulus has disappeared, a
target is presented either in the same place where the threatening sti-
mulus was or on the opposite side of the screen. Participants are then
asked to identify the target by pressing the appropriate key on a key-
board. In the dot-probe tasks attentional bias scores were calculated
from the response times, subtracting response times in trials, where the
target replaced a neutral stimulus from response times in trials, where
the target replaced the threatening stimulus. Positive scores indicate
increased attention towards the threatening stimuli while negative
scores indicate reduced attention towards the threatening stimuli.
In the spatial cueing task attentional bias and avoidance were in-
vestigated separately by examining reaction times in congruent trials,
in which the target was presented in the same side of the screen as the
threatening image, and incongruent trials, in which the target was
presented on the other side of the screen relative to the threatening
image (Ellenbogen et al., 2012). The ﬁnal attentional bias scores are
calculated by subtracting response time in the congruent neutral trials
from response times in the congruent threatening trials. The attentional
avoidance scores are scores are calculated by subtracting response time
in the incongruent neutral trials from response times in the incongruent
threatening trials. Thus, as above and despite diﬀerent methods, posi-
tive scores indicate increased attention towards the threatening stimuli
Fig. 1. Literature search ﬂow diagram.
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and negative scores indicate reduced attention towards the threatening
stimuli in both tasks. Further, two of the studies varied the cue pre-
sentation duration or used masked cue presentation (Brune et al., 2013;
Domes et al., 2016; Ellenbogen et al., 2012).
Three studies investigated attentional bias towards disorder-speciﬁc
threatening stimuli in ED, namely AN and BN, using the dot-probe
paradigm (Table 1). These studies used food, body shape, and body
weight related images as threatening stimuli. As above, positive at-
tentional bias scores indicated greater attention towards the disorder-
speciﬁc threatening images, and negative scores indicated attention
away from the stimuli. One of the studies varied the cue presentation
duration (Kim et al., In prep), and another study investigated atten-
tional bias with varied inter-trial interval (500 ms or 1250 ms) before
and after a smoothie challenge (Leppanen et al., 2017a).
Five studies investigated the eﬀects of a single dose of intranasal
oxytocin on attention towards regions of interest (ROIs) in threatening
images using eye tracking (Table 1). Three of the studies deﬁned the
ROIs as the eye and mouth region of angry and disgusted faces (Bertsch
et al., 2013; Domes et al., 2013; Hubble et al., 2017; Lischke et al.,
2012b). One study investigated ﬁxation towards predeﬁned regions of
interest in threatening scenes taken from the international picture af-
fective system (Lischke et al., 2012a). The ROIs were predeﬁned based
on pilot data. The outcome measure was preferential ﬁxation towards
the ROIs relative to the rest of the face or the background of the image.
2.6. Statistical analysis
Statistical analyses were conducted with the Metafor package in R
(R Core Team, 2015; Viechtbauer, 2010). For studies using between
subjects design, standardised, unbiased eﬀect sizes were estimated by
calculating Hedges’ g (Hedges, 1981) and 95% conﬁdence intervals. For
studies using within subjects design standardised mean change with
change score standardisation (SMCC) along with 95% conﬁdence in-
tervals was calculated. Where correlation between the two conditions
was not reported to calculate the SMCC eﬀect size estimate, the cor-
relation was estimated using the following formula: + −SD SD SDchange
SD SD
1 2
2 * 1 * 2
2 2 2
(Morris and DeShon, 2002). The Hedges’ g and SMCC eﬀect size esti-
mates are both on the same scale and were interpreted as small
(≥0.20), medium (≥0.50), and large (≥0.80). Positive eﬀect sizes
indicated oxytocin-induced increase in startle response, approach, and
attention towards threatening stimuli. Negative eﬀect sizes indicated
oxytocin-induced reduction in startle response, approach, and attention
towards threatening stimuli.
Because a number of studies used a variety of paradigms to in-
vestigate diﬀerent aspects of threat processing, the same participants
were included in a meta-analysis more than once. To account for con-
founding eﬀects arising from this, we conducted multivariate meta-
analyses with an auto-regressive structure. Between-study hetero-
geneity was examined with the Cochran's Q index. Signiﬁcant hetero-
geneity between studies was further investigated with meta-regressions
to examine the moderating eﬀects of the following variables: age, the
study design, the dose administered (in IU), the type of task used, di-
agnosis, the type of stimuli used, and the proportion of female parti-
cipants in the sample. Signiﬁcance level was set at p<0.05.
Presence of outliers was investigated by calculating standardised
residuals of each study included in the meta-analyses. If the Z scores of
the standardised residuals exceeded±1.96, the study was deemed an
inﬂuential outlier and was thus removed from the analyses
(Viechtbauer and Cheung, 2010).
Publication bias based on funnel plot asymmetry was investigated
with Begg's rank correlation test (Begg and Mazumdar, 1994). Ad-
ditionally, where signiﬁcant eﬀects were present their robustness was
assessed with the Rosenthal's fail-safe N analysis (Rosenthal, 1979). The
analysis provides a fail-safe number of studies with non-signiﬁcant re-
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null. The eﬀect is considered robust if the fail-safe N exceeds the Ro-
senthal criterion, 5k+10, where k is the number of studies included in
the meta-analysis (Rosenthal, 1991).
Finally, we explored whether the included studies had large enough
sample sizes to have adequate power to detect an eﬀect of oxytocin on
threat processing. According to the power analysis conducted with
G*Power (Faul et al., 2007), between subjects studies should have at
least 64 participants in each group and within subjects studies should




Characteristics of the 26 included studies are presented in Table 1.
The eﬀect size (ES) column shows the standardised eﬀect size estimate
along with 95% conﬁdence intervals for each study. The power column
show whether the study had a suﬃciently large sample size to have
80% power to detect at least a moderate (ES ≥ 0.5) eﬀect of oxytocin.
Only one study using within subjects design met the sample size re-
quirement of suﬃcient power. Six other studies using within subjects
design came close to having suﬃcient power (sample size ≥ 30).
3.2. Eﬀects of oxytocin on startle response to threat
The studies investigating the eﬀects of a single dose of intranasal
oxytocin on physiological startle response to general threat and learned
threat are presented in Fig. 2. Overall, the meta-analysis revealed that
intranasal oxytocin signiﬁcantly increased startle response to threat
with a small eﬀect size (ES = 0.32, 95% CI [0.13, 0.52], Z = 3.27, p =
0.001). We further explored the eﬀects of oxytocin on startle response
to general threat and learned threat following conditioning. Intranasal
oxytocin signiﬁcantly increased startle response to general threat with a
small eﬀect size (ES = 0.30, 95% CI [0.07, 0.53], Z = 2.55, p =
0.011). Oxytocin-induced increase in startle response following con-
ditioning also approached signiﬁcance with a small eﬀect size (ES =
0.41, 95% CI [−0.01, 0.82], Z = 1.90, p = 0.058).
There was no signiﬁcant between-study heterogeneity (Q = 11.32,
p = 0.297, I2 = 29.00), and thus, no meta-regressions were conducted.
Begg's rank correlation test based on the funnel plot did not indicate
there was evidence of signiﬁcant publication bias (τ= 0.24, p = 0.359,
Supplementary Fig. 1). The Rosenthal's fail-safe N analysis revealed that
55 studies with non-signiﬁcant results would need to be added to the
present meta-analysis to reduce the observed eﬀect to null. This exceeds
the Rosenthal criterion (55> (5×7+10) = 45) suggesting that the
eﬀect observed was robust.
3.3. Eﬀects of oxytocin on attentional responses towards threat
3.3.1. Attentional bias towards social threat
The studies investigating the eﬀects of a single dose of intranasal
oxytocin on attentional bias towards social threat are presented in
Fig. 3. Overall, a single dose of intranasal oxytocin did not signiﬁcantly
inﬂuence attentional bias towards social threat (ES = −0.10, 95% CI
[−0.50, 0.29], Z = −0.51, p = 0.612). We then further explored the
eﬀects within the healthy and clinical populations. Among the healthy
individuals, oxytocin did not signiﬁcantly impact attentional bias to-
wards social threat (ES =−0.42, 95% CI [−1.07, 0.23], Z =−1.26, p
= 0.208). There was also no signiﬁcant eﬀects of oxytocin among the
mixed clinical group (ES = 0.13, 95% CI [−0.35, 0.61], Z = 0.54 p =
0.593).
The overall meta-analysis revealed signiﬁcant between-study het-
erogeneity (Q = 73.53, p<0.001), which was explored further with
meta-regressions. Together the stimuli used, the stimulus presentation
time, and the diagnostic group signiﬁcantly moderated some of the
between-study heterogeneity (QM = 43.41, p<0.0001), still leaving
signiﬁcant residual heterogeneity (QR = 24.60, p = 0.004). This
suggests that the eﬀects of oxytocin on attentional bias were the
strongest among highly anxious people and people with BPD when the
angry faces were presented for 500 ms or less time. However, only one
study included people with BPD and only one study included highly
anxious people and, thus, these ﬁndings should be interpreted with
caution. The proportion of female participants in the study (QM =
0.03, p = 0.859), the study design (QM = 0.11, p = 0.744), age (QM
= 0.295, p = 0.589), the task used (QM = 0.29, p = 0.963), and the
dose administered (QM = 0.01, p = 0.929) did not signiﬁcantly
moderate the between study heterogeneity.
The Begg's rank correlation test based on the funnel plot asymmetry
did not reveal evidence of signiﬁcant publication bias (τ = 0.09, p =
0.565; Supplementary Fig. 2).
3.3.2. Attentional bias towards disorder-speciﬁc threat
The studies investigating the eﬀects of a single dose of intranasal
oxytocin on attentional bias towards disorder-speciﬁc threatening sti-
muli are presented in Fig. 4. Only studies including people with ED,
namely AN and BN, had investigated these eﬀects. The disorder-speciﬁc
threatening stimuli consisted of negative body shape related, body
weight related, and food related images.
The meta-analysis showed that overall a single dose of intranasal
Fig. 2. Forest plot of studies investigating the eﬀects of intranasal
oxytocin on the startle response to threat. Grillon et al. (2013)(a)
= female participants, Grillon et al. (2013)(b) = male partici-
pants, Angry faces (f) = angry female faces, Angry faces (m) =
angry male faces, EMG = electromyography.
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oxytocin did not signiﬁcantly inﬂuence attentional bias towards dis-
order-speciﬁc stimuli in eating disorders (ES =−0.05, 95% CI [−0.28,
0.18], Z = −0.43, p = 0.670). We further explored the eﬀect of a
single dose of oxytocin separately on the diﬀerent types of disorder
speciﬁc stimuli used. Intranasal oxytocin did not signiﬁcantly inﬂuence
attentional bias towards negative body shape related stimuli (ES =
−0.07, 95% CI [−0.66, 0.52], Z = −0.23, p = 0.818), body weight
related stimuli (g = 0.09, 95% CI [−0.12, 0.30], Z = 0.86, p = 0.388),
or food related stimuli (ES = −0.10, 95% CI [−0.36, 0.15], Z =
−0.79, p = 0.429).
There was signiﬁcant between-study heterogeneity (Q= 24.52, p =
0.017), which was explored further with meta-regressions. Diagnostic
group signiﬁcantly explained the between-study heterogeneity (QM =
6.37, p = 0.012), still leaving some unaccounted heterogeneity that
approached signiﬁcance (QR = 18.15, p = 0.078). This suggests that
people with BN showed greater oxytocin induced increase in attentional
bias towards disorder-speciﬁc stimuli (ES = 0.15, 95% CI [−0.03,
0.33], Z = 1.66, p = 0.096), whereas people with AN showed greater
oxytocin-induced increase in attentional avoidance of disorder-speciﬁc
stimuli (ES =−0.16, 95% CI [−0.33, 0.03], Z = −1.92, p = 0.055).
However, neither of these eﬀects reached signiﬁcance and only one
study investigated the eﬀects of oxytocin in people with BN. Therefore,
these ﬁndings should be interpreted with caution. Self-reported anxiety
(QM = 0.20, p = 0.655), self-reported depression (QM = 1.41, p =
0.235), self-reported eating disorder symptomatology (QM= 0.04, p =
0.846), the stimuli used (QM= 1.56, p = 0.458), age (QM= 0.01, p =
0.937), and variations in the task used (QM= 0.08, p = 0.995) did not
signiﬁcantly moderate the between study heterogeneity. The propor-
tion of female participants in the study, the dose administered, and the
study design were not entered as predictors in the meta-regression as all
included studies recruited only female participants, used the same
within subjects design, and administered the same dose.
The Begg's rank correlation test based on the funnel plot asymmetry
did not reveal evidence of signiﬁcant publication bias (τ=−0.15, p =
0.510; Supplementary Fig. 3).
3.3.3. Fixation towards regions of interest
The studies investigating the eﬀects of a single dose of intranasal
oxytocin on ﬁxation towards ROIs in threatening images are presented
in Fig. 5. The meta-analysis showed that a single dose of oxytocin did
not signiﬁcantly inﬂuence ﬁxation towards ROIs in threatening images
(g = −0.08, 95% CI [−0.23, 0.08], Z = −0.96, p = 0.339).
There was signiﬁcant between-study heterogeneity (Q= 22.65, p =
0.031), which was explored further with meta-regressions. The ROI
Fig. 3. Forest plot of studies investigating the eﬀects
of intranasal oxytocin on the attentional bias towards
social threat. Ellenbogen et al. (2012) (a) = con-
gruent trials, Ellenbogen et al. (2012) (b) = incon-
gruent trials, AN = anorexia nervosa; BN = bulimia
nervosa; BPD = borderline personality disorder, ms
= milliseconds.
Fig. 4. Forest plot of studies investigating the eﬀects
of intranasal oxytocin on attentional bias towards
disorder speciﬁc threat. Leppanen et al. (2017a) (a)
= before smoothie challenge, Leppanen et al.
(2017a) (b) = after smoothie challenge, AN = an-
orexia nervosa, BN = bulimia nervosa, ms = milli-
seconds, ITI = inter-trial interval.
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used (QM = 1.53, p = 0.465), age (QM = 0.01, = 0.931), the pro-
portion of female participants in the study (QM= 0.28, p = 0.597), the
study design (QM = 0.65, p = 0.419), the task used (QM = 1.53, p =
0.216), how ﬁxation was measured (QM = 3.02, p = 0.388), the type
of stimuli used (QM = 2.87, p = 0.238), the diagnosis (QM = 1.80, p
= 0.179), and the dose administered (QM = 0.25, p = 0.615) did not
signiﬁcantly moderate the heterogeneity.
Begg's rank correlation test based on the funnel plots did not reveal
any signiﬁcant publication bias (τ=−0.17, p = 0.435, Supplementary
Fig. 4).
3.4. Eﬀects of oxytocin on approach and avoidance responses to threat
It was not possible to conduct a full meta-analysis of the studies
investigating the eﬀects of oxytocin on approach and avoidance re-
sponses due to the small number of studies and the variety of diﬀerent
outcome measures used. The signiﬁcance of the ﬁndings from each
study was then investigated by examining the 95% conﬁdence intervals
of the eﬀect size estimates according to the guidelines stated in the
Cochrane Handbook for Systematic Reviews (Higgins and Green, 2011).
Two studies used a between subjects design to investigate the eﬀects
of a single dose of intranasal oxytocin on approach and avoidance re-
action times (Preckel et al., 2014; Radke et al., 2017). The study by
Preckel et al. (2014) examined only approach reaction times to social
and non-social threat. The study found that intranasal oxytocin led to a
small reduction in reaction times when approaching threatening social
stimuli (ES = 0.34, 95% CI [−0.14, 0.83], total N = 67). There was a
negligible reduction in reaction times when approaching non-social
threatening stimuli (ES = 0.07, 95% CI [−0.41, 0.55], total N = 67).
However, in both cases the 95% conﬁdence intervals overlapped zero
indicating that neither eﬀect was statistically signiﬁcant. Conversely,
Radke et al. (2017) found that oxytocin led to a non-signiﬁcant increase
in approach reaction times towards social threat with a moderate eﬀect
size (ES =−0.51, 95% [−1.07, 0.04], total N = 52), and a signiﬁcant
increase in avoidance reaction times with a moderate eﬀect size (ES =
−0.56, 95% CI [−1.11, −0.002], total N = 52). These contradictory
ﬁndings may be some way explained by the diﬀerences in sample size.
Two studies by Radke et al. (2013) and Mitchell et al. (2016) used
within subjects design to investigate approach/avoidance bias in
healthy people and people with alcohol dependence disorder respec-
tively. Radke et al. (2013) found a signiﬁcant oxytocin-induced increase
in approach bias towards threatening social stimuli with a moderate
eﬀect size among healthy individuals (ES = 0.52, 95% CI [0.09, 0.95],
N = 24). Similarly, Mitchell et al. (2016) found a negligible oxytocin-
induced increase in approach bias towards threatening non-social
stimuli in people with alcohol dependence disorder (ES = 0.16, 95% CI
[−0.19, 0.51], N = 32), although this did not reach signiﬁcance. Taken
together these ﬁndings suggest that oxytocin may increase approach
bias towards threatening stimuli, particularly threatening social stimuli.
However, further research is needed to conﬁrm this ﬁnding.
Finally, the study by Theodoridou et al. (2013) used a between
subjects design to investigate the eﬀects of intranasal oxytocin on both
approach and avoidance responses to social threat (total N = 120). The
authors did not report the relevant data to allow eﬀect sizes to be
calculated, but reported test statistics that showed no signiﬁcant eﬀect
of intranasal oxytocin on approach or avoidance responses
(Theodoridou et al., 2013).
Taken together these studies indicate that there is uncertainty about
the eﬀects of intranasal oxytocin on approach and avoidance responses
to threatening stimuli. Indeed, the 95% conﬁdence interval ranges in all
studies were very wide (Higgins and Green, 2011). Still, there was some
indication that oxytocin may inﬂuence approach responses to threa-
tening stimuli, particularly social threat. However, it is of interest that
the two studies that showed signiﬁcant eﬀect size estimates also had
smaller sample sizes (within subjects N = 24; between subjects N =
52) than the other studies reporting no signiﬁcant eﬀects of oxytocin
(within subjects N = 32, between subjects N = 67 − 120). Thus,
further research with larger samples is needed.
4. Discussion
The aim of the present review was to examine the eﬀects of a single
dose of intranasal oxytocin on threat processing in healthy and clinical
populations. The majority of the studies included only healthy in-
dividuals and no studies investigated the inﬂuence of intranasal oxy-
tocin on the physiological startle response among clinical populations.
The ﬁndings revealed that intranasal oxytocin signiﬁcantly increased
the startle response to threatening stimuli in healthy individuals with a
small eﬀect size. However, a single dose of intranasal oxytocin did not
signiﬁcantly inﬂuence attentional bias towards social threat or disorder
speciﬁc threat, or ﬁxation to regions of interest in threatening stimuli.
The ﬁndings for eﬀects of a single dose of oxytocin on approach and
avoidance responses towards threat were inconsistent, calling for fur-
ther research with large samples.
In preclinical studies, oxytocin has been shown to facilitate extinc-
tion and generally inhibit anxiety- and fear-related responses and be-
haviours in rodents (Calcagnoli et al., 2015; Huber et al., 2005;
Neumann and Slattery, 2016; Viviani et al., 2011). Conversely, the
present review did not ﬁnd evidence of signiﬁcant overall eﬀects of
intranasal oxytocin on attentional or behavioural approach or
Fig. 5. Forest plot of studies investigating the eﬀects
of intranasal oxytocin on ﬁxation towards regions of
interest in threating images. ROI = region of in-
terest, BPD = borderline personality disorder.
Lischke et al. (2012a) used predeﬁned regions of
interest based on pilot data.
J. Leppanen et al. -RXUQDORI$IIHFWLYH'LVRUGHUV²

avoidance responses to threat in humans. Instead, we found that a
single dose of intranasal oxytocin signiﬁcantly increased startle re-
sponse to threatening stimuli in healthy individuals. Based on the
present ﬁndings, in healthy humans, oxytocin appears to primarily in-
ﬂuence the salience of threatening stimuli, possibly indicating that
oxytocin plays a role in arousal but not behavioural responding in
humans. This interpretation is supported by ﬁndings from recent neu-
roimaging studies investigating neural responses to social threat in
healthy humans. These studies have reported oxytocin-induced in-
creases in neural activation in regions, including the amygdala, which
are associated with processing of salience and arousal (Frijling et al.,
2016; Gorka et al., 2015; Koch et al., 2016). This interpretation is also
supported by ﬁndings from a previous meta-analysis that found that a
single dose of intranasal oxytocin improved early detection of anger
and late detection of fear in healthy humans (Shahrestani et al., 2013).
Furthermore, a recent meta-analytic review by our group found that a
single dose of oxytocin improved recognition of basic emotions, pri-
marily fear and disgust, among healthy individuals (Leppanen et al.,
2017b). Thus, these ﬁndings suggest that rather than having global
eﬀects on threat processing, oxytocin may inﬂuence speciﬁc aspects of
threat processing, such as arousal.
Regarding clinical populations, the present review found that a
single dose of intranasal oxytocin did not signiﬁcantly inﬂuence at-
tentional bias towards social threat among clinical populations. These
ﬁndings are somewhat surprising considering the number of systematic
reviews suggesting that oxytocin may be an eﬀective new target for
treatments in psychiatric disorders alleviating psychopathology in a
number of disorders (Bakermans-Kranenburg and van Ijzendoorn,
2013; MacDonald and Feifel, 2013; MacDonald and MacDonald, 2010;
Meyer-Lindenberg et al., 2011). One possible interpretation of the
present ﬁndings is that although it may be eﬀective in targeting certain
symptoms, intranasal oxytocin may have little eﬀect on threat proces-
sing among the clinical populations. This interpretation is in line with
ﬁndings from recent work investigating the eﬀectiveness of intranasal
oxytocin as a treatment enhancer in depression and BPD, which found
that intranasal oxytocin did not improve anxiety or aﬃliative behaviour
during therapy or clinical interview (Brune et al., 2015; MacDonald
et al., 2013). Additionally, another study found that intranasal oxytocin
did not improve self-reported anxiety among people with social anxiety
disorder following exposure therapy (Guastella et al., 2009).
It is of note, however, that the present review was only able to in-
vestigate the eﬀects of a single dose of intranasal oxytocin on atten-
tional responses to threat among clinical populations due to lack of
studies. Thus, it is possible that intranasal oxytocin does not have a
signiﬁcant eﬀect on threat related attentional or behavioural responses,
but may modulate other aspects of threat processing among clinical
population. Indeed, a previous meta-analysis found that a single dose of
oxytocin reduced the cortisol response to stressful stimuli among clin-
ical populations (Cardoso et al., 2014). Similarly, a recent systematic
review reported that intranasal oxytocin may be eﬀective in combating
anxiety and stress in disorder characterised by dysfunction of the cen-
tral nervous system (Chapman et al., 2013). Furthermore, a recent ex-
perimental study found that a single dose of oxytocin increased heart
rate response to trauma related stimuli while reducing self-reported
trauma-related imagery among people with PTSD (Sack et al., 2017).
These ﬁndings suggest that oxytocin may increase arousal while low-
ering stress and anxiety responses to threatening stimuli among clinical
populations. However, further research with larger samples is still
needed.
Another possible interpretation of the present ﬁndings is that there
is substantial heterogeneity within and between clinical groups that
could dilute the true eﬀects of intranasal oxytocin on social threat
processing among clinical populations (Lamers et al., 2010; Melartin
et al., 2002; Wessman et al., 2009). Indeed, in the present study there
was signiﬁcant between study heterogeneity in the meta-analysis in-
vestigating eﬀects of oxytocin on attentional bias towards threat among
clinical populations. Findings from preclinical and human studies also
suggest that the eﬀects of oxytocin may be mediated by baseline levels
of anxiety and other individual diﬀerences, such as attachment diﬃ-
culties (Bartz et al., 2011; Bosch et al., 2005; Olﬀ et al., 2013; Zik and
Roberts, 2015). Environmental diﬀerences, such as the conditions
under which participants are tested, have also been suggested to in-
ﬂuence the eﬀects of oxytocin (Bartz et al., 2011; Olﬀ et al., 2013). This
suggestion is in line with ﬁndings from our previous single dose study,
which found that the eﬀects of intranasal oxytocin on attentional bias
towards food images in people with AN was dependent not only on
whether the task was delivered before or after a smoothie challenge,
but also on the inter-trial interval used in the task (Leppanen et al.,
2017a). Although, further research could help gain better under-
standing of the eﬀects of intranasal oxytocin on threat processing
among clinical populations, these ﬁndings raise some questions about
the therapeutic potential and eﬀectiveness of intranasal oxytocin in the
treatment of psychiatric disorders.
4.1. Limitations and future directions
The main limitation of this review is the small number of studies
investigating the eﬀects of intranasal oxytocin on diﬀerent aspects of
threat processing. Indeed, there were so few studies investigating the
eﬀects of a single dose of intranasal oxytocin on behavioural approach
and avoidance responses to threatening stimuli, we were not able to
conduct a full meta-analysis. Furthermore, only one of the studies re-
viewed here met our sample size requirement for adequate statistical
power. These limitations caused particular concern when reviewing
studies investigating the eﬀects of a single dose of oxytocin on approach
and avoidance responses. The only two that showed signiﬁcant eﬀects
of oxytocin had smaller sample size than the other similar studies that
did not show signiﬁcant eﬀects of oxytocin. It is possible that these
ﬁndings were driven by the fact that smaller studies can sometimes
overestimate eﬀect sizes even when no true eﬀect is present (Walum
et al., 2016; Zhang et al., 2013). Together, these ﬁndings suggest that
this is still a relatively unexplored ﬁeld, and as further research with
larger samples is needed.
Additionally, there is relative paucity of research investigating the
eﬀects a single dose of intranasal oxytocin on threat processing among
clinical populations. In the present review we were only able to in-
vestigate the eﬀects of a single dose of oxytocin on attentional bias
towards threat among clinical populations, but not the physiological
startle response, approach and avoidance responses, or ﬁxation re-
sponse due to a lack of studies. Further research is needed to shed light
on the eﬀects of oxytocin on elevated threat sensitivity in psychiatric
disorders.
The dot-probe and spatial cueing tasks that were used to examine
the eﬀects of oxytocin on attention to social threat demonstrated that
variation of task parameters, such as stimulus presentation time and
inter-trial interval, had an impact on the eﬀects of oxytocin. These
factors added heterogeneity into the meta-analyses and inﬂuenced the
interpretation of the ﬁndings. Short stimulus presentation duration is
believed to tap into early attentional responses while longer stimulus
duration is believed to examine late attention (Bantin et al., 2016).
However, there are still some uncertainties regarding what should be
used as the cut-oﬀ for early and late attention, with some eye tracking
and electroencephalogram (EEG) studies reporting attentional shifts as
early as 200 ms after stimulus onset (Bantin et al., 2016; Belyusar et al.,
2013; Hedge and Leonards, 2013). Additionally, working memory and
executive functioning studies have demonstrated that varying the inter-
trial interval can impact performance, with shorter inter-trial intervals
utilising more automated responding, while longer inter-trial intervals
allow for more controlled responding (Cermak, 1970; Shipstead and
Engle, 2013). Thus, to avoid these issues, future studies may beneﬁt
from utilising other methods to assess attentional bias, such as eye
tracking or EEG, and working towards developing standardised
J. Leppanen et al. -RXUQDORI$IIHFWLYH'LVRUGHUV²

measures.
Finally, there was signiﬁcant between study heterogeneity in the
meta-analysis investigating the eﬀects of a single dose of oxytocin on
attentional bias towards social threat and disorder-speciﬁc threat.
Despite conducting meta-regressions to investigate moderating eﬀects
of age, dose, the type of task used, the type of stimuli used, and study
design, we were not able to ascertain the source of the heterogeneity.
Factors such as anxiety, attachment style, and alexithymia have been
found to inﬂuence the eﬀects of oxytocin on a number of diﬀerent tasks
(Bartz et al., 2011; Bosch et al., 2005; Olﬀ et al., 2013; Zik and Roberts,
2015). However, since these variables were not explored or reported in
the majority of the included studies we were unable to explore their
moderator eﬀects in most of the meta-analyses. Thus, further work in-
vestigating potential moderators of the eﬀects of oxytocin on atten-
tional bias towards threatening stimuli would be of interest.
5. Conclusions
The aim of the present review was to examine the eﬀects of a single
dose of intranasal oxytocin on threat processing in healthy and clinical
populations. The ﬁndings revealed that oxytocin signiﬁcantly increased
the physiological startle response to threat in healthy people with a
small eﬀect size. Oxytocin did not have signiﬁcant eﬀects on attentional
bias towards social or disorder-speciﬁc threat or on ﬁxation towards
threatening stimuli among healthy or clinical populations. There was
also no convincing evidence that oxytocin signiﬁcantly inﬂuences
threat related behavioural approach or avoidance responses. These
ﬁndings suggest that oxytocin may primarily inﬂuence the salience of
threatening stimuli possibly indicating that oxytocin plays a role in
emotional, but not behavioural processing in humans. Large scale re-
search investigating the eﬀects of oxytocin on physiological startle re-
sponse among clinical populations would be of interest.
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A B S T R A C T
Accurate interpretation and appropriate expression of emotions are key aspects of social-cognition. Several
mental disorders are characterised by transdiagnostic diﬃculties in these areas and, recently, there has been
increasing interest in exploring the eﬀects of oxytocin on social-emotional functioning.
This review consists of 33 studies. Fifteen of the studies included people with autism spectrum disorder,
schizophrenia, borderline personality disorder, frontotemporal dementia, anorexia nervosa, bulimia nervosa,
post-traumatic stress disorder, depression, and opioid and alcohol dependence. We conducted ten meta-analyses
examining the eﬀects of intranasal oxytocin on expression of emotions, emotional theory of mind, sensitivity to
recognise basic emotions, and recognition of basic emotions.
A single dose of intranasal oxytocin signiﬁcantly improved the recognition of basic emotions, particularly
fear, and increased the expression of positive emotions among the healthy individuals. Oxytocin did not
signiﬁcantly inﬂuence theory of mind or the expression of negative emotions among the healthy individuals.
Finally, intranasal oxytocin did not signiﬁcantly inﬂuence interpretation or expression of emotions among the
clinical populations.
1. Introduction
Accurate interpretation of other’s emotions, appropriate expression
of one’s own emotions, and reciprocity within interactions are key
aspects of social cognition. In social interaction, emotion expression is
believed to be dependent on accurate interpretation of social signals
(Hess and Fischer, 2013; Künecke et al., 2014). According to the
embodied simulation theory, emotion expression and mimicry, in turn,
play an important role in facilitating the interpretation of others’
expressions, empathy, and prosocial behaviour in recipients (Gallese,
2005). Indeed, behavioural studies have documented that automatic
mimicry of emotions facilitates recognition, whereas blocking mimicry
impairs recognition accuracy and sensitivity (Argaud et al., 2016; Duﬀy
and Chartrand, 2015; Künecke et al., 2014; Rychlowska et al., 2014;
Schneider et al., 2013). Anomalies in emotion expression also have
social and aﬀective consequences, with incongruent emotion expression
increasing the desire for greater social distance and negative social
evaluation by the recipient (Brown et al., 2015; Szczurek et al., 2012).
Similarly, expressive suppression has been found to increase the
suppressors’ blood pressure, subjective anxiety, and social isolation
(Butleretal.,2003;Gross,2002).
Anomaliesinsocial-emotionalfunctioningareimportanttransdiag-
nostic features in several psychiatric disorders (Bora andBerk, 2016;
Bora and Köse, 2016; Chung et al., 2014;Davies et al., 2016;Henry
et al.,2014;Kring andMoran, 2008).Meta-analyses have found that
people with eating disorders (EDs), depression, schizophrenia, and
autism spectrum disorders (ASD) have similar diﬃculties in accurate
interpretationofemotions, including recognitionofbasicemotions in
facesandtoneofvoicewithsmalleﬀectsizesand inemotionaltheory
ofmindwithmedium to largeeﬀect sizes (BoraandBerk,2016;Bora
andKöse,2016;Caglar-Nazalietal.,2014;Chungetal.,2014;Uljarevic
andHamilton,2013).Recent systematic reviewshavealso found that
people with schizophrenia, EDs, depression, ASD, and borderline
personalitydisorder(#1D)displaylesspositivefacialaﬀectinresponse
to positive emotional stimuli (Davies et al., 2016; Kring andMoran,
2008).Furthermore,ameta-analysisof537 task-based fMRI studies in
depression,bipolardisorder, schizophrenia, and obsessive-compulsive
disorder failed toﬁnd signiﬁcantdiﬀerencesbetween thedisorders in
whole brain neural response to social and cognitive tasks (Sprooten
etal.,2016).Together theseﬁndingssuggest thatanomalies in social-
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emotional processing in psychiatric disorders may have shared under-
lying mechanisms. Given social and aﬀective consequences of these
diﬃculties, better understanding of the underlying processes is of
interest. One such possible mechanism is the oxytocin system.
Preclinical studies have found that the neuropeptide, oxytocin, may
regulate social-emotional functioning (Dölen et al., 2013; Hicks et al.,
2012; Lim and Young, 2006; Lukas et al., 2011; Onaka et al., 2012).
Endogenous oxytocin has been found to play an important role in the
central and medial amygdala, facilitating formation of social bonds,
maternal behaviour, and social recognition in rodents (Lim and Young,
2006; Onaka et al., 2012). Additionally, a recent study found that
formation of social reward was dependent on coordinated activity
between oxytocin and serotonin in the mouse nucleus accumbens
(Dölen et al., 2013). In rodents, the administration of oxytocin receptor
agonist and exogenous synthetic oxytocin has also been found to
increase social place preference and reduce social defeat induced
avoidance (Hicks et al., 2012; Lukas et al., 2011). Conversely, the
administration of oxytocin receptor antagonist, has been found to
increase corticosteroid levels and induce social avoidance in monkeys
during times of stress (Cavanaugh et al., 2016).
Recently there has been increasing interest in translating these
ﬁndings into humans and the eﬀects of intranasal oxytocin on social-
emotional function has been widely studied (Bakermans-Kranenburg
and van Ijzendoorn, 2013; Bartz et al., 2011; Guastella and MacLeod,
2012; Shahrestani et al., 2013; van Ijzendoorn and Bakermans-
Kranenburg, 2012). A few previous meta-analytic reviews have found
that intranasal oxytocin improves recognition of anger and happiness,
and increases in-group trust among healthy individuals with small
eﬀect sizes (Shahrestani et al., 2013; van Ijzendoorn and Bakermans-
Kranenburg, 2012). However, to our knowledge no meta-analyses to
date have investigated the eﬀects of a single dose of oxytocin on
recognition of all six basic emotions, other aspects of emotion inter-
pretation, including theory of mind or sensitivity to recognise basic
emotions, or on emotion expression among healthy individuals.
To date, two meta-analytic reviews have investigated the eﬀects of
intranasal oxytocin on diﬀerent aspects of social-emotional functioning
in a variety of clinical groups (Bakermans-Kranenburg and van
Ijzendoorn, 2013; Ooi et al., 2017). One reported small, but generally
positive eﬀect of intranasal oxytocin on social-emotional functioning
and psychopathology among people with ASD, anxiety disorders,
depression, schizophrenia, and BPD (Bakermans-Kranenburg and van
Ijzendoorn, 2013). The other meta-analysis found no signiﬁcant eﬀects
of intranasal oxytocin on social-emotional processing in ASD (Ooi et al.,
2017). However, these reviews were quite heterogeneous pooling
studies assessing psychopathology and social-emotional processing, or
single dose and repeated dose studies into one meta-analysis
(Bakermans-Kranenburg and van Ijzendoorn, 2013; Ooi et al., 2017).
To our knowledge no previous meta-analyses have investigated the
eﬀects of a single dose of intranasal oxytocin separately on diﬀerent
aspects of interpretation and expression of emotions among both
healthy and clinical populations. In order to consider the possibility
of translating animal studies more widely into treatment for psychiatric
disorders it is important to consider various key outcomes and whether
there is evidence that they might be modiﬁed by oxytocin.
The aim of the current review was to pool studies investigating the
eﬀects of a single dose of intranasal oxytocin on various aspects of
social-emotional functioning among healthy and clinical populations.
Speciﬁcally, we aimed to examine the eﬀects of intranasal oxytocin on
theory of mind, recognition of basic emotions, sensitivity to recognise
basic emotions, and on emotion expression among healthy and clinical
populations. We tested the hypothesis that oxytocin would improve all
aspects of social-emotional functioning.
2. Methodology
2.1. Literature searches
Electronic databases, including OVID (journals@OVID, PsycINFO,
PsycARTICLES, Embase, AGRIS, MEDLINE), PubMed, and Web of
Knowledge core collection, were searched for studies published during
available years up to February 2017 in accordance with the PRISMA
guidelines (Moher et al., 2009). Two separate literature searches were
conducted in order to uncover studies investigating the eﬀects of a
single dose of intranasal oxytocin on interpretation and expression of
emotions in a social context. The ﬁrst literature search was conducted
with the following search terms: oxytocin AND emotion AND (interpreta-
tion OR recognition OR identiﬁcation OR labelling OR “theory of mind” OR
mentalising OR perception OR empath*). The second search was con-
ducted with the following search terms: oxytocin AND emotion AND
(expression OR mimicry OR mirroring OR communication OR responsive-
ness OR expressivity). Additionally, to ensure no studies were missed by
the initial search, the bibliographies of included studies were searched
for additional studies.
2.2. Eligibility criteria
Studies were included if they met the following inclusion criteria: 1)
investigated the eﬀects of a single dose of intranasal exogenous
oxytocin on interpretation or expression of emotions in a social context
among either healthy adult participants or adult clinical populations
(18 years old or older); 2) compared the eﬀects of intranasal oxytocin
with intranasal placebo spray; 3) investigated short term outcomes; and
4) randomly allocated participants to oxytocin and placebo groups or,
in the case of crossover, within subjects studies, randomised the
treatment order. Any studies, which used tasks that did not include a
social component, such as the bumper car theory of mind task where
social context is inferred from the movement of triangles on a computer
screen, were excluded. Trials, in which participants either received
repeated doses of oxytocin or in which long term outcomes of a single
dose of oxytocin were assessed, were excluded. Studies that included
only children or adolescents were excluded, because the majority of
them were longer trials and the eﬀects of oxytocin on social-emotional
processing can be diﬀerent in adults and children. Full-text articles
published in peer reviewed journals and where possible, published
conference abstracts were included.
In total, ﬁve studies were excluded after further screening because
they incorporated tasks that were very diﬀerent compared to the other
included studies despite being otherwise relevant. These studies
included a theory of mind task involving infant stimuli, continuously
assessing the mood of a target on a video clip on a 9-point Likert scale,
manipulating the context in which emotional stimuli was presented,
recognising emotions from a point-light-display, and interpreting basic
emotions from tone of voice in diﬀerent languages (Bartz et al., 2010;
Bernaerts et al., 2016; De Dreu et al., 2016; Perry et al., 2013; Voorthuis
et al., 2014).
2.3. Study selection
The literature searches were conducted by one author (J.L.). The
studies yielded from the literature search were then screened based on
their titles and abstracts. Full text articles were then assessed for
eligibility followed by ﬁnal screening and assessment by two authors
(J.L. and K.W.N.). Where appropriate conference abstracts of studies
not yet published were also screened and assessed for eligibility. If
deemed eligible the authors were contacted in order to gain access to
the data. Only studies that both authors agreed on were included in the
ﬁnal systematic review and meta-analyses. Any cases where eligibility
remained in question were brought to the whole team for further
discussion and assessment. The study selection processes of the two
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searches are presented in Figs. 1 and 2.
2.4. Data collection and synthesis
Seventeen studies reported their results in ﬁgures or otherwise did
not include the relevant data in the paper or supplementary materials.
The corresponding authors of these papers were contacted by K.W.N. in
order to gain access to the relevant data. The authors of the following
papers provided the required data via personal correspondence: Aoki
et al. (2014), Averbeck et al. (2012), Cardoso et al. (2014a), Chen et al.
(2015), Fischer-Shofty et al. (2010), Kirkpatrick et al. (2014), Koch
et al. (2016), Korb et al. (2016), and Luminet et al. (2011).
In order to conduct meta-analyses means, standard deviations, and
samples sizes for both oxytocin and placebo groups or sessions were
extracted from the studies or acquired through personal correspon-
dence. Where standard error of the mean was reported, standard
deviation was estimated with the following formula SD SE N= * .
Altogether ten meta-analyses were conducted to investigate the eﬀects
of a single dose of intranasal oxytocin on interpretation and expression
of emotions. The ﬁrst meta-analysis investigated the eﬀects of intrana-
sal oxytocin on emotional theory of mind among healthy and clinical
populations. The second meta-analysis investigated the eﬀects of a
single dose of intranasal oxytocin on interpretation of basic emotions
among healthy and clinical populations. Five out of ﬁfteen studies
included in the overall basic emotion recognition meta-analysis in-
cluded all six basic emotions. Thus, to provide further information
about the eﬀects of intranasal oxytocin on each of the six basic
emotions, separate meta-analyses were conducted on recognition of
anger, fear, disgust, sadness, surprise, and happiness among healthy
and clinical populations. The last two meta-analyses investigated the
eﬀects of intranasal oxytocin on emotion recognition sensitivity and
expression of congruent emotions in response to emotionally provoking
stimuli. The clinical category included people with ASD, schizophrenia,
depression, anorexia nervosa (AN), bulimia nervosa (BN), BPD, post-
traumatic stress disorder, behavioural variant of frontotemporal de-
mentia (FTD), alcohol dependence disorder, and opioid dependence
disorder.
Additional information regarding age, the oxytocin dose (in inter-
national units [IU]), the speciﬁc diagnosis of clinical participants, the
proportion of female participants in the sample, and type of task used
were also recorded. We also included information regarding the
presence of ceiling eﬀects in accuracy scores. Since there are currently
no guidelines to indicate what should be used as a cut-oﬀ for ceiling
eﬀects, we chose an arbitrary cut-oﬀ of 85%. Studies, in which the
accuracy scores were greater than or equal to 85%, were coded as
having evidence of ceiling eﬀects. The additional information was used
to conduct meta-regressions to identify variables that might explain any
potential between-study heterogeneity.
2.5. Emotion interpretation tasks
The emotion interpretation tasks included are summarised in
Table 1. The theory of mind tasks included the Reading the Mind in
the Eyes task (RMET) (Baron-Cohen et al., 2001), Mayer-Salovey-
Caruso Emotional Intelligence Test (MSCEIT) (Mayer et al., 2003),
The Awareness of Social Inference Test (TASIT) (McDonald et al.,
Fig. 1. PRISMA ﬂow chart of the study selection process for the emotion interpretation
meta-analyses.
Fig. 2. PRISMA ﬂow chart of the study selection process for the emotion expression meta-
analyses.
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2003), and the Sally Anne task (Baron-Cohen et al., 1985). In the RMET
participants are presented with 36 photographs of eyes and asked to
select one of four words that best describes the complex emotion
displayed. The MSCEIT has six subscales, three of which were of
interest for the current review and assessed perception of emotions in
others and understanding of how emotions change and blend together.
The TASIT has three subscales, two of which were of interest for the
current review and assessed emotional evaluation and social-emotional
inference based on verbal and visual stimuli. Finally, the Sally Anne
task assesses emotional and cognitive theory of mind with black and
white comic strips. The current reviewed only included data on
emotional theory of mind.
The studies that investigated the eﬀects of a single dose of intranasal
oxytocin on interpretation of basic emotions mostly used standard
emotion recognition paradigms in which participants were presented
with a photograph of a face depicting a basic emotion and asked to
identify the emotion. A subset of studies used dynamic emotion
recognition tasks, in which participants were presented with a neutral
face that gradually morphed into the full emotion, or masked emotion
recognition tasks, in which the photograph of a face depicting a basic
emotion was either preceded or followed by a neutral face. The
outcome was recognition accuracy. All studies used standardised
stimuli to assess emotion recognition accuracy.
All studies examining interpretation sensitivity used similar dy-
namic emotion recognition tasks as described above. In these tasks
participants were initially presented with a neutral face that gradually
morphed into full emotion. The outcome was estimated as the intensity
percentage at which participants accurately recognised the emotion.
Lower the intensity percentage, the more sensitive the participants were
to detect the emotion. All studies used standardised stimuli to assess
emotion recognition sensitivity.
2.6. Emotion expression tasks
The emotion expression tasks included are summarised in Table 1.
All included studies used diﬀerent paradigms to elicit positive and
negative emotions. One of the studies presented participants with
emotionally provoking positive and negative images from the Interna-
tional Aﬀective Picture System (IAPS). Two of the studies presented
participants with short ﬁlm clips. In one study the ﬁlm clips depicted
either a happy face that gradually morphed into an angry expression or
an angry face that gradually morphed into a happy expression. The
other study presented participants with excerpts from movies that were
designed to elicit happy and sad emotions. Lastly, one study assessed
expressions of ﬂight and aﬃliation during a clinical interview. Partici-
pants facial expression were recorded either by manually assessing
facial expression using the Facial Expression Coding System (FACES,
(Kring and Sloan, 1991)), using facial electromyography (EMG), or
using automated facial emotion detection software, Noldus FaceReader
(Noldus Information Technology b.v., www.noldus.com).
2.7. Statistical analysis
All statistical analysis was performed using R (R Core Team, 2015).
For studies using between subjects design Hedges’ g was calculated to
estimate unbiased eﬀect size with 95% conﬁdence intervals. For studies
using within subjects design standardised mean change (SMC) with
change score standardisation was calculated to estimate eﬀect size with
95% conﬁdence intervals. The SMC controls for the correlation in task
performance between the two assessments (oxytocin session and
placebo session). Where correlation between the two assessments was
not reported, the correlation coeﬃcient was estimated using the
following formula r = SD SD SDchangeSD SD
1 + 2 −
2 × 1 × 2
2 2 2
(Morris and DeShon, 2002).
Both Hedges’ g and SMC eﬀect size estimates are on the same scale and
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(≥0.80) (Hedges, 1981). In nine of the ten meta-analyses higher scores
indicated either greater accuracy or greater facial expressivity. Thus, in
these meta-analyses positive eﬀect size indicated improved emotion
interpretation accuracy or increased emotion expression following
oxytocin administration, whereas negative eﬀect size indicated poorer
emotion interpretation or reduced emotion expression following oxyto-
cin administration. In the meta-analysis investigating emotion recogni-
tion sensitivity lower scores indicated greater sensitivity to recognise
the facial expressions. Thus, in this meta-analysis negative eﬀect sizes
indicated increased sensitivity to recognise emotions following oxyto-
cin administration and positive eﬀect sizes indicated reduced sensitivity
to recognise emotions following oxytocin administration. Signiﬁcance
threshold was set at p < 0.05 unless otherwise stated.
The user contributed Metafor package was used to conduct the
meta-analyses, meta-regressions, and publication bias estimation
(Viechtbauer, 2010). The meta-analyses were conducted with a multi-
variate random eﬀects model with an autoregressive structure using the
rma.mv function in Metafor to account for correlations arising from
multiple outcomes from the same sample. Between-study heterogeneity
was assessed by calculating Cochran’s Q index and I2 index. Where
between-study heterogeneity was found meta-regressions were con-
ducted and the moderator eﬀects of the following variables was
assessed: age, the dose administered (in IU), the speciﬁc diagnosis of
clinical participants, the type of task used, the proportion of female
participants in the sample, and whether there were ceiling eﬀects
present (accuracy≥ 85%). All binary and categorical moderators were
dummy coded and entered into the meta-regression using the factor
function. The impact of each moderator was assessed in separate
models.
Inﬂuential studies and extreme outliers were identiﬁed by inspect-
ing Cook’s distance plots and the standardised residuals of each
individual study. Where the z-score of the standardised residuals
exceeded 1.96, the study was deemed to be an outlier (Viechtbauer
and Cheung, 2010). To test the impact of any outliers on the pooled
eﬀect size estimate, we conducted the meta-analysis with the outlier
present followed by a meta-regression to examine whether the outlier
signiﬁcantly explained the between study heterogeneity. If the outlier
signiﬁcantly explained the heterogeneity, the outlier was excluded and
only results from the meta-analysis without the outlier were reported in
full. This procedure led to exclusion of one study (Xu et al., 2015) from
two separate meta-analyses.
Publication bias was investigated with Begg's rank correlation test
for funnel plot asymmetry (Begg and Mazumdar, 1994) and where
signiﬁcant eﬀects were present Rosenthal’s ﬁle drawer analysis was also
conducted (Rosenthal, 1979). The robustness of the signiﬁcant ﬁndings
was assessed by calculating the Rosenthal’s criterion (5n+ 10, n= the
number of studies in the meta-analysis) and comparing that ﬁgure to
the fail-safe N from the ﬁle drawer analysis. If the fail-safe N exceeded
the criterion the ﬁndings were considered robust, if it did not this was
taken as an indicator of publication bias.
Finally, the statistical power of each study included in the review
was assessed by comparing the sample sizes in these studies against that
recommended by a power calculation conducted with G*Power (Faul
et al., 2007). According to the power calculation studies using between
subjects design should have at least 64 participants in each group while
studies using within subjects design should have at least 34 participants
altogether, to have adequate statistical power (≥80%) to reliably




The characteristics of the 33 included studies are summarised in
Table 1. The eﬀect size estimate (ES) represents standardised mean
diﬀerence (Hedges’ g) or standardised mean change (SMC) in inter-
pretation and expression of emotions following oxytocin and placebo.
The last column in Table 1 indicates whether the study met the sample
size requirement for adequate statistical power (≥80%) to reliably
Fig. 3. Eﬀects of intranasal oxytocin vs. placebo on theory of mind. Positive eﬀect sizes indicate improved theory of mind following oxytocin administration; negative eﬀect sizes indicate
reduced theory of mind following oxytocin administration. RMET = Reading the mind in the eyes test; MSCEIT = Mayer-Salovey-Caruso Emotional Intelligence Test; TASIT = The
Awareness of Social Inference Test; AN = anorexia nervosa; ASD = autism spectrum disorder; frontotemporal dementia = FTD.
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detect at least a medium sized eﬀect between the oxytocin and placebo
groups or conditions. None of the studies that used between subjects
design met the requirement for adequate power, but ﬁve of the studies
that used within subjects design did meet this requirement.
3.2. Eﬀects of oxytocin on interpretation of emotions
3.2.1. Theory of mind
Fourteen studies were included in the meta-analysis investigating
the eﬀects of a single dose of intranasal oxytocin on emotional theory of
mind (Fig. 3). Six of the studies included clinical populations, namely
individuals with ASD, AN, depression, schizophrenia, and FTD, and two
studies included individuals with substance dependence disorder,
including opioid and alcohol dependence. Overall, there was no
signiﬁcant eﬀect of oxytocin on theory of mind (ES = 0.09, Z = 1.14,
p = 0.256, 95% CI [−0.06, 0.24], k = 23, N of levels = 17). When the
healthy and clinical groups were inspected separately there was no
evidence of signiﬁcant eﬀect of intranasal oxytocin on emotional theory
of mind within either group (Healthy: ES = 0.07, Z = 0.76, p = 0.447,
95% CI [-0.10, 0.24], k = 13, N of levels = 9; Clinical: ES = 0.10,
Z = 0.74, p = 0.457, 95% CI [-0.17, 0.37], k = 10, N of levels = 8).
There was evidence of signiﬁcant between-study heterogeneity
(Q = 65.85, p< 0.0001, I2 = 58.42%), which was further explored
with meta-regressions. The ﬁndings from the meta-regressions were
corrected for multiple comparisons with Bonferroni correction (0.05/6)
and p< 0.008 was considered signiﬁcant. The meta-regressions re-
vealed a signiﬁcant moderator eﬀect of age (Qm= 7.33, p = 0.007;
Supplementary Fig. 1), still leaving some residual heterogeneity
(Qr = 34.26, p = 0.012). This ﬁnding suggests that younger partici-
pants showed greater oxytocin-induced improvement in emotional
theory of mind. The dose administered (Qm= 1.04, p = 0.309;
Supplementary Fig. 2), the type of task used (Qm= 2.78, p = 0.427),
the diagnostic group (Qm= 0.01, p = 0.918), and the proportion of
female participants in the sample (Qm= 1.36, p = 0.243;
Supplementary Fig. 3) did not signiﬁcantly explain the between-study
heterogeneity.
Begg’s rank correlation test of funnel plot asymmetry approached
signiﬁcance suggesting there may have been some publication bias
(T = 0.29, p = 0.057; Supplementary Fig. 4).
3.2.2. Recognition of basic emotions
Seventeen studies investigated the eﬀects of intranasal oxytocin on
total basic emotion recognition accuracy. Based on standardised
residuals and Cook’s distance, one study by Xu et al. (2015) was
identiﬁed as an extreme outlier (standardised res. = 2.68, Z = 4.56,
SE = 0.59; Supplementary Table 1; Supplementary Fig. 5). The impact
of the outlier on the meta-analysis was investigated by conducting a
meta-analysis with the outlier present, which yielded a signiﬁcant
oxytocin-induced improvement in recognition of basic emotions with a
small eﬀect size along with signiﬁcant between-study heterogeneity
(ES = 0.28, Z = 2.56, p = 0.011, 95% CI [0.07, 0.50], k = 33, N of
levels = 23, Q = 99.98, p< 0.0001, I2 = 81.12%). We then investi-
gated whether the outlier was signiﬁcantly diﬀerent from the other
studies by conducting a meta-regression, which revealed that the
outlier signiﬁcantly explained the between-study heterogeneity
(Qm= 46.98, p < 0.0001) leaving no signiﬁcant residual heteroge-
neity (Qr = 43.51, p = 0.067). Therefore, the outlier was removed
from further analysis.
Full meta-analysis was conducted with the remaining sixteen studies
(Fig. 4). Five of the studies included clinical populations, namely people
with schizophrenia, BPD, ASD, and post-traumatic stress disorder. The
meta-analysis revealed that intranasal oxytocin administration im-
proved overall basic emotion interpretation accuracy with a negligible
eﬀect size (ES = 0.18, Z = 3.09, p = 0.002, 95% CI [0.06, 0.29],
k = 32, N of levels = 22). When the eﬀects of intranasal oxytocin on
basic emotions recognition were further investigated within the healthy
and clinical populations, the results showed that oxytocin signiﬁcantly
improved basic emotion recognition among the healthy individuals
with a negligible eﬀect size (ES = 0.13, Z = 2.30, p = 0.022, 95% CI
[0.02, 0.24], k = 23, N of levels = 17). Among the mixed clinical
population oxytocin-induced improvement on basic emotion recogni-
tion approached signiﬁcance with a small eﬀect size (ES = 0.27,
Z = 1.82, p = 0.069, 95% CI [-0.02, 0.57], k = 9, N of levels = 5).
The between-study heterogeneity approached signiﬁcance
(Q = 42.08, p = 0.089, I2 = 30.27%), and was therefore, explored
further with meta-regressions. The ﬁndings from the meta-regressions
were corrected for multiple comparisons with Bonferroni correction
(0.05/7) and p< 0.007 was considered signiﬁcant. The proportion of
female participants in the sample (Qm= 1.34, p = 0.247;
Supplementary Fig. 6), the diagnostic group (Qm= 3.47, p = 0.482),
age (Qm= 0.67, p = 0.414; Supplementary Fig. 7), the dose adminis-
tered (Qm= 0.49, p = 0.486; Supplementary Fig. 8), the type of task
used (Qm= 1.32, p = 0.858), and the presence of ceiling eﬀects
(Qm= 1.48, p = 0.224) did not signiﬁcantly explain the between-
study heterogeneity.
Begg’s rank correlation test of funnel plot asymmetry did not reveal
signiﬁcant publication bias (T =−0.08, p = 0.506; Supplementary
Fig. 9). Rosenthal’s the ﬁle drawer analysis indicated a fail-safe N of
182, suggesting that 182 studies ﬁnding no signiﬁcant eﬀects of
oxytocin on recognition of basic emotions would be required to reduce
the observed eﬀects to null. This exceeds Rosenthal’s criterion for this
meta-analysis (5n+10=90) suggesting that the eﬀect was quite robust.
Since the total scores in most of the included studies did not consist
of all six basic emotions further meta-analyses were conducted to
examine if he above eﬀect was driven by a subset of basic emotions.
Thus, we conducted six additional meta-analyses to investigate the
eﬀects of a single dose of intranasal oxytocin on the recognition of
anger, fear, disgust, sadness, surprise, and happiness. Where possible
the studies were divided into healthy and clinical subgroups, which
were both inspected separately.
3.2.3. Recognition of anger
Ten studies investigated the eﬀects of intranasal oxytocin on
recognition of anger (Fig. 5). Two of these studies included people
with schizophrenia and BPD.
Overall, oxytocin administration did not signiﬁcantly improve
recognition of anger (ES = 0.05, Z = 1.03, p = 0.305, 95% CI
[−0.05, 0.15], k = 18, N of levels = 11). When the groups were
inspected separately, there was no signiﬁcant eﬀect of oxytocin on
recognition of anger within the healthy (ES = 0.04, Z = 0.71,
p = 0.476, 95% CI [−0.07, 0.14], k = 14, N of levels = 9) or clinical
groups (ES = 0.17, Z = 1.10, p = 0.275, 95% CI [−0.13, 0.47], k = 4,
N of levels = 2).
There was no evidence of signiﬁcant between-study heterogeneity
(Q = 21.16, p = 0.219, I2 = 3.45e-09%) There was also no evidence of
signiﬁcant publication bias on the Begg’s rank correlation test of funnel
plot asymmetry (T = 0.03, p = 0.881; Supplementary Fig. 10).
3.2.4. Recognition of fear
Nine studies investigated the eﬀects of intranasal oxytocin on
recognition of fear (Fig. 6). Two of the studies included people with
schizophrenia and BPD.
Overall, oxytocin administration signiﬁcantly improved recognition
of fear with a small eﬀect size (ES = 0.21, Z = 2.95, p = 0.003, 95% CI
[0.07, 0.34], k = 14, N of levels = 10). This eﬀect was driven by a
signiﬁcant oxytocin-induced improvement in recognition of fear among
the healthy individuals with a small eﬀect size (ES = 0.24, Z = 2.63,
p = 0.009, 95% CI [0.06, 0.41], k = 10, N of levels = 8). There was no
signiﬁcant eﬀect of oxytocin among the mixed clinical population
(ES = 0.16, Z = 1.05, p = 0.295, 95% CI [-0.14, 0.46]).
The between-study heterogeneity approached signiﬁcance
(Q = 19.95, p = 0.096, I2 = 20.92%) and was therefore explored
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Fig. 4. Eﬀect of oxytocin vs. placebo on overall basic emotion recognition. Positive eﬀect sizes indicate improved emotion recognition following oxytocin administration; negative eﬀect
sizes indicate reduced emotion recognition following oxytocin administration. HEDT: 30% = Hexagon emotion discrimination task: morphed faces 30% intensity; HEDT: 70%
= Hexagon emotion discrimination task: morphed faces 70% intensity; DANVA = Diagnostic Analysis of Non-Verbal Accuracy; ASD = Autism spectrum disorder; BPD = Borderline
personality disorder; PTSD = Post-traumatic stress disorder. Kirkpatrick et al., 2014: a = 20IU of intranasal oxytocin, b = 40IU of intranasal oxytocin. Campbell et al., 2014: a = young
female participants, Campbell et al., 2014: b = young male participants, Campbell et al., 2014: c = older female participants, Campbell et al., 2014: d = older male participants.
Fig. 5. Eﬀect of oxytocin vs. placebo on recognition of anger. Positive eﬀect sizes indicate improved recognition of anger following oxytocin administration; negative eﬀect sizes indicate
reduced recognition of anger following oxytocin administration. HEDT: 30%= Hexagon emotion discrimination task: morphed faces 30% intensity; HEDT: 70%= Hexagon emotion
discrimination task: morphed faces 70% intensity; BPD = Borderline personality disorder. Kirkpatrick et al., 2014: a = 20IU of intranasal oxytocin, b = 40IU of intranasal oxytocin.
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further with meta-regressions. The ﬁndings from the meta-regressions
were corrected for multiple comparisons with Bonferroni correction
(0.05/7) and p< 0.007 was considered signiﬁcant. The dose adminis-
tered (Qm= 4.19, p = 0.041; Supplementary Fig. 11), the proportion
of female participants in the sample (Qm= 0.23, p = 0.632;
Supplementary Fig. 12), the presence of ceiling eﬀects (Qm= 0.05,
p = 0.831), age (Qm= 2.56, p = 0.109; Supplementary Fig. 13), the
type of task used (Qm= 0.78, p = 0.676), and the diagnostic group
(Qm= 0.90, p = 0.638) did not signiﬁcantly explain the between-
study heterogeneity.
There was no evidence of signiﬁcant publication bias on the Begg’s
rank correlation test of funnel plot asymmetry (T =−0.08, p = 0.747;
Supplementary Fig. 14). Rosenthal’s ﬁle drawer analysis revealed a fail-
safe N of 59, suggesting that 59 additional studies reporting no eﬀect of
oxytocin would be needed to reduce the observed eﬀect to null. This
exceeds Rosenthal’s criterion for this meta-analysis (5n+10 = 55),
suggesting the eﬀect was quite robust.
3.2.5. Recognition of disgust
Four studies investigated the eﬀects of oxytocin on the recognition
of disgust (Fig. 7). Because only one of these studies included clinical
populations, namely people with schizophrenia, it was not possible to
investigate the eﬀects of oxytocin separately within the healthy and
clinical populations. Thus, the data was analysed across groups.
The meta-analysis showed a negligible oxytocin-induced improve-
ment in the recognition of disgust, which approached signiﬁcance
(ES = 0.18, Z = 1.73, p = 0.083, 95% CI [-0.02, 0.39], k = 5, N of
levels = 4).
There was no evidence of signiﬁcant between-study heterogeneity
(Q = 2.07, p = 0.722, I2 = 2.73e-08%).
There was no evidence of signiﬁcant publication bias on the Begg’s
rank correlation test of funnel plot asymmetry (T = 0.20, p = 0.817;
Supplementary Fig. 15).
3.2.6. Recognition of sadness
Seven studies investigated the eﬀects of oxytocin on the recognition
of sadness (Fig. 8). As above, since only one study included a clinical
group, people with schizophrenia, the meta-analysis was conducted
across groups.
The meta-analysis revealed no signiﬁcant eﬀects of oxytocin on the
recognition of sadness (ES = 0.04, Z = 0.53, p = 0.594, 95% CI [-0.10,
0.17]). There was also no signiﬁcant between-study heterogeneity
(Q = 7.59, p = 0.474, I2 = 16.67%).
There was no evidence of signiﬁcant publication bias on the Begg’s
rank correlation test of funnel plot asymmetry (T = 0.33, p = 0.260;
Supplementary Fig. 16).
3.2.7. Recognition of surprise
Four studies investigated the eﬀects of oxytocin on the recognition
of surprise (Fig. 9). Since only one study included a clinical group,
people with schizophrenia, the meta-analysis was conducted across
groups.
The meta-analysis revealed no signiﬁcant eﬀect of oxytocin on the
recognition of surprise (ES =−0.02, Z =−0.16, p = 0.874, 95% CI
[-0.22, 0.19], k = 5, N of levels = 4). There was also no evidence of
signiﬁcant between-study heterogeneity (Q = 3.72, p = 0.445,
I2 = 1.90e-08%)
There was no evidence of signiﬁcant publication bias on Begg’s rank
correlation test of funnel plot asymmetry (T = 0.20, p = 0.817;
Supplementary Fig. 17).
3.2.8. Recognition of happiness
Twelve studies investigated the eﬀects on intranasal oxytocin on the
recognition of happiness. Following inspection of the standardised
residuals and Cook’s distance one study by Xu et al. (2015) was
identiﬁed as an extreme outlier (standardised res. = 2.83, Z = 3.27,
SE = 0.87; Supplementary Table 2, Supplementary Fig. 18). The meta-
analysis with the outlier present yielded no signiﬁcant eﬀect of oxytocin
on the recognition of happiness, but there was signiﬁcant between-
study heterogeneity (ES = 0.31, Z = 1.26, p = 0.207, 95% CI [-0.17,
0.79], k = 20, N of levels = 12, Q = 93.93, p< 0.0001,
I2 = 93.34%). A meta-regression revealed that the outlier signiﬁcantly
Fig. 6. Eﬀects of oxytocin vs. placebo on recognition of fear. Positive eﬀect sizes indicate improved recognition of fear following oxytocin administration; negative eﬀect sizes indicate
reduced recognition of fear following oxytocin administration. HEDT: 30%= Hexagon emotion discrimination task: morphed faces 30% intensity; HEDT: 70%= Hexagon emotion
discrimination task: morphed faces 70% intensity.
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explained the between-study heterogeneity (Qm= 51.44, p< 0.0001)
leaving no signiﬁcant residual heterogeneity (Qr = 28.36, p = 0.057).
Therefore, the outlier was removed from further analysis.
The eleven remaining studies were included in the ﬁnal meta-
analysis (Fig. 10). Two of the studies included clinical groups, people
with schizophrenia and BPD. Overall, oxytocin did not signiﬁcantly
improve the recognition of happiness (ES = 0.08, Z = 1.07, p = 0.284,
95% CI [-0.07, 0.23], k = 19, N of levels = 12). When the healthy and
clinical groups were inspected separately, there were no diﬀerential
eﬀects among the healthy (ES = 0.10, Z = 1.18, p = 0.237, 95% CI
[-0.06, 0.26], k = 15, N of levels = 10), or mixed clinical populations
(ES =−0.07, Z =−0.23, p = 0.821, 95% CI [-0.72, 0.57]).
The between-study heterogeneity approached signiﬁcance
(Q = 27.87, p = 0.064, I2 = 33.62%) and was explored further with
meta-regressions. The ﬁndings from the meta-regressions were cor-
rected for multiple comparisons with Bonferroni correction (0.05/7)
and p< 0.007 was considered signiﬁcant. The type of task used
(Qm= 11.36, p = 0.010), the proportion of female participants in
the sample (Qm= 0.84, p = 0.360; Supplementary Fig. 19), age
(Qm= 0.07, p = 0.789; Supplementary Fig. 20), the dose administered
Fig. 7. Eﬀect of oxytocin vs. placebo on recognition of disgust. Positive eﬀect sizes indicate improved recognition of disgust following oxytocin administration; negative eﬀect sizes
indicate reduced recognition of disgust following oxytocin administration. HEDT: 30% = Hexagon emotion discrimination task: morphed faces 30% intensity; HEDT: 70% = Hexagon
emotion discrimination task: morphed faces 70% intensity; BPD = Borderline personality disorder. Kirkpatrick et al., 2014: a = 20IU of intranasal oxytocin, b = 40IU of intranasal
oxytocin.
Fig. 8. Eﬀect of oxytocin vs. placebo on recognition of sadness. Positive eﬀect sizes indicate improved recognition of sadness following oxytocin administration; negative eﬀect sizes
indicate reduced recognition of sadness following oxytocin administration. HEDT: 30% = Hexagon emotion discrimination task: morphed faces 30% intensity; HEDT: 70% = Hexagon
emotion discrimination task: morphed faces 70% intensity. Kirkpatrick et al., 2014: a = 20IU of intranasal oxytocin, b = 40IU of intranasal oxytocin.
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(Qm = 2.67, p = 0.103; Supplementary Fig. 21), the diagnostic group
(Qm= 2.84, p = 0.242), and the presence of ceiling eﬀects
(Qm = 3.29, p = 0.070), did not signiﬁcantly explain the between-
study heterogeneity.
There was no evidence of signiﬁcant publication bias on the Begg’s
rank correlation test of funnel plot asymmetry (T =−0.13, p = 0.447;
Supplementary Fig. 22).
3.2.9. Emotion recognition sensitivity
Three studies investigated the eﬀects of intranasal oxytocin on
emotion recognition sensitivity (Fig. 11). Because only one of these
studies included clinical groups, people with AN and BN, the meta-
analysis was conducted across groups.
Overall, intranasal oxytocin did not signiﬁcantly inﬂuence emotion
recognition sensitivity (ES =−0.14, Z =−1.45, p = 0.146, 95% CI
Fig. 9. Eﬀect of oxytocin vs. placebo on recognition of surprise. Positive eﬀect sizes indicate improved recognition of surprise following oxytocin administration; negative eﬀect sizes
indicate reduced recognition of surprise following oxytocin administration. HEDT: 30% = Hexagon emotion discrimination task: morphed faces 30% intensity; HEDT: 70% = Hexagon
emotion discrimination task: morphed faces 70% intensity.
Fig. 10. Eﬀect of oxytocin vs. placebo on recognition of happiness. Positive eﬀect sizes indicate improved recognition of happiness following oxytocin administration; negative eﬀect sizes
indicate reduced recognition of happiness following oxytocin administration. HEDT: 30% = Hexagon emotion discrimination task: morphed faces 30% intensity; HEDT: 70% = Hexagon
emotion discrimination task: morphed faces 70% intensity; BPD = Borderline personality disorder. Kirkpatrick et al., 2014: a = 20IU of intranasal oxytocin, b = 40IU of intranasal
oxytocin.
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[-0.34, 0.05], k = 20, N of levels = 5). We then investigated recogni-
tion sensitivity of each emotion separately and found that oxytocin did
not signiﬁcantly improve the sensitivity to recognise happiness
(ES =−0.11, Z =−1.24, p = 0.216, 95% CI [-0.29, 0.07], k = 5, N
of levels = 5), sadness (ES =−0.17, Z =−1.25, p = 0.212, 95% CI
[-0.43, 0.09], k = 5, N of levels = 5), fear (ES =−0.03, Z =−0.42,
p = 0.674, 95% CI [-0.20, 0.13], k = 5, N of levels = 5), or anger
(ES =−0.20, Z =−1.64, p = 0.100, 95% CI [-0.43, 0.04], k = 5, N
of levels = 5).
The between-study heterogeneity approached signiﬁcance
(Q = 29.31, p = 0.061, I2 = 67.31%) and was explored further with
meta-regressions. The ﬁndings from the meta-regressions were cor-
rected for multiple comparisons with Bonferroni correction (0.05/5)
and p< 0.01 was considered signiﬁcant. The proportion of female
participants in the sample (Qm= 0.03, p = 0.864; Supplementary
Fig. 23), age (Qm= 1.27, p = 0.261; Supplementary Fig. 24), the dose
administered (Qm= 0.03, p = 0.864; Supplementary Fig. 25), and the
diagnostic group (Qm= 2.03, p = 0.567) did not signiﬁcantly explain
the heterogeneity.
Begg’s rank correlation test of funnel plot asymmetry revealed
evidence of signiﬁcant publication bias (T =−0.74, p< 0.0001;
Supplementary Fig. 26) indicating that small studies ﬁnding larger
eﬀects were more likely to be published.
3.3. Eﬀects of oxytocin on emotion expression
Four studies investigated the eﬀects of a single dose of intranasal
oxytocin on expression of congruent emotions in response to emotion-
ally provoking stimuli (Fig. 12). Three studies included individuals with
clinical conditions, including BPD, Schizophrenia, and AN.
Overall, there was no signiﬁcant eﬀect of oxytocin on emotion
expression (ES = 0.08, Z = 0.87, p = 0.385, 95% CI [-0.10, 0.26],
k = 14, N of levels = 7). When the data was further inspected, the
meta-analysis showed that oxytocin signiﬁcantly increased the expres-
sion of positive emotions among the healthy individuals with a small
eﬀect size (ES = 0.25, Z = 2.29, p = 0.022, 95% CI [0.04, 0.47],
k = 4, N of levels = 4). Oxytocin did not signiﬁcantly inﬂuence the
expression of negative emotions among the healthy individuals
(ES = 0.10, Z = 0.55, p = 0.585, 95% CI [−0.27, 0.47], k = 4, N of
levels = 4). There was also no evidence of signiﬁcant eﬀects of
oxytocin on the expression of positive or negative emotions among
the clinical populations (Positive ES = 0.02, Z = 0.13, p = 0.896, 95%
CI [−0.22, 0.25], k = 3, N of levels = 3; Negative: ES =−0.08, Z
−0.35, p = 0.726, 95% CI [−0.52, 0.36], k = 3, N of levels = 3).
There was signiﬁcant between-study heterogeneity (Q = 23.14,
p = 0.040, I2 = 35.95%), which was explored further with meta-
regressions. The proportion of female participants in the sample, age,
and the dose administered individually signiﬁcantly explained the
heterogeneity (Supplementary Figs. 27–29). These variables were, thus,
entered into a full model which signiﬁcantly explained the between-
study heterogeneity (Qm= 8.80, p = 0.032) leaving no signiﬁcant
residual heterogeneity (Qr = 14.33, p = 0.158). This ﬁnding suggests
that older male participants who received 24IU of intranasal oxytocin
showed greater oxytocin induced increase in facial expressivity.
However, this meta-analysis consisted of only four studies and, thus,
this ﬁnding should be interpreted with caution. The diagnostic group
(Qm= 6.14, p = 0.105)did not signiﬁcantly explain the heterogeneity.
There was no evidence of signiﬁcant publication bias on the Begg's
rank correlation test of funnel plot asymmetry (T =−0.03, p = 0.915;
Supplementary Fig. 30). However, Rosenthal’s ﬁle drawer analysis
revealed a fail-safe N of 1, indicating that only 1 study ﬁnding no
signiﬁcant eﬀects of oxytocin on emotion expression would be needed
to reduce the observed signiﬁcant eﬀect to null. This does not exceed
the Rosenthal’s criterion for this meta-analysis (5k+10 = 30) indicat-
ing that this ﬁnding is not robust and there is likely to be substantial
publication bias present.
4. Discussion
The aim of the current meta-analytic review was to investigate the
Fig. 11. Eﬀect of oxytocin vs. placebo on emotion recognition sensitivity. Negative eﬀect sizes indicate improved emotion recognition sensitivity following oxytocin administration;
positive eﬀect sizes indicate reduced emotion recognition sensitivity following oxytocin administration. All studies used dynamic emotion recognition task. BN = Bulimia nervosa,
AN = Anorexia nervosa.
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eﬀects of a single dose of intranasal oxytocin on interpretation and
expression of emotions among healthy and clinical populations. Most
the studies recruited only healthy individuals, but thirteen studies also
included people with clinical disorders and two studies included people
with substance dependence disorder. The meta-analyses revealed that a
single dose of intranasal oxytocin signiﬁcantly improved the recogni-
tion of basic emotions, particularly fear, but only among healthy
individuals with small to negligible eﬀect sizes. Oxytocin also increased
the expression of positive emotions with a small eﬀect size among the
healthy individuals. Intranasal oxytocin did not signiﬁcantly inﬂuence
theory of mind among the healthy individuals. Although, the oxytocin-
induced improvement in basic emotion recognition approached sig-
niﬁcance, overall there were no signiﬁcant eﬀects on intranasal
oxytocin on the interpretation or expression of emotions among the
mixed clinical population.
The oxytocin-induced increase in the expression of positive emo-
tions in healthy individuals is in line with ﬁndings from previous
systematic reviews and suggests that oxytocin plays an important role
in facilitating prosocial behaviour in humans (Bakermans-Kranenburg
and van Ijzendoorn, 2013; Churchland and Winkielman, 2012;
Guastella and MacLeod, 2012). This ﬁnding is also supported by
previous work that has documented increased trust and cooperation
particularly towards the members of a safe “in-group” following
oxytocin administration (van Ijzendoorn and Bakermans-Kranenburg,
2012). Together these ﬁndings suggest that oxytocin may facilitate pro-
social behaviour among healthy individuals. However, it is of impor-
tance to note that the oxytocin-induced increase in the expression of
positive emotions was not robust, and it is likely that there was
substantial publication bias present.
The present ﬁndings also showed that intranasal oxytocin improved
recognition of basic emotions, which appeared to be largely driven by
oxytocin-induced signiﬁcant improvement in fear recognition and
nearly signiﬁcant improvement in disgust recognition. These results
may seem surprising in this light of the ﬁndings above. However, these
results are in line with a previous meta-analysis, which also found that
intranasal oxytocin improved early recognition of angry faces and late
recognition of fearful faces among healthy individuals (Shahrestani
et al., 2013). Additionally, intranasal oxytocin has also been found to
increase attention and approach towards negative social-emotional
stimuli, such as angry and fearful facial expressions (Clark-Elford
et al., 2015; Simon et al., 2012; Tollenaar et al., 2013).
Recent systematic reviews have attempted to explain the recent
emergence of similar seemingly contradictory ﬁndings by suggesting
that the eﬀects of intranasal oxytocin may be modulated by social
boundaries (Olﬀ et al., 2013; Zik and Roberts, 2015). This hypothesis
suggests that oxytocin may be of evolutionary importance in social
interactions, increasing pro-social behaviour towards “safe” stimuli and
defensiveness towards “unsafe” stimuli (Olﬀ et al., 2013; Zik and
Roberts, 2015). Thus, when faced with positive social-emotional cues
oxytocin may facilitate pro-social behaviour, trust, and cooperation.
Conversely, when presented with unfamiliar or negative stimuli
oxytocin administration may increase attention and alertness towards
these potentially threatening, negative social-emotional cues. Although
this hypothesis has not been previously linked to the eﬀects of oxytocin
on social-emotional processing, it is consistent with the present ﬁndings
and is supported by several behavioural studies using investment and
trust games. These studies have documented that intranasal oxytocin
increases empathy towards “in-group” members as well as cooperation
and compliance within the “in-group” (De Dreu and Kret, 2016; Ten
Velden et al., 2017). Oxytocin also reduced cooperation with “out-
group” members even when the “out-group” members are generous
towards the participants (Daughters et al., 2017).
Although, the oxytocin-induced improvement in basic emotion
recognition approached signiﬁcance, overall the present series of
meta-analyses found no signiﬁcant oxytocin-induced changes in inter-
pretation or expression of emotions among the mixed clinical popula-
tion. One possible explanation is that the diﬀerent disorders included in
the mixed clinical group were too heterogeneous and that there were
too few studies with the same disorder group to draw ﬁrm conclusions.
Indeed, there was signiﬁcant heterogeneity between the diagnostic
groups in the present series of meta-analyses. However, there were also
substantial diﬀerences in eﬀect size estimates between studies that
Fig. 12. Eﬀect of oxytocin vs. placebo on emotion expression. Positive eﬀect sizes indicate increased emotion expression following oxytocin administration; negative eﬀect sizes indicate
reduced emotion expression following oxytocin administration. IAPS = International aﬀective picture system; AN = anorexia nervosa; BPD = Borderline personality disorder.
J. Leppanen et al. 1HXURVFLHQFHDQG%LREHKDYLRUDO5HYLHZV²

included patient groups with the same diagnosis, suggesting that there
may be individual diﬀerences within the diagnostic groups that
modulate the eﬀects of oxytocin.
Large-scale cohort studies have documented that clinical popula-
tions have inter-individual variability with substantial heterogeneity in
types of comorbidity and aetiological risk (Lamers et al., 2010; Melartin
et al., 2002; Sterling et al., 2008; Wessman et al., 2009). A few recent
systematic reviews have also suggested that the eﬀects of oxytocin on
social-emotional functioning may be moderated by contextual and
individual diﬀerences (Bartz et al., 2011; Olﬀ et al., 2013). Factors
such as attachment style and experience of early parental care have
been found to moderate the eﬀects of oxytocin; those scoring low on
attachment avoidance and harsh parenting showed greater oxytocin-
induced increase in social cooperation and positive response to crying
infants (Bakermans-Kranenburg et al., 2011; Fang et al., 2014; Olﬀ
et al., 2013). Thus, further investigation of potential contextual and
individual diﬀerences that may modulate the eﬀects of oxytocin is of
interest.
4.1. Limitations, recommendations and future directions
The majority of the studies included in the present review did not
meet the sample size requirement for adequate statistical power to
reliably detect at least a moderate eﬀect of the drug. Although meta-
analyses are a powerful method to pool studies and increase statistical
power (Greco et al., 2013), it is important that individual studies also
have adequate power. This has been suggested to be a particularly big
problem in oxytocin research and the potential source of the wide range
of diﬀerent and sometimes contradictory ﬁndings arising from diﬀerent
studies (Walum et al., 2016). These problems may go some way to
explain the between-study heterogeneity and publication bias in the
present review. Therefore, we recommend that future studies should
recruit much larger number of participants to ensure that reliable
eﬀects of intranasal oxytocin can be detected.
Several studies investigating the eﬀects of a single dose of intranasal
oxytocin on recognition of basic emotions had evidence of ceiling
eﬀects with mean accuracy percentages over 85%. Even though
presence of ceiling eﬀects did not have signiﬁcant impact on the
present ﬁndings, such eﬀects make it diﬃcult to ﬁnd the true eﬀect
of the drug or intervention because performance is already at max-
imum. Future studies investigating the eﬀects of intranasal oxytocin on
the recognition of basic emotions, should opt for alternative tasks, for
example presenting images where the emotion is less than 100%
present.
Six of the meta-analyses in the present review had evidence of
between-study heterogeneity and in four of them we were unable to
identify the source of the heterogeneity. Previous studies have reported
several confounding factors such as individual diﬀerences in anxiety
and attachment security that can inﬂuence the eﬀects of oxytocin on
social-emotional processing (Bakermans-Kranenburg et al., 2011; Fang
et al., 2014; Olﬀ et al., 2013). The impact of these factors were not
explored or reported in majority of the studies included in the present
review meaning that it was not possible for us to explore the impact of
these factors had on the meta-analyses. We recommend that future
studies explore the impact of individual diﬀerences to gain better
understanding of the impact of potential confounding factors on the
eﬀects of intranasal oxytocin.
Finally, there has recently been some doubt regarding the eﬀects of
intranasal oxytocin on social-emotional functioning in general and
criticism directed at the lack of compelling theoretical framework to
explain the contradictory ﬁndings reported thus far (Lane et al., 2016;
Leng and Ludwig, 2016). Some important questions have also been
raised regarding if and how intranasal oxytocin accesses the brain and
in what quantities (Leng and Ludwig, 2016). These criticisms have
become increasingly important to address in the light of recent
replication failures (Lane et al., 2015; Radke and de Bruijn, 2015).
We have taken some steps in the present review to introduce a potential
theoretical framework, but several issues still remain unanswered. For
instance, there are a number of methodological obstacles, such as
individual diﬀerences in the nasal cavity physiology, the nasal spray
formulations used, and the devices used to deliver the drug, that need to
be considered (Quintana et al., 2016). Furthermore, there are uncer-
tainties regarding the site and mechanism of action of exogenous
intranasal oxytocin in humans due to lack of suitable radio tracers
(Paloyelis et al., 2016). There has also been some suggestion that
oxytocin has important eﬀects in the periphery, moderating cardiovas-
cular functioning and the peripheral cortisol response, which may
inﬂuence social behaviour (Cardoso et al., 2014b; Gutkowska et al.,
2014). Further research is needed to answer these important questions
particularly if oxytocin is to be used as a treatment enhancer to support
clinical care.
5. Conclusions
The current meta-analytic review pooled studies investigating the
eﬀects of a single dose of intranasal oxytocin on social-cognition. There
was no signiﬁcant eﬀect of intranasal oxytocin on interpretation or
expression of emotions among the mixed clinical population. Intranasal
oxytocin signiﬁcantly improved recognition of basic emotions, particu-
larly fear, and increased the expression of positive emotions, but only
among the healthy individuals. These ﬁndings are in line with previous
work that has found that the eﬀects of oxytocin may be modulated by
social boundaries. Further large-scale research is needed to better
understand of the role of intranasal oxytocin in social-emotional
processing and potential moderators of its’ eﬀects.
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Supplementary	 Figure	18.	Cook’s	Distance	plot	of	 all	 studies	 initially	 included	 in	 the	meta-analysis	



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































food	 restriction	 in	 people	 with	 eating	 disorders	 (Engel	 et	 al.,	 2013;	 Lavender	 et	 al.,	 2013).	 These	
findings	have	led	to	the	suggestion	that	eating	disorder	behaviours	may	be	compensatory	mechanisms	
used	to	cope	with	negative	emotions	(Haynos	and	Fruzzetti,	2011;	Brockmeyer	et	al.,	2012).	However,	




on	 eating	 behaviour.	 The	 findings	 from	 the	 experimental	 studies	 corroborate	 findings	 from	 the	
ecological	momentary	assessments	suggesting	that	negative	mood	increases	caloric	consumption	in	
people	with	binge	eating	forms	of	eating	disorders	as	well	as	in	people	at	risk	of	developing	eating	
























using	 a	wide	 range	 of	 different	 experimental	 paradigms	 and	 only	 two	 studies	 investigated	 neural	
responses	to	facial	affect	(McAdams	and	Smith,	2015).	A	study	by	Fonville	et	al.	(2014)	found	increased	
activation	 of	 the	 fusiform	 gyrus	 in	 people	 with	 AN	 while	 viewing	 positive	 facial	 expressions	 of	
increasing	 intensity.	 Cowdrey	 et	 al.	 (2012),	 on	 the	 other	 hand,	 found	 no	 significant	 differences	 in	













disorders,	common	comorbid	disorders	 in	AN,	has	demonstrated	anomalies	 in	neural	 responses	to	
infant	emotion	(Baeken	et	al.,	2010;	Schechter	et	al.,	2012;	Wonch	et	al.,	2016).	Relative	to	healthy	
individuals,	people	with	depression	and	PTSD	show	elevated	emotional	reactivity	in	regions	such	as	
the	 amygdala	 and	 insula,	 as	 well	 as	 increased	 recruitment	 of	 regions	 associated	 with	 emotion	
regulation,	 including	 the	PFC,	 in	 response	 to	 infant	emotion	 (Baeken	et	al.,	2010;	Schechter	et	al.,	












in	 these	 regions.	 A	 wealth	 of	 neuroimaging	 studies	 among	 healthy	 individuals	 has	 documented	
increased	activation	of	prefrontal	and	amygdala	 regions	while	viewing	negative	and	 threat-related	







and	 amygdala	 activation	 in	 response	 to	 positive	 social-emotional	 cues,	 such	 as	 smiling	 faces	 and	
positive	infant	stimuli	(Grimm	et	al.,	2008;	Jaworska	et	al.,	2015;	Wonch	et	al.,	2016).	Taken	together,	
it	 is	 possible	 that	 people	with	 AN	may	 react	 to	 positive	 infant	 stimuli	 as	 though	 it	 is	 negative	 or	
threatening,	while	failing	to	respond	appropriately	to	negative	adult	social-emotional	cues.		
	
Relative	to	the	healthy	comparison	participants,	 the	AN	group	also	had	 increased	activation	 in	 the	
posterior	insula	in	response	to	happy	adult	faces	and	negatively	valenced	infant	faces.	Among	healthy	






and	 Fukudo,	 2013).	 These	 findings	 have	been	 suggested	 to	 indicate	 atypical	 elevated	distress	 and	
sympathetic	arousal	(Schechter	et	al.,	2012;	Kano	and	Fukudo,	2013).	Taken	together,	people	with	AN	




Preclinical	 studies	 have	 suggested	 that	 the	 neuropeptide	 oxytocin	 plays	 a	 role	 in	 several	 distinct	
functions,	including	stress	and	threat	processing,	and	social	functioning	(Onaka,	2004;	Yoshida	et	al.,	
2009;	Onaka	et	al.,	2012).	These	findings	have	sparked	a	great	deal	of	interest	in	examining	the	effect	
of	 intranasally	 delivered	 oxytocin	 among	 humans,	 particularly	 among	 those	 with	 disorders	
232	
	






























significant	effects	of	oxytocin	on	 subjective	anxiety	or	mood	 (Alvares	et	al.,	 2012;	Churchland	and	
Winkielman,	 2012).	 Additionally,	 considering	 the	 close	 relationship	 between	 mood	 and	 eating	






















increase	 in	 the	startle	 response	 to	 threat	among	healthy	people.	Contextual	 factors	and	 individual	
differences	 have	 been	 previously	 suggested	 to	 be	 important	 factors	 influencing	 the	 effects	 of	
intranasal	oxytocin	in	humans	(Bartz	et	al.,	2011;	Olff	et	al.,	2013).	Indeed,	other	behavioural	studies	




to	 food	 images	 in	AN,	do	not	 seem	 to	 translate	 to	 improvements	 in	 self-reported	mood	or	eating	
behaviour	(Kim	et	al.,	2014a).	Although	further	exploration	of	the	effects	of	oxytocin	on	threat-related	








Finally,	 the	 findings	 in	 this	 thesis	 demonstrate	 that	 intranasal	 oxytocin	 does	 not	 appear	 to	 have	
substantial	effects	on	social-emotional	processing	in	the	AN	or	HC	group	(Figure	3).	Our	second	meta-
analytic	review	found	that	intranasal	oxytocin	did	not	significantly	improve	theory	of	mind,	sensitivity	





















as	 on	 the	 treatment	 of	 AN.	 A	 number	 of	 theoretical	models	 of	 AN	 highlight	 the	 role	 of	 elevated	
negative	mood,	 anxiety,	 and	 threat	 sensitivity	 as	 important	predisposing	 and	maintenance	 factors	
(Connan	et	al.,	2003;	Hatch	et	al.,	2010;	Treasure	and	Schmidt,	2013;	Treasure	and	Cardi,	2017).	The	
models	suggest	that	prior	to	the	onset	of	full	illness	people	with	AN	show	elevated	sensitivity	to	stress	











was	no	significant	change	 in	self-reported	anxiety	or	 smoothie	 intake.	Similarly,	a	 longer	pilot	 trial	
found	 that	 although	 repeated	 administration	 of	 oxytocin	 reduced	 salivary	 cortisol,	 there	 was	 no	
significant	change	in	subjective	anxiety	or	eating	behaviour	in	inpatients	with	AN	(Russell	et	al.,	2013).	
These	 findings	 suggest	 that	 there	 may	 be	 a	 general	 disconnect	 between	 physiological	 state	 and	
subjective	experience	and	behaviour	in	AN.	This	notion	is	supported	by	findings	that	people	with	AN	
show	high	alexithymia	and	have	difficulties	detecting	and	interpreting	physiological	signals	of	hunger	

















reactions	to	 infant	emotional	display	can	have	profoundly	negative	 impact	on	the	 infant	(Feldman,	
2007,	 2012).	 A	 good	 example	 of	 this	 is	 the	 famous	 still-face	 paradigm,	 which	 demonstrated	 the	
distressing	effect	of	 blunted	 facial	 response	has	on	an	 infant	 (Weinberg	 and	Tronick,	 1994).	 Thus,	
interventions	targeting	anomalies	in	social-emotional	processing	in	AN	are	of	importance.		
	
Finally,	 the	 findings	 presented	 here	 highlight	 the	 importance	 of	 further	 exploring	 the	 impact	 of	
contextual	 factors	 and	 individual	 differences	 on	 the	 effects	 of	 intranasal	 oxytocin	 in	 healthy	 and	
clinical	populations.	Particularly	if	intranasal	oxytocin	is	to	be	considered	as	a	potential	treatment	in	
psychiatric	disorders	in	general,	it	is	of	importance	to	establish	how	certain	contextual	cues	can	cause	
the	 effects	 of	 oxytocin	 to	 become	 counterproductive.	 Furthermore,	 some	 experimental	 work	 has	
already	 documented	 that	 individual	 differences	 in	 early	 experiences	 can	 influence	 the	 effects	 of	
239	
	
oxytocin,	 with	 those	 without	 attachment	 difficulties	 showing	 more	 positive	 effects	 of	 oxytocin	
(Bakermans-Kranenburg	et	al.,	2011;	Fang	et	al.,	2014).	Furthermore,	people	who	have	experienced	
childhood	trauma	have	been	documented	to	have	reduced	levels	of	CSF	oxytocin	and	anomalies	in	
oxytocin	 response	 to	 stress	 (Heim	 et	 al.,	 2008;	 Pierrehumbert	 et	 al.,	 2010).	 Considering	 many	
individuals	with	AN	or	other	psychiatric	disorders	report	high	incidence	of	insecure	attachment	and	














sources	 of	 heterogeneity,	 such	 as	 AN	 subtypes,	 effect	 of	 anti-depressant	 medication	 on	 neural	








unable	 to	 accurately	 identify	 the	 gender	 of	 the	 infant	 faces.	 The	 participants	 in	 Chapter	 4	 were	
informed	that	the	task	was	difficult	and	the	main	point	was	to	attend	to	the	stimuli	and	not	spend	too	
much	time	on	the	gender	 identification	task.	Still	 it	 is	possible	that	such	a	difficult	 task	could	have	
impacted	the	results.	Additionally,	the	difference	in	task	performance	was	the	primary	reason	we	were	
not	able	to	statistically	compare	neural	responses	to	positively	valenced	adult	and	infant	faces	in	the	











the	Mind	 in	 the	Eyes	 task	 also	 requires	participants	 to	be	 very	proficient	 in	 English	 and	pay	 great	
attention	to	detail.	As	people	with	AN	show	detail	focus	at	the	cost	of	the	bigger	picture	(Lang	et	al.,	






















It	 is	 also	 possible	 that	 the	 effects	 of	 intranasal	 oxytocin	 on	 the	 various	 tasks	 was	 influenced	 by	
individual	differences,	such	as	alexithymia	or	attachment	style.	Previous	work	has	found	that	these	
factors	 influence	 the	 effects	 of	 intranasal	 oxytocin	 on	 tasks	 assessing	 various	 aspects	 of	 social	
cognition	(Bakermans-Kranenburg	et	al.,	2011;	Luminet	et	al.,	2011;	Fang	et	al.,	2014).	Furthermore,	
recent	 theoretical	models	have	 suggested	 that	 the	effects	of	oxytocin	 could	also	be	 influenced	by	
social	boundaries,	the	formation	of	which	is	likely	impacted	by	individual	differences	in	attachment	
style	and	previous	experiences	(Olff	et	al.,	2013;	Zik	and	Roberts,	2015).	As	such	individual	differences	

















The	systematic	 reviews	also	 included	 few	studies	with	clinical	groups.	 Indeed,	 the	conclusion	 from	






Finally,	 all	 studies	 included	 in	 this	 thesis	 focused	 on	 examining	 cross-sectional	 differences.	 Cross-
sectional	studies	allow	examination	of	multiple	outcomes	and	generation	of	further	hypotheses,	but	




















not	 have	 substantial	 effects	 on	 social-emotional	 processing	 in	 general	 among	 healthy	 or	 clinical	
populations.	 Although	 further	 research	 is	 still	 needed,	 taken	 together,	 these	 findings	 suggest	 that	
intranasal	oxytocin	may	not	be	a	useful	 in	 the	 treatment	of	AN.	The	 findings	 in	 this	 thesis	 further	
suggest	that	although	physiological	stress	is	 likely	to	contribute	to	core	eating	disorder	behaviours,	
interventions	focusing	solely	on	reducing	stress	hormone	 levels	are	unlikely	to	produce	substantial	
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Appendices		
10.1 Eating	Disorders	Examination	Questionnaire	(EDEQ)	
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10.2 Depression,	Anxiety,	and	Stress	Scale	(DASS)	
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10.3 Autism	Spectrum	Quotient	(short	version;	AQ-10)	
	
